AU679350B2 - Arthropodicidal tetrahydropyrimidines - Google Patents
Arthropodicidal tetrahydropyrimidines Download PDFInfo
- Publication number
- AU679350B2 AU679350B2 AU19134/95A AU1913495A AU679350B2 AU 679350 B2 AU679350 B2 AU 679350B2 AU 19134/95 A AU19134/95 A AU 19134/95A AU 1913495 A AU1913495 A AU 1913495A AU 679350 B2 AU679350 B2 AU 679350B2
- Authority
- AU
- Australia
- Prior art keywords
- pyr
- group
- independently selected
- optionally substituted
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000005326 tetrahydropyrimidines Chemical class 0.000 title description 5
- -1 CI-CIO alkylthio Chemical group 0.000 claims description 144
- 150000001875 compounds Chemical class 0.000 claims description 111
- 125000001424 substituent group Chemical group 0.000 claims description 35
- 239000000203 mixture Substances 0.000 claims description 31
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 25
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 21
- 125000003545 alkoxy group Chemical group 0.000 claims description 19
- 229910052799 carbon Inorganic materials 0.000 claims description 18
- 229910052736 halogen Inorganic materials 0.000 claims description 17
- 150000002367 halogens Chemical class 0.000 claims description 17
- 229910052757 nitrogen Inorganic materials 0.000 claims description 15
- 125000003118 aryl group Chemical group 0.000 claims description 12
- 125000004414 alkyl thio group Chemical group 0.000 claims description 11
- 125000001188 haloalkyl group Chemical group 0.000 claims description 11
- 241000238421 Arthropoda Species 0.000 claims description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 8
- 125000003342 alkenyl group Chemical group 0.000 claims description 7
- 125000005842 heteroatom Chemical group 0.000 claims description 7
- 125000001624 naphthyl group Chemical group 0.000 claims description 7
- 229910052717 sulfur Inorganic materials 0.000 claims description 7
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 125000004076 pyridyl group Chemical group 0.000 claims description 6
- 239000011593 sulfur Substances 0.000 claims description 6
- 125000006374 C2-C10 alkenyl group Chemical group 0.000 claims description 5
- 125000005865 C2-C10alkynyl group Chemical group 0.000 claims description 5
- 125000002947 alkylene group Chemical group 0.000 claims description 5
- 125000000304 alkynyl group Chemical group 0.000 claims description 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 5
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 5
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052732 germanium Inorganic materials 0.000 claims description 4
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical group C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000004450 alkenylene group Chemical group 0.000 claims description 3
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 3
- 125000004419 alkynylene group Chemical group 0.000 claims description 3
- 125000004441 haloalkylsulfonyl group Chemical group 0.000 claims description 3
- 125000004995 haloalkylthio group Chemical group 0.000 claims description 3
- 229910052710 silicon Inorganic materials 0.000 claims description 3
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 2
- CWWPDZCSTPGOPL-UHFFFAOYSA-N [1-[(6-chloropyridin-3-yl)methyl]-2-methyl-8-nitro-2,3,5,7-tetrahydroimidazo[1,2-c]pyrimidin-6-yl]methyl-trimethylsilane Chemical compound CC1CN2CN(C[Si](C)(C)C)CC([N+]([O-])=O)=C2N1CC1=CC=C(Cl)N=C1 CWWPDZCSTPGOPL-UHFFFAOYSA-N 0.000 claims description 2
- KRIOEHNLOIADEH-UHFFFAOYSA-N [1-[(6-chloropyridin-3-yl)methyl]-8-nitro-2,3,5,7-tetrahydroimidazo[1,2-c]pyrimidin-6-yl]methyl-trimethylsilane Chemical compound C12=C([N+]([O-])=O)CN(C[Si](C)(C)C)CN2CCN1CC1=CC=C(Cl)N=C1 KRIOEHNLOIADEH-UHFFFAOYSA-N 0.000 claims description 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 2
- 125000005347 halocycloalkyl group Chemical group 0.000 claims description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 2
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 4
- 125000004737 (C1-C6) haloalkoxy group Chemical group 0.000 claims 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 2
- 125000000027 (C1-C10) alkoxy group Chemical group 0.000 claims 1
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 1
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 1
- 125000006643 (C2-C6) haloalkenyl group Chemical group 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 125000004406 C3-C8 cycloalkylene group Chemical group 0.000 claims 1
- 101710180366 CDP-L-myo-inositol myo-inositolphosphotransferase Proteins 0.000 claims 1
- 241000282461 Canis lupus Species 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 74
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 59
- 101150065749 Churc1 gene Proteins 0.000 description 59
- 102100038239 Protein Churchill Human genes 0.000 description 59
- 238000006243 chemical reaction Methods 0.000 description 43
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 36
- 238000012360 testing method Methods 0.000 description 32
- 239000002904 solvent Substances 0.000 description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 29
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 23
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 18
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 16
- 241000607479 Yersinia pestis Species 0.000 description 16
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 15
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 14
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 14
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 14
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 13
- 239000003921 oil Substances 0.000 description 13
- 239000007921 spray Substances 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 150000001412 amines Chemical class 0.000 description 12
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 12
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- 150000004985 diamines Chemical class 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000002689 soil Substances 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 230000009418 agronomic effect Effects 0.000 description 7
- 239000003085 diluting agent Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 235000013601 eggs Nutrition 0.000 description 7
- 235000019256 formaldehyde Nutrition 0.000 description 7
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 7
- 239000004033 plastic Substances 0.000 description 7
- 229920003023 plastic Polymers 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 241000254175 Anthonomus grandis Species 0.000 description 5
- 241000238631 Hexapoda Species 0.000 description 5
- 241001556089 Nilaparvata lugens Species 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 5
- 241000256251 Spodoptera frugiperda Species 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000005507 spraying Methods 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 241001425390 Aphis fabae Species 0.000 description 4
- 241000489976 Diabrotica undecimpunctata howardi Species 0.000 description 4
- 241000488562 Eotetranychus Species 0.000 description 4
- 206010061217 Infestation Diseases 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229940125904 compound 1 Drugs 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- 241000238876 Acari Species 0.000 description 3
- 244000075850 Avena orientalis Species 0.000 description 3
- 235000007319 Avena orientalis Nutrition 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 101150041968 CDC13 gene Proteins 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000086608 Empoasca vitis Species 0.000 description 3
- 241001414662 Macrosteles fascifrons Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 3
- 241000244206 Nematoda Species 0.000 description 3
- 241001454293 Tetranychus urticae Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 3
- 239000000370 acceptor Substances 0.000 description 3
- 125000005219 aminonitrile group Chemical group 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 229940113088 dimethylacetamide Drugs 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000004495 emulsifiable concentrate Substances 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- NYPJDWWKZLNGGM-UHFFFAOYSA-N fenvalerate Chemical compound C=1C=C(Cl)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-UHFFFAOYSA-N 0.000 description 3
- 239000002917 insecticide Substances 0.000 description 3
- 239000003880 polar aprotic solvent Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 150000004756 silanes Chemical class 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 125000004665 trialkylsilyl group Chemical group 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 241001124076 Aphididae Species 0.000 description 2
- 241001600408 Aphis gossypii Species 0.000 description 2
- 244000045232 Canavalia ensiformis Species 0.000 description 2
- 241000426497 Chilo suppressalis Species 0.000 description 2
- 239000005046 Chlorosilane Substances 0.000 description 2
- 241001279823 Diuraphis noxia Species 0.000 description 2
- 241000256244 Heliothis virescens Species 0.000 description 2
- 241000258937 Hemiptera Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- HQMLIDZJXVVKCW-REOHCLBHSA-N L-alaninamide Chemical compound C[C@H](N)C(N)=O HQMLIDZJXVVKCW-REOHCLBHSA-N 0.000 description 2
- 241001470017 Laodelphax striatella Species 0.000 description 2
- 241000966204 Lissorhoptrus oryzophilus Species 0.000 description 2
- 241000358422 Nephotettix cincticeps Species 0.000 description 2
- 241001671709 Nezara viridula Species 0.000 description 2
- 241001446843 Oebalus pugnax Species 0.000 description 2
- 241000209094 Oryza Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 241001570894 Oulema oryzae Species 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 235000010617 Phaseolus lunatus Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000006004 Quartz sand Substances 0.000 description 2
- 241000073849 Scotinophara lurida Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000180219 Sitobion avenae Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 241000176086 Sogatella furcifera Species 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 230000000895 acaricidal effect Effects 0.000 description 2
- 239000000642 acaricide Substances 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- OMFRMAHOUUJSGP-IRHGGOMRSA-N bifenthrin Chemical compound C1=CC=C(C=2C=CC=CC=2)C(C)=C1COC(=O)[C@@H]1[C@H](\C=C(/Cl)C(F)(F)F)C1(C)C OMFRMAHOUUJSGP-IRHGGOMRSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000003559 chemosterilizing effect Effects 0.000 description 2
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical class Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000013100 final test Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 125000000262 haloalkenyl group Chemical group 0.000 description 2
- 125000000232 haloalkynyl group Chemical group 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- 125000000842 isoxazolyl group Chemical group 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- VOEYXMAFNDNNED-UHFFFAOYSA-N metolcarb Chemical compound CNC(=O)OC1=CC=CC(C)=C1 VOEYXMAFNDNNED-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 230000001069 nematicidal effect Effects 0.000 description 2
- 239000005645 nematicide Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 125000002524 organometallic group Chemical group 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 125000000168 pyrrolyl group Chemical group 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000003206 sterilizing agent Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- XLNZEKHULJKQBA-UHFFFAOYSA-N terbufos Chemical compound CCOP(=S)(OCC)SCSC(C)(C)C XLNZEKHULJKQBA-UHFFFAOYSA-N 0.000 description 2
- DPKBAXPHAYBPRL-UHFFFAOYSA-M tetrabutylazanium;iodide Chemical compound [I-].CCCC[N+](CCCC)(CCCC)CCCC DPKBAXPHAYBPRL-UHFFFAOYSA-M 0.000 description 2
- 125000000335 thiazolyl group Chemical group 0.000 description 2
- XERJKGMBORTKEO-VZUCSPMQSA-N (1e)-2-(ethylcarbamoylamino)-n-methoxy-2-oxoethanimidoyl cyanide Chemical compound CCNC(=O)NC(=O)C(\C#N)=N\OC XERJKGMBORTKEO-VZUCSPMQSA-N 0.000 description 1
- NHOWDZOIZKMVAI-UHFFFAOYSA-N (2-chlorophenyl)(4-chlorophenyl)pyrimidin-5-ylmethanol Chemical compound C=1N=CN=CC=1C(C=1C(=CC=CC=1)Cl)(O)C1=CC=C(Cl)C=C1 NHOWDZOIZKMVAI-UHFFFAOYSA-N 0.000 description 1
- RYAUSSKQMZRMAI-ALOPSCKCSA-N (2S,6R)-4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1C[C@H](C)O[C@H](C)C1 RYAUSSKQMZRMAI-ALOPSCKCSA-N 0.000 description 1
- URDNHJIVMYZFRT-KGLIPLIRSA-N (2r,3r)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pentan-3-ol Chemical compound C([C@H]([C@H](O)C(C)(C)C)N1N=CN=C1)C1=CC=C(Cl)C=C1Cl URDNHJIVMYZFRT-KGLIPLIRSA-N 0.000 description 1
- CXNPLSGKWMLZPZ-GIFSMMMISA-N (2r,3r,6s)-3-[[(3s)-3-amino-5-[carbamimidoyl(methyl)amino]pentanoyl]amino]-6-(4-amino-2-oxopyrimidin-1-yl)-3,6-dihydro-2h-pyran-2-carboxylic acid Chemical compound O1[C@@H](C(O)=O)[C@H](NC(=O)C[C@@H](N)CCN(C)C(N)=N)C=C[C@H]1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-GIFSMMMISA-N 0.000 description 1
- LDVVMCZRFWMZSG-OLQVQODUSA-N (3ar,7as)-2-(trichloromethylsulfanyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)Cl)C(=O)[C@H]21 LDVVMCZRFWMZSG-OLQVQODUSA-N 0.000 description 1
- AHAREKHAZNPPMI-AATRIKPKSA-N (3e)-hexa-1,3-diene Chemical compound CC\C=C\C=C AHAREKHAZNPPMI-AATRIKPKSA-N 0.000 description 1
- XUNYDVLIZWUPAW-UHFFFAOYSA-N (4-chlorophenyl) n-(4-methylphenyl)sulfonylcarbamate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC(=O)OC1=CC=C(Cl)C=C1 XUNYDVLIZWUPAW-UHFFFAOYSA-N 0.000 description 1
- XGWIJUOSCAQSSV-XHDPSFHLSA-N (S,S)-hexythiazox Chemical compound S([C@H]([C@@H]1C)C=2C=CC(Cl)=CC=2)C(=O)N1C(=O)NC1CCCCC1 XGWIJUOSCAQSSV-XHDPSFHLSA-N 0.000 description 1
- ZFHGXWPMULPQSE-SZGBIDFHSA-N (Z)-(1S)-cis-tefluthrin Chemical compound FC1=C(F)C(C)=C(F)C(F)=C1COC(=O)[C@@H]1C(C)(C)[C@@H]1\C=C(/Cl)C(F)(F)F ZFHGXWPMULPQSE-SZGBIDFHSA-N 0.000 description 1
- CKPCAYZTYMHQEX-NBVRZTHBSA-N (e)-1-(2,4-dichlorophenyl)-n-methoxy-2-pyridin-3-ylethanimine Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=N/OC)/CC1=CC=CN=C1 CKPCAYZTYMHQEX-NBVRZTHBSA-N 0.000 description 1
- IAKOZHOLGAGEJT-UHFFFAOYSA-N 1,1,1-trichloro-2,2-bis(p-methoxyphenyl)-Ethane Chemical compound C1=CC(OC)=CC=C1C(C(Cl)(Cl)Cl)C1=CC=C(OC)C=C1 IAKOZHOLGAGEJT-UHFFFAOYSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- JWUCHKBSVLQQCO-UHFFFAOYSA-N 1-(2-fluorophenyl)-1-(4-fluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanol Chemical compound C=1C=C(F)C=CC=1C(C=1C(=CC=CC=1)F)(O)CN1C=NC=N1 JWUCHKBSVLQQCO-UHFFFAOYSA-N 0.000 description 1
- WURBVZBTWMNKQT-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butan-2-one Chemical compound C1=NC=NN1C(C(=O)C(C)(C)C)OC1=CC=C(Cl)C=C1 WURBVZBTWMNKQT-UHFFFAOYSA-N 0.000 description 1
- RURQAJURNPMSSK-UHFFFAOYSA-N 1-(4-chlorophenoxy)-3-{[2-(4-ethoxyphenyl)-3,3,3-trifluoropropoxy]methyl}benzene Chemical compound C1=CC(OCC)=CC=C1C(C(F)(F)F)COCC1=CC=CC(OC=2C=CC(Cl)=CC=2)=C1 RURQAJURNPMSSK-UHFFFAOYSA-N 0.000 description 1
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 description 1
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 1
- MGNFYQILYYYUBS-UHFFFAOYSA-N 1-[3-(4-tert-butylphenyl)-2-methylpropyl]piperidine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1CCCCC1 MGNFYQILYYYUBS-UHFFFAOYSA-N 0.000 description 1
- CRSBERNSMYQZNG-UHFFFAOYSA-N 1-dodecene Chemical class CCCCCCCCCCC=C CRSBERNSMYQZNG-UHFFFAOYSA-N 0.000 description 1
- YIKWKLYQRFRGPM-UHFFFAOYSA-N 1-dodecylguanidine acetate Chemical compound CC(O)=O.CCCCCCCCCCCCN=C(N)N YIKWKLYQRFRGPM-UHFFFAOYSA-N 0.000 description 1
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 1
- 125000006017 1-propenyl group Chemical group 0.000 description 1
- 125000000530 1-propynyl group Chemical group [H]C([H])([H])C#C* 0.000 description 1
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- MZVKNFPDQWHQKT-UHFFFAOYSA-N 2,4-difluoro-6-nitrophenol Chemical compound OC1=C(F)C=C(F)C=C1[N+]([O-])=O MZVKNFPDQWHQKT-UHFFFAOYSA-N 0.000 description 1
- HZJKXKUJVSEEFU-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile Chemical compound C=1C=C(Cl)C=CC=1C(CCCC)(C#N)CN1C=NC=N1 HZJKXKUJVSEEFU-UHFFFAOYSA-N 0.000 description 1
- BOTNFCTYKJBUMU-UHFFFAOYSA-N 2-[4-(2-methylpropyl)piperazin-4-ium-1-yl]-2-oxoacetate Chemical compound CC(C)C[NH+]1CCN(C(=O)C([O-])=O)CC1 BOTNFCTYKJBUMU-UHFFFAOYSA-N 0.000 description 1
- SKCNYHLTRZIINA-UHFFFAOYSA-N 2-chloro-5-(chloromethyl)pyridine Chemical compound ClCC1=CC=C(Cl)N=C1 SKCNYHLTRZIINA-UHFFFAOYSA-N 0.000 description 1
- CYEJMVLDXAUOPN-UHFFFAOYSA-N 2-dodecylphenol Chemical compound CCCCCCCCCCCCC1=CC=CC=C1O CYEJMVLDXAUOPN-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- ZRDUSMYWDRPZRM-UHFFFAOYSA-N 2-sec-butyl-4,6-dinitrophenyl 3-methylbut-2-enoate Chemical compound CCC(C)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1OC(=O)C=C(C)C ZRDUSMYWDRPZRM-UHFFFAOYSA-N 0.000 description 1
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 1
- FSCWZHGZWWDELK-UHFFFAOYSA-N 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione Chemical compound O=C1C(C)(C=C)OC(=O)N1C1=CC(Cl)=CC(Cl)=C1 FSCWZHGZWWDELK-UHFFFAOYSA-N 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000005660 Abamectin Substances 0.000 description 1
- 241000115186 Aceria mangiferae Species 0.000 description 1
- 241001506414 Aculus Species 0.000 description 1
- YRRKLBAKDXSTNC-UHFFFAOYSA-N Aldicarb sulfonyl Natural products CNC(=O)ON=CC(C)(C)S(C)(=O)=O YRRKLBAKDXSTNC-UHFFFAOYSA-N 0.000 description 1
- YRRKLBAKDXSTNC-WEVVVXLNSA-N Aldoxycarb Chemical compound CNC(=O)O\N=C\C(C)(C)S(C)(=O)=O YRRKLBAKDXSTNC-WEVVVXLNSA-N 0.000 description 1
- 241000239223 Arachnida Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000005874 Bifenthrin Substances 0.000 description 1
- 241001674044 Blattodea Species 0.000 description 1
- 241001643374 Brevipalpus Species 0.000 description 1
- 241000987201 Brevipalpus californicus Species 0.000 description 1
- 241001034435 Brevipalpus obovatus Species 0.000 description 1
- 241001643371 Brevipalpus phoenicis Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 239000005885 Buprofezin Substances 0.000 description 1
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000005745 Captan Substances 0.000 description 1
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 1
- STUSTWKEFDQFFZ-UHFFFAOYSA-N Chlordimeform Chemical compound CN(C)C=NC1=CC=C(Cl)C=C1C STUSTWKEFDQFFZ-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- RAPBNVDSDCTNRC-UHFFFAOYSA-N Chlorobenzilate Chemical compound C=1C=C(Cl)C=CC=1C(O)(C(=O)OCC)C1=CC=C(Cl)C=C1 RAPBNVDSDCTNRC-UHFFFAOYSA-N 0.000 description 1
- 239000005747 Chlorothalonil Substances 0.000 description 1
- 239000005944 Chlorpyrifos Substances 0.000 description 1
- 241000676704 Cletus Species 0.000 description 1
- 241001219931 Cletus trigonus Species 0.000 description 1
- 241000098289 Cnaphalocrocis medinalis Species 0.000 description 1
- 241000008892 Cnaphalocrocis patnalis Species 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 239000005752 Copper oxychloride Substances 0.000 description 1
- 239000005756 Cymoxanil Substances 0.000 description 1
- 239000005892 Deltamethrin Substances 0.000 description 1
- 241001124144 Dermaptera Species 0.000 description 1
- LWLJUMBEZJHXHV-UHFFFAOYSA-N Dienochlor Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C1(Cl)C1(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl LWLJUMBEZJHXHV-UHFFFAOYSA-N 0.000 description 1
- 239000005760 Difenoconazole Substances 0.000 description 1
- 239000005893 Diflubenzuron Substances 0.000 description 1
- 239000005947 Dimethoate Substances 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 239000005766 Dodine Substances 0.000 description 1
- 241000488563 Eotetranychus carpini Species 0.000 description 1
- 241000079320 Epitrimerus Species 0.000 description 1
- 241001558857 Eriophyes Species 0.000 description 1
- 241001221110 Eriophyidae Species 0.000 description 1
- 239000005895 Esfenvalerate Substances 0.000 description 1
- 239000005958 Fenamiphos (aka phenamiphos) Substances 0.000 description 1
- 239000005778 Fenpropimorph Substances 0.000 description 1
- 239000005899 Fipronil Substances 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 239000005785 Fluquinconazole Substances 0.000 description 1
- 239000005786 Flutolanil Substances 0.000 description 1
- 239000005787 Flutriafol Substances 0.000 description 1
- 239000005789 Folpet Substances 0.000 description 1
- RHJOIOVESMTJEK-UHFFFAOYSA-N Fosthietan Chemical compound CCOP(=O)(OCC)N=C1SCS1 RHJOIOVESMTJEK-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000005661 Hexythiazox Substances 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical class NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005906 Imidacloprid Substances 0.000 description 1
- 239000005796 Ipconazole Substances 0.000 description 1
- 239000005867 Iprodione Substances 0.000 description 1
- 241000256602 Isoptera Species 0.000 description 1
- 241000255777 Lepidoptera Species 0.000 description 1
- 241000661348 Leptocorisa acuta Species 0.000 description 1
- 241000284249 Leptocorisa chinensis Species 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000005949 Malathion Substances 0.000 description 1
- 239000005807 Metalaxyl Substances 0.000 description 1
- 239000005956 Metaldehyde Substances 0.000 description 1
- 239000005868 Metconazole Substances 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 239000005916 Methomyl Substances 0.000 description 1
- 239000005811 Myclobutanil Substances 0.000 description 1
- 241000721623 Myzus Species 0.000 description 1
- 241000721621 Myzus persicae Species 0.000 description 1
- 241000488557 Oligonychus Species 0.000 description 1
- 241000238814 Orthoptera Species 0.000 description 1
- 239000005950 Oxamyl Substances 0.000 description 1
- 241000488581 Panonychus citri Species 0.000 description 1
- 241000488583 Panonychus ulmi Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 239000005813 Penconazole Substances 0.000 description 1
- 239000005814 Pencycuron Substances 0.000 description 1
- 239000005921 Phosmet Substances 0.000 description 1
- 241000497192 Phyllocoptruta oleivora Species 0.000 description 1
- 239000005923 Pirimicarb Substances 0.000 description 1
- 241000242594 Platyhelminthes Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000005820 Prochloraz Substances 0.000 description 1
- 239000005822 Propiconazole Substances 0.000 description 1
- 241001415024 Psocoptera Species 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 241000258242 Siphonaptera Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000005839 Tebuconazole Substances 0.000 description 1
- 239000005658 Tebufenpyrad Substances 0.000 description 1
- 239000005939 Tefluthrin Substances 0.000 description 1
- 241000488607 Tenuipalpidae Species 0.000 description 1
- 241001454295 Tetranychidae Species 0.000 description 1
- 241000344246 Tetranychus cinnabarinus Species 0.000 description 1
- 241000488577 Tetranychus mcdanieli Species 0.000 description 1
- 241000488530 Tetranychus pacificus Species 0.000 description 1
- 241000916142 Tetranychus turkestani Species 0.000 description 1
- 239000005842 Thiophanate-methyl Substances 0.000 description 1
- 241001414989 Thysanoptera Species 0.000 description 1
- 239000005846 Triadimenol Substances 0.000 description 1
- 239000005848 Tribasic copper sulfate Substances 0.000 description 1
- 239000005942 Triflumuron Substances 0.000 description 1
- 240000001260 Tropaeolum majus Species 0.000 description 1
- 235000004424 Tropaeolum majus Nutrition 0.000 description 1
- 229930195482 Validamycin Natural products 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241001414985 Zygentoma Species 0.000 description 1
- FHTSIFHJYGMMMD-UHFFFAOYSA-N [C]1=CC=CO1 Chemical class [C]1=CC=CO1 FHTSIFHJYGMMMD-UHFFFAOYSA-N 0.000 description 1
- INISTDXBRIBGOC-CGAIIQECSA-N [cyano-(3-phenoxyphenyl)methyl] (2s)-2-[2-chloro-4-(trifluoromethyl)anilino]-3-methylbutanoate Chemical compound N([C@@H](C(C)C)C(=O)OC(C#N)C=1C=C(OC=2C=CC=CC=2)C=CC=1)C1=CC=C(C(F)(F)F)C=C1Cl INISTDXBRIBGOC-CGAIIQECSA-N 0.000 description 1
- YASYVMFAVPKPKE-UHFFFAOYSA-N acephate Chemical compound COP(=O)(SC)NC(C)=O YASYVMFAVPKPKE-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000001345 alkine derivatives Chemical class 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- IYABWNGZIDDRAK-UHFFFAOYSA-N allene Chemical group C=C=C IYABWNGZIDDRAK-UHFFFAOYSA-N 0.000 description 1
- 229960002587 amitraz Drugs 0.000 description 1
- QXAITBQSYVNQDR-ZIOPAAQOSA-N amitraz Chemical compound C=1C=C(C)C=C(C)C=1/N=C/N(C)\C=N\C1=CC=C(C)C=C1C QXAITBQSYVNQDR-ZIOPAAQOSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960000892 attapulgite Drugs 0.000 description 1
- 239000005667 attractant Substances 0.000 description 1
- RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 description 1
- CJJOSEISRRTUQB-UHFFFAOYSA-N azinphos-methyl Chemical group C1=CC=C2C(=O)N(CSP(=S)(OC)OC)N=NC2=C1 CJJOSEISRRTUQB-UHFFFAOYSA-N 0.000 description 1
- 125000003943 azolyl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 1
- CHQVQXZFZHACQQ-UHFFFAOYSA-M benzyl(triethyl)azanium;bromide Chemical compound [Br-].CC[N+](CC)(CC)CC1=CC=CC=C1 CHQVQXZFZHACQQ-UHFFFAOYSA-M 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- OIPMQULDKWSNGX-UHFFFAOYSA-N bis[[ethoxy(oxo)phosphaniumyl]oxy]alumanyloxy-ethoxy-oxophosphanium Chemical compound [Al+3].CCO[P+]([O-])=O.CCO[P+]([O-])=O.CCO[P+]([O-])=O OIPMQULDKWSNGX-UHFFFAOYSA-N 0.000 description 1
- CXNPLSGKWMLZPZ-UHFFFAOYSA-N blasticidin-S Natural products O1C(C(O)=O)C(NC(=O)CC(N)CCN(C)C(N)=N)C=CC1N1C(=O)N=C(N)C=C1 CXNPLSGKWMLZPZ-UHFFFAOYSA-N 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- PRLVTUNWOQKEAI-VKAVYKQESA-N buprofezin Chemical compound O=C1N(C(C)C)\C(=N\C(C)(C)C)SCN1C1=CC=CC=C1 PRLVTUNWOQKEAI-VKAVYKQESA-N 0.000 description 1
- 125000006309 butyl amino group Chemical group 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- RYAGRZNBULDMBW-UHFFFAOYSA-L calcium;3-(2-hydroxy-3-methoxyphenyl)-2-[2-methoxy-4-(3-sulfonatopropyl)phenoxy]propane-1-sulfonate Chemical compound [Ca+2].COC1=CC=CC(CC(CS([O-])(=O)=O)OC=2C(=CC(CCCS([O-])(=O)=O)=CC=2)OC)=C1O RYAGRZNBULDMBW-UHFFFAOYSA-L 0.000 description 1
- JHRWWRDRBPCWTF-OLQVQODUSA-N captafol Chemical compound C1C=CC[C@H]2C(=O)N(SC(Cl)(Cl)C(Cl)Cl)C(=O)[C@H]21 JHRWWRDRBPCWTF-OLQVQODUSA-N 0.000 description 1
- 229940117949 captan Drugs 0.000 description 1
- 239000006013 carbendazim Substances 0.000 description 1
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 description 1
- DUEPRVBVGDRKAG-UHFFFAOYSA-N carbofuran Chemical compound CNC(=O)OC1=CC=CC2=C1OC(C)(C)C2 DUEPRVBVGDRKAG-UHFFFAOYSA-N 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- HKMOPYJWSFRURD-UHFFFAOYSA-N chloro hypochlorite;copper Chemical compound [Cu].ClOCl HKMOPYJWSFRURD-UHFFFAOYSA-N 0.000 description 1
- RCTFHBWTYQOVGJ-UHFFFAOYSA-N chloroform;dichloromethane Chemical compound ClCCl.ClC(Cl)Cl RCTFHBWTYQOVGJ-UHFFFAOYSA-N 0.000 description 1
- OWKFZBJFYBIPMX-UHFFFAOYSA-N chlorogermane Chemical class [GeH3]Cl OWKFZBJFYBIPMX-UHFFFAOYSA-N 0.000 description 1
- PFIADAMVCJPXSF-UHFFFAOYSA-N chloroneb Chemical compound COC1=CC(Cl)=C(OC)C=C1Cl PFIADAMVCJPXSF-UHFFFAOYSA-N 0.000 description 1
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 description 1
- SBPBAQFWLVIOKP-UHFFFAOYSA-N chlorpyrifos Chemical compound CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl SBPBAQFWLVIOKP-UHFFFAOYSA-N 0.000 description 1
- JNGZXGGOCLZBFB-IVCQMTBJSA-N compound E Chemical group N([C@@H](C)C(=O)N[C@@H]1C(N(C)C2=CC=CC=C2C(C=2C=CC=CC=2)=N1)=O)C(=O)CC1=CC(F)=CC(F)=C1 JNGZXGGOCLZBFB-IVCQMTBJSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 125000002993 cycloalkylene group Chemical group 0.000 description 1
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 229960001591 cyfluthrin Drugs 0.000 description 1
- QQODLKZGRKWIFG-QSFXBCCZSA-N cyfluthrin Chemical compound CC1(C)[C@@H](C=C(Cl)Cl)[C@H]1C(=O)O[C@@H](C#N)C1=CC=C(F)C(OC=2C=CC=CC=2)=C1 QQODLKZGRKWIFG-QSFXBCCZSA-N 0.000 description 1
- WCMMILVIRZAPLE-UHFFFAOYSA-M cyhexatin Chemical compound C1CCCCC1[Sn](C1CCCCC1)(O)C1CCCCC1 WCMMILVIRZAPLE-UHFFFAOYSA-M 0.000 description 1
- 229960002483 decamethrin Drugs 0.000 description 1
- OWZREIFADZCYQD-NSHGMRRFSA-N deltamethrin Chemical compound CC1(C)[C@@H](C=C(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 OWZREIFADZCYQD-NSHGMRRFSA-N 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- JYIMWRSJCRRYNK-UHFFFAOYSA-N dialuminum;disodium;oxygen(2-);silicon(4+);hydrate Chemical compound O.[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Al+3].[Al+3].[Si+4] JYIMWRSJCRRYNK-UHFFFAOYSA-N 0.000 description 1
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 description 1
- BIXZHMJUSMUDOQ-UHFFFAOYSA-N dichloran Chemical compound NC1=C(Cl)C=C([N+]([O-])=O)C=C1Cl BIXZHMJUSMUDOQ-UHFFFAOYSA-N 0.000 description 1
- UWQMKVBQKFHLCE-UHFFFAOYSA-N diclomezine Chemical compound C1=C(Cl)C(C)=C(Cl)C=C1C1=NNC(=O)C=C1 UWQMKVBQKFHLCE-UHFFFAOYSA-N 0.000 description 1
- UOAMTSKGCBMZTC-UHFFFAOYSA-N dicofol Chemical compound C=1C=C(Cl)C=CC=1C(C(Cl)(Cl)Cl)(O)C1=CC=C(Cl)C=C1 UOAMTSKGCBMZTC-UHFFFAOYSA-N 0.000 description 1
- JXSJBGJIGXNWCI-UHFFFAOYSA-N diethyl 2-[(dimethoxyphosphorothioyl)thio]succinate Chemical compound CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC JXSJBGJIGXNWCI-UHFFFAOYSA-N 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- BQYJATMQXGBDHF-UHFFFAOYSA-N difenoconazole Chemical compound O1C(C)COC1(C=1C(=CC(OC=2C=CC(Cl)=CC=2)=CC=1)Cl)CN1N=CN=C1 BQYJATMQXGBDHF-UHFFFAOYSA-N 0.000 description 1
- 229940019503 diflubenzuron Drugs 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- FBOUIAKEJMZPQG-BLXFFLACSA-N diniconazole-M Chemical compound C1=NC=NN1/C([C@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-BLXFFLACSA-N 0.000 description 1
- YDEXUEFDPVHGHE-GGMCWBHBSA-L disodium;(2r)-3-(2-hydroxy-3-methoxyphenyl)-2-[2-methoxy-4-(3-sulfonatopropyl)phenoxy]propane-1-sulfonate Chemical compound [Na+].[Na+].COC1=CC=CC(C[C@H](CS([O-])(=O)=O)OC=2C(=CC(CCCS([O-])(=O)=O)=CC=2)OC)=C1O YDEXUEFDPVHGHE-GGMCWBHBSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- AWZOLILCOUMRDG-UHFFFAOYSA-N edifenphos Chemical compound C=1C=CC=CC=1SP(=O)(OCC)SC1=CC=CC=C1 AWZOLILCOUMRDG-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000000967 entomopathogenic effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- NYPJDWWKZLNGGM-RPWUZVMVSA-N esfenvalerate Chemical compound C=1C([C@@H](C#N)OC(=O)[C@@H](C(C)C)C=2C=CC(Cl)=CC=2)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-RPWUZVMVSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004634 feeding behavior Effects 0.000 description 1
- ZCJPOPBZHLUFHF-UHFFFAOYSA-N fenamiphos Chemical compound CCOP(=O)(NC(C)C)OC1=CC=C(SC)C(C)=C1 ZCJPOPBZHLUFHF-UHFFFAOYSA-N 0.000 description 1
- XQUXKZZNEFRCAW-UHFFFAOYSA-N fenpropathrin Chemical compound CC1(C)C(C)(C)C1C(=O)OC(C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 XQUXKZZNEFRCAW-UHFFFAOYSA-N 0.000 description 1
- YYJNOYZRYGDPNH-MFKUBSTISA-N fenpyroximate Chemical compound C=1C=C(C(=O)OC(C)(C)C)C=CC=1CO/N=C/C=1C(C)=NN(C)C=1OC1=CC=CC=C1 YYJNOYZRYGDPNH-MFKUBSTISA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229940013764 fipronil Drugs 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- GBIHOLCMZGAKNG-CGAIIQECSA-N flucythrinate Chemical compound O=C([C@@H](C(C)C)C=1C=CC(OC(F)F)=CC=1)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 GBIHOLCMZGAKNG-CGAIIQECSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- IJJVMEJXYNJXOJ-UHFFFAOYSA-N fluquinconazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1N1C(=O)C2=CC(F)=CC=C2N=C1N1C=NC=N1 IJJVMEJXYNJXOJ-UHFFFAOYSA-N 0.000 description 1
- FQKUGOMFVDPBIZ-UHFFFAOYSA-N flusilazole Chemical compound C=1C=C(F)C=CC=1[Si](C=1C=CC(F)=CC=1)(C)CN1C=NC=N1 FQKUGOMFVDPBIZ-UHFFFAOYSA-N 0.000 description 1
- PTCGDEVVHUXTMP-UHFFFAOYSA-N flutolanil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C(F)(F)F)=C1 PTCGDEVVHUXTMP-UHFFFAOYSA-N 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- HKIOYBQGHSTUDB-UHFFFAOYSA-N folpet Chemical compound C1=CC=C2C(=O)N(SC(Cl)(Cl)Cl)C(=O)C2=C1 HKIOYBQGHSTUDB-UHFFFAOYSA-N 0.000 description 1
- KVGLBTYUCJYMND-UHFFFAOYSA-N fonofos Chemical compound CCOP(=S)(CC)SC1=CC=CC=C1 KVGLBTYUCJYMND-UHFFFAOYSA-N 0.000 description 1
- 239000002316 fumigant Substances 0.000 description 1
- 125000003838 furazanyl group Chemical group 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- IYUKFAFDFHZKPI-UHFFFAOYSA-N hydron;methyl 2-aminopropanoate;chloride Chemical compound Cl.COC(=O)C(C)N IYUKFAFDFHZKPI-UHFFFAOYSA-N 0.000 description 1
- 229940056881 imidacloprid Drugs 0.000 description 1
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- QTYCMDBMOLSEAM-UHFFFAOYSA-N ipconazole Chemical compound C1=NC=NN1CC1(O)C(C(C)C)CCC1CC1=CC=C(Cl)C=C1 QTYCMDBMOLSEAM-UHFFFAOYSA-N 0.000 description 1
- FCOAHACKGGIURQ-UHFFFAOYSA-N iprobenfos Chemical compound CC(C)OP(=O)(OC(C)C)SCC1=CC=CC=C1 FCOAHACKGGIURQ-UHFFFAOYSA-N 0.000 description 1
- ONUFESLQCSAYKA-UHFFFAOYSA-N iprodione Chemical compound O=C1N(C(=O)NC(C)C)CC(=O)N1C1=CC(Cl)=CC(Cl)=C1 ONUFESLQCSAYKA-UHFFFAOYSA-N 0.000 description 1
- WPOOICLZIIBUBM-UHFFFAOYSA-H iron;iron(3+);methyl-dioxido-oxo-$l^{5}-arsane Chemical compound [Fe].[Fe+3].[Fe+3].C[As]([O-])([O-])=O.C[As]([O-])([O-])=O.C[As]([O-])([O-])=O WPOOICLZIIBUBM-UHFFFAOYSA-H 0.000 description 1
- HOQADATXFBOEGG-UHFFFAOYSA-N isofenphos Chemical compound CCOP(=S)(NC(C)C)OC1=CC=CC=C1C(=O)OC(C)C HOQADATXFBOEGG-UHFFFAOYSA-N 0.000 description 1
- UFHLMYOGRXOCSL-UHFFFAOYSA-N isoprothiolane Chemical compound CC(C)OC(=O)C(C(=O)OC(C)C)=C1SCCS1 UFHLMYOGRXOCSL-UHFFFAOYSA-N 0.000 description 1
- PVTHJAPFENJVNC-MHRBZPPQSA-N kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 description 1
- 230000000974 larvacidal effect Effects 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229960000453 malathion Drugs 0.000 description 1
- YKSNLCVSTHTHJA-UHFFFAOYSA-L maneb Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S YKSNLCVSTHTHJA-UHFFFAOYSA-L 0.000 description 1
- 229920000940 maneb Polymers 0.000 description 1
- 230000007758 mating behavior Effects 0.000 description 1
- BCTQJXQXJVLSIG-UHFFFAOYSA-N mepronil Chemical compound CC(C)OC1=CC=CC(NC(=O)C=2C(=CC=CC=2)C)=C1 BCTQJXQXJVLSIG-UHFFFAOYSA-N 0.000 description 1
- GKKDCARASOJPNG-UHFFFAOYSA-N metaldehyde Chemical compound CC1OC(C)OC(C)OC(C)O1 GKKDCARASOJPNG-UHFFFAOYSA-N 0.000 description 1
- XWPZUHJBOLQNMN-UHFFFAOYSA-N metconazole Chemical compound C1=NC=NN1CC1(O)C(C)(C)CCC1CC1=CC=C(Cl)C=C1 XWPZUHJBOLQNMN-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- MEBQXILRKZHVCX-UHFFFAOYSA-N methidathion Chemical compound COC1=NN(CSP(=S)(OC)OC)C(=O)S1 MEBQXILRKZHVCX-UHFFFAOYSA-N 0.000 description 1
- UHXUZOCRWCRNSJ-QPJJXVBHSA-N methomyl Chemical compound CNC(=O)O\N=C(/C)SC UHXUZOCRWCRNSJ-QPJJXVBHSA-N 0.000 description 1
- 229950003442 methoprene Drugs 0.000 description 1
- 229930002897 methoprene Natural products 0.000 description 1
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 description 1
- CIEXPHRYOLIQQD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-2-furoylalaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)C1=CC=CO1 CIEXPHRYOLIQQD-UHFFFAOYSA-N 0.000 description 1
- XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 description 1
- 229960001952 metrifonate Drugs 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- KRTSDMXIXPKRQR-AATRIKPKSA-N monocrotophos Chemical compound CNC(=O)\C=C(/C)OP(=O)(OC)OC KRTSDMXIXPKRQR-AATRIKPKSA-N 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 150000008320 nitroethenes Chemical class 0.000 description 1
- 150000002829 nitrogen Chemical group 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000012053 oil suspension Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000001979 organolithium group Chemical group 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 231100000194 ovacidal Toxicity 0.000 description 1
- 230000003151 ovacidal effect Effects 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- UWVQIROCRJWDKL-UHFFFAOYSA-N oxadixyl Chemical compound CC=1C=CC=C(C)C=1N(C(=O)COC)N1CCOC1=O UWVQIROCRJWDKL-UHFFFAOYSA-N 0.000 description 1
- KZAUOCCYDRDERY-UHFFFAOYSA-N oxamyl Chemical compound CNC(=O)ON=C(SC)C(=O)N(C)C KZAUOCCYDRDERY-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052625 palygorskite Inorganic materials 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- RLBIQVVOMOPOHC-UHFFFAOYSA-N parathion-methyl Chemical group COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1 RLBIQVVOMOPOHC-UHFFFAOYSA-N 0.000 description 1
- OGYFATSSENRIKG-UHFFFAOYSA-N pencycuron Chemical compound C1=CC(Cl)=CC=C1CN(C(=O)NC=1C=CC=CC=1)C1CCCC1 OGYFATSSENRIKG-UHFFFAOYSA-N 0.000 description 1
- 229960000490 permethrin Drugs 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 235000020030 perry Nutrition 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003090 pesticide formulation Substances 0.000 description 1
- 239000003444 phase transfer catalyst Substances 0.000 description 1
- 239000003016 pheromone Substances 0.000 description 1
- BULVZWIRKLYCBC-UHFFFAOYSA-N phorate Chemical compound CCOP(=S)(OCC)SCSCC BULVZWIRKLYCBC-UHFFFAOYSA-N 0.000 description 1
- IOUNQDKNJZEDEP-UHFFFAOYSA-N phosalone Chemical compound C1=C(Cl)C=C2OC(=O)N(CSP(=S)(OCC)OCC)C2=C1 IOUNQDKNJZEDEP-UHFFFAOYSA-N 0.000 description 1
- LMNZTLDVJIUSHT-UHFFFAOYSA-N phosmet Chemical compound C1=CC=C2C(=O)N(CSP(=S)(OC)OC)C(=O)C2=C1 LMNZTLDVJIUSHT-UHFFFAOYSA-N 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical compound CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- YFGYUFNIOHWBOB-UHFFFAOYSA-N pirimicarb Chemical compound CN(C)C(=O)OC1=NC(N(C)C)=NC(C)=C1C YFGYUFNIOHWBOB-UHFFFAOYSA-N 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000056 polyoxyethylene ether Polymers 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- WHHIPMZEDGBUCC-UHFFFAOYSA-N probenazole Chemical compound C1=CC=C2C(OCC=C)=NS(=O)(=O)C2=C1 WHHIPMZEDGBUCC-UHFFFAOYSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 description 1
- QYMMJNLHFKGANY-UHFFFAOYSA-N profenofos Chemical compound CCCSP(=O)(OCC)OC1=CC=C(Br)C=C1Cl QYMMJNLHFKGANY-UHFFFAOYSA-N 0.000 description 1
- ZYHMJXZULPZUED-UHFFFAOYSA-N propargite Chemical compound C1=CC(C(C)(C)C)=CC=C1OC1C(OS(=O)OCC#C)CCCC1 ZYHMJXZULPZUED-UHFFFAOYSA-N 0.000 description 1
- STJLVHWMYQXCPB-UHFFFAOYSA-N propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridine hydrochloride Substances [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- XRJLAOUDSILTFT-UHFFFAOYSA-N pyroquilon Chemical compound O=C1CCC2=CC=CC3=C2N1CC3 XRJLAOUDSILTFT-UHFFFAOYSA-N 0.000 description 1
- FBQQHUGEACOBDN-UHFFFAOYSA-N quinomethionate Chemical compound N1=C2SC(=O)SC2=NC2=CC(C)=CC=C21 FBQQHUGEACOBDN-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229940080817 rotenone Drugs 0.000 description 1
- JUVIOZPCNVVQFO-UHFFFAOYSA-N rotenone Natural products O1C2=C3CC(C(C)=C)OC3=CC=C2C(=O)C2C1COC1=C2C=C(OC)C(OC)=C1 JUVIOZPCNVVQFO-UHFFFAOYSA-N 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000003620 semiochemical Substances 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- JXHJNEJVUNHLKO-UHFFFAOYSA-N sulprofos Chemical compound CCCSP(=S)(OCC)OC1=CC=C(SC)C=C1 JXHJNEJVUNHLKO-UHFFFAOYSA-N 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- ZZYSLNWGKKDOML-UHFFFAOYSA-N tebufenpyrad Chemical compound CCC1=NN(C)C(C(=O)NCC=2C=CC(=CC=2)C(C)(C)C)=C1Cl ZZYSLNWGKKDOML-UHFFFAOYSA-N 0.000 description 1
- IWVCMVBTMGNXQD-UHFFFAOYSA-N terramycin dehydrate Natural products C1=CC=C2C(O)(C)C3C(O)C4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O IWVCMVBTMGNXQD-UHFFFAOYSA-N 0.000 description 1
- UBCKGWBNUIFUST-YHYXMXQVSA-N tetrachlorvinphos Chemical compound COP(=O)(OC)O\C(=C/Cl)C1=CC(Cl)=C(Cl)C=C1Cl UBCKGWBNUIFUST-YHYXMXQVSA-N 0.000 description 1
- LITQZINTSYBKIU-UHFFFAOYSA-F tetracopper;hexahydroxide;sulfate Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Cu+2].[Cu+2].[Cu+2].[Cu+2].[O-]S([O-])(=O)=O LITQZINTSYBKIU-UHFFFAOYSA-F 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- BAKXBZPQTXCKRR-UHFFFAOYSA-N thiodicarb Chemical compound CSC(C)=NOC(=O)NSNC(=O)ON=C(C)SC BAKXBZPQTXCKRR-UHFFFAOYSA-N 0.000 description 1
- QGHREAKMXXNCOA-UHFFFAOYSA-N thiophanate-methyl Chemical compound COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC QGHREAKMXXNCOA-UHFFFAOYSA-N 0.000 description 1
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 1
- 229960002447 thiram Drugs 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 description 1
- YWSCPYYRJXKUDB-KAKFPZCNSA-N tralomethrin Chemical compound CC1(C)[C@@H](C(Br)C(Br)(Br)Br)[C@H]1C(=O)O[C@H](C#N)C1=CC=CC(OC=2C=CC=CC=2)=C1 YWSCPYYRJXKUDB-KAKFPZCNSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- BAZVSMNPJJMILC-UHFFFAOYSA-N triadimenol Chemical compound C1=NC=NN1C(C(O)C(C)(C)C)OC1=CC=C(Cl)C=C1 BAZVSMNPJJMILC-UHFFFAOYSA-N 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- NFACJZMKEDPNKN-UHFFFAOYSA-N trichlorfon Chemical compound COP(=O)(OC)C(O)C(Cl)(Cl)Cl NFACJZMKEDPNKN-UHFFFAOYSA-N 0.000 description 1
- MUDDKLJPADVVKF-UHFFFAOYSA-N trichlorogermane Chemical class Cl[GeH](Cl)Cl MUDDKLJPADVVKF-UHFFFAOYSA-N 0.000 description 1
- ZDHXKXAHOVTTAH-UHFFFAOYSA-N trichlorosilane Chemical class Cl[SiH](Cl)Cl ZDHXKXAHOVTTAH-UHFFFAOYSA-N 0.000 description 1
- DQJCHOQLCLEDLL-UHFFFAOYSA-N tricyclazole Chemical compound CC1=CC=CC2=C1N1C=NN=C1S2 DQJCHOQLCLEDLL-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 description 1
- XAIPTRIXGHTTNT-UHFFFAOYSA-N triflumuron Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)NC(=O)C1=CC=CC=C1Cl XAIPTRIXGHTTNT-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YVWPNDBYAAEZBF-UHFFFAOYSA-N trimethylsilylmethanamine Chemical compound C[Si](C)(C)CN YVWPNDBYAAEZBF-UHFFFAOYSA-N 0.000 description 1
- JARYYMUOCXVXNK-IMTORBKUSA-N validamycin Chemical compound N([C@H]1C[C@@H]([C@H]([C@H](O)[C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)CO)[C@H]1C=C(CO)[C@H](O)[C@H](O)[C@H]1O JARYYMUOCXVXNK-IMTORBKUSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000004562 water dispersible granule Substances 0.000 description 1
- 238000001238 wet grinding Methods 0.000 description 1
- 239000004563 wettable powder Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/30—Germanium compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N55/00—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur
- A01N55/02—Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur containing metal atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
- C07F7/0814—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
III C~ -I II I WO 95/21846 PCT/US95/01616 1
TITLE
ARTHROPODICIDAL TETRAHYDROPYRIMIDINES The present invention pertains to tetrahydropyrimidines which are useful as arthropodicides. U.S. 4,831,036 discloses insecticidal tetrahydropyrimidines that do not suggest those of the instant invention.
SUMMARY OF THE INVENTION This invention pertains to compounds of Formula I, including all geometric and stereoisomers, agriculturally suitable salts thereof, agricultural compositions containing them and their use to control arthropods in both agronomic and nonagronomic environments. The compounds are:
R
4
I
wherein X is selected from the group Si and Ge; A is selected from the group C 1
-C
20 alkylene, C 2
-C
20 alkenylene, C2-C 20 alkynylene, C 3
-C
8 cycloalkylene, C 7
-C
10 aralkylene and phenylene, each group optionally substituted with 1-3 substituents independently selected from W; or A is a direct bond;
R
1 and R 3 are independently selected from the group H, CI-CIO alkyl, C 2
-C
10 alkenyl or C 2
-C
10 alkynyl, each group optionally substituted with 1-2 substituents independently selected from the group halogen, CN, C(O)R 7
C(S)R
7
NO
2 OH, SC(O)R 7
SC(S)R
7
OC(O)R
7
OC(S)R
7
NR
8
C(O)R
7
NR
8
C(S)R
7 SH, Si(R 8
)(R
9
C
1
-C
4 alkoxy, C 1
-C
4 haloalkoxy, CI-C 4 alkylthio, CI-C 4 alkylamino, C 2
-C
8 dialkylamino, C 3
-C
8 cycloalkyl and phenyl optionally substituted with 1-3 substituents independently selected from W1; C 3
-C
8 cycloalkyl optionally substituted with 1-3 substituents independently selected from the group halogen, C 1
-C
2 alkyl and Cl-C 2 haloalkyl; C(O)R 1 1
C(S)R
11 phenyl optionally substituted with 1-3 substituents independently selected from W 1
CI-C
3 alkyl substituted with a 5- or 6-membered aromatic ring, attached through carbon or nitrogen, containing 1 to 4 heteroatoms independently selected from the group 0-4 nitrogen, 0-1 oxygen, and 0-1 sulfur, the ring optionally substituted with 1-3 substituents independently selected from W 1 and a 5- or 6-membered I I I WO 95/21846 PCTIUS95101616 2 aromatic ring, attached through carbon or nitrogen, containing 1 to 4 heteroatoms independently selected from the group 0-4 nitrogen, 0-I1 oxygen, and 0-1 sulfur, the ring optionally substituted with 1-3 substituents independently selected from WI1;
R
2 is selected from the group H, C I-C 6 alkyl, C I-C 6 haloalkyl, C 2
-C
6 alkenyl,
C
2
-C
6 haloalkenyl, C2-C 6 alkynyl, C 2
-C
6 haloalkynyl, C 3
-C
7 cycloalkyl,
C
3
-C
7 halocycloalkyl and C 4
-C
7 cycloalkylakyl, each group optionally substituted with 1-3 substituents independently selected from W; or
R
2 and R 3 can be taken together as CH 2
CH
2 and CH 2
)CH
2
CH
2 each group optionally substituted with 1-2 CH 3
R
4 is selected from the group H and C 3
-C
6 trialkylsilyl; or R 4 is selected from the group C I-C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C 1 I-C 10 alkoxy, C 1 I-C 10 alkylthio, phenyl, phenoxy, phenylthio and naphthyl, each group optionally substituted with 1-3 substituents; independently selected from W 1
R
5 and R 6 are independently selected from the group CI-CI 0 alkyl, C 2
-CI
0 alkenyl, C 2 -C 10 alkynyl, C 1 I-C 10 alkoxy, C I-C 10 alkylthio, phenyl, phenoxy, phenylthio and naphthyl, each group optionally substituted with 1-3 substituents independently selected from W I; OH; and C 3
-C
6 trialkylsilyl;
R
7 is selected from the group H, NH 2 OH, C I-C 6 alkyl, C I-C 6 haloalkyl, C I-C 6 alkoxy, C 1
-C
6 haloalkoxy, C 1
-C
6 alkylthio, C 1
-C
4 alkylamino, C2-C 8 dialkylainino and phenyl option'tly substituted with 1-3 substituents independently selected from WI;
R
8 is H; or R 8 is selected from the group C I-C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, C I-C 10 alkoxy, phenoxy, phenyl and naphthyl, each group optionally substituted with 1-3 substituents independently selected from W I;
R
9 and R 10 are independently selected from the group C I-C 10 alkyl, C 2 -C 10 alcenyl, C 2 -C 10 alkynyl, C I-C 10 alkoxy, phenoxy, phenyl and naphthyl, each group optionally substituted with 1-3 substituents; independently selected from WI; and OH; R I is selected from the group H, NH 2 OH, C I-C 6 alkyl, CI -C 6 haloalkyl, C I-C 6 alkoxy, C I-C 6 haloalkoxy, C 1
I-C
2 alkylthio, C I-C 4 alkylamino, C 2
-C
8 dialkylamino and phenyl. optionally substituted with 1-3 substituents independently selected from WI; W is selected from the group halogen, CN, NO 2 OH, CI-C 6 alkyl, C 1
-C
6 haloalkyl, C 1
-C
6 alkoxy and CI-C 6 haloalkoxy; and WI is selected from the group halogen, CN, NO 2
CI-C
2 alkyl, C 1
-C
2 haloalkyl, C I-C 2 alkoxy, C I-C 2 haloalkoxy, C I-C 2 alkylthio, C I-C 2 haloalkylthio,
C
1
-C
2 alkylsulfonyl, CI-C 2 haloalkylsulfonyl, CI-C 4 alkylamino, C,-C 8 dialkylamino and C 3
-C
6 trialkylsilyl;,.
WO 95/21846 PCTIUS95/01616 3 Preferred Compounds A are compounds of Formula I wherein A is C
I
-C
6 alkylene;
R
1 is Cl-C 3 alkyl substituted with a 5- or 6-membered aromatic ring, attached through carbon or nitrogen, containing 1 to 4 heteroatoms independently selected from the group 0-4 nitrogen, 0-1 oxygen, and 0-1 sulfur, the ring optionally substituted with 1-3 substituents independently selected from W 1
R
4 is selected from the group CI-Clo alkyl and phenyl, each group optionally substituted with 1-3 substituents independently selected from W 1
R
5 and R 6 are independently selected from the group CI-C 10 alkyl and phenyl, each group optionally substituted with 1-3 substituents independently selected from W 1 and W1 is selected from the group halogen and C -C 2 haloalkyl.
Preferred Compounds B are compounds of Preferred A wherein X is Si;
R
1 is CH 2 substituted with pyridyl, thiazole or isoxazole, the ring optionally substituted with 1-2 halogen or 1-2 methyl;
R
2 and R 3 are taken together as CH 2
CH
2 or CH 2
CH
2
CH
2 each group optionally substituted with 1-2 CH 3 and
R
4
R
5 and R 6 are independently selected from CI-C 3 alkyl, C,-C 3 alkoxy and phenyl.
Preferred Compounds C are compounds of Preferred A wherein Xis Si;
R
1 is CH 2 substituted with pyridyl, thiazole or isoxazole, the ring optionally substituted with 1-2 halogen;
R
2 is selected from the group H and C 1
-C
3 alkyl; and
R
4
R
5 and R 6 are independently selected from CI-C 3 alkyl, C.IC 3 alkoxy and phenyl.
Specifically preferred for biological activity is Compound D of Preferred B which is: 1-[(6-chloro-3-pyridinyl)methyl]-1,2,3,5,6,7-hexahydro-2-methyl-8-nitro- 6-[(trimethylsilyl)methyl]imidazo[1,2-c]pyrimidine.
Specifically preferred for biological activity is Compound E of Preferred B which is: 1-[(6-chloro-3-pyridinyl)methyl]-1,2,3,5,6,7-hexahydro-8-nitro- 6-[(trimethylsilyl)methyl]imidazo[1 ,2-c]pyrimidine.
Compounds of this invention can exist as one or more stereoisomers. The various stereoisomers include enantiomers, diastereomers and geometric isomers. One skilled in the art will appreciate that one stereoisomer may be more active and/or may exhibit beneficial effects when enriched relative to the other stereoisomer(s) or when separated C I I I WO 95/21846 PCTIUS95101616 4 from the other stereoisomer(s). Additionally, the skilled artisan knows how to separate said stereoisomers. Accordingly, the present invention comprises racemic mixtures, individual stereoisomers, and optically active mixtures of compounds of Formula I as well as agriculturally suitable salts thereof.
The term or 6-membered aromatic ring" is defined as those rings which satisfy the Hiickel rule; examples include 5- or 6-membered monocyclic aromatic rings containing 0 to 4 heteroatoms such as phenyl, furyl, furazanyl, thienyl, pyrrolyl, pyrazolyl, oxazolyl, oxadiazolyl, imidazolyl, isoxazolyl, thiazolyl, thiadiazolyl isothiazolyl, tetrazolyl, pyridyl, pyrimidinyl, pyridazinyl, pyrazinyl and triazinyl with said ring attached through any available carbon or nitrogen. For example, when the aromatic ring is furyl, it can be 2-furyl or 3-furyl, for pyrrolyl, the aromatic ring is 1-pyrrolyl, 2-pyrrolyl or 3-pyrrolyl, for pyridyl, the aromatic ring is 2-pyridyl, 3-pyridyl or 4-pyridyl and similarly for other monocyclic aromatic rings.
In the above recitations, the term "alkyl", used either alone or in compound words such as "alkylthio" or "haloalkyl" denotes straight-chain or branched alkyl, such as, methyl, ethyl, n-propyl, i-propyl, or the different isomers through C 1 0 Examples of "alkylene" include CH 2
CH
2
CH
2
CH
2
CH
2
CH
2 and the different isomers through C 20 "Alkenyl" denotes straight-chain or branched alkenes such as ethenyl, 1-propenyl, 2-propenyl, and the different isomers through C 10 "Alkenyl" also denotes polyenes such as 1,3-hexadiene. Examples of "alkenylene" include CH=CH, CH2CH=CH,
CH=CHCH
2 and the different isomers through C 20 "Alkynyl" denotes straight-chain or branched alkynes such as emtynyl, 1-propynyl, 3-propynyl and the different isomers through C 1 0 Examples of "alkynylene" include C-C, CH 2 C=C, C=CCH 2 and the different isomers through C 20 "Alkoxy" denotes, for example, methoxy, ethoxy, n-propyloxy, isopropyloxy and the different isomers through C 10 "Alkylthio" denotes straight-chain or branched alkylthio moieties such as methylthio, ethylthio, and the different propylthio, butylthio, pentylthio and hexylthio isomers. "Alkylsulfonyl" denotes
CH
3
S(O)
2 and CH 3
CH
2 S(0) 2 "Alkylamino" denotes methylamino, ethylamino, n-propylaniino, isopropylamino and the different butylamino isomers. "Dialkylamino" denotes nitrogen substituted with two alkyl groups, which may be different. Examples include N,N-dimethylamino and N-ethyl-N-methylamino. "Cycloalkyl" denotes, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl.
Examples of "cycloalkylalkyl" include cyclopropylmethyl, cyclopropylethyl, cyclobutylmethyl and the different C 6 and C 7 isomers bonded to straight-chain or branched alkyl groups. The term "halogen", either alone or in compound words such as "haloalkyl", denotes fluorine, chlorine, bromine or iodine. Further, when used in compound words such as "haloalkyl", said alkyl may be partially or fully substituted with halogen atoms which may be the same or different. Examples of "haloalkyl" include F 3 C, CICH 2
CF
3
CH
2 and CF 3 CC1 2 Examples of "haloalkenyl" include (C1) 2
C=CHCH
2 and c i ~dC-l~ II~ WO 95/21846 PCT/US95/01616
CF
3
CH
2
CH=CHCH
2 Examples of "haloalkynyl" include HC=CCHCI, CF 3
C=C,
CCI
3 CC and FCH 2
C=CCH
2 Examples of "haloalkoxy" include CF 3 O, CC1 3 CH2O,
CF
2
HCH
2
CH
2 0 and CF 3
CH
2 0. Examples of "haloalkylthio" include CCl 3 S, CF 3 S, and CC13CH 2 S. Examples of "haloalkylsulfonyl" include CF 3
SO
2 CC1 3
SO
2
CF
3
CH
2
SO
2 and CF 3
CF
2
SO
2 The total number of carbon atoms in a substituent group is indicated by the "Ci-Cj" prefix where i andj are numbers from 1 to 20. For example, C 1
-C
20 alkylene designates methylene, ethylene, and propylene through dodecylene isomers; C 2 alkoxy designates CH 3
CH
2 and C 3 alkoxy designates CH 3
CH
2
CH
2 0- or
(CH
3 2
CHO-.
DETAILS OF THE INVENTION The compounds of Formula I can be prepared by the reaction of Formula II compounds with one or more equivalents of an amine of Formula III and at least two molar equivalents of formaldehyde in a suitable solvent as depicted in Scheme 1. These reactions are typically carried out at temperatures ranging from 0 °C to the reflux temperature of the solvent, with 0 oC-25 °C being preferred. Scheme 1 reactions are typically complete within one day, however, certain Scheme 1 reactions may require longer reaction times (up to 5 days). Suitable solvents include alcohols such as methanol and ethanol, water, and polar aprotic solvents such as tetrahydrofuran and dimethylformamide. Formaldehyde can be used in amounts of about 2-10 molar equivalents.
Either solid paraformaldehyde or aqueous solutions of formaldehyde can be used. In some cases, it is desirable to use a small amount of a strong, non-oxidizing acid, such as hydrochloric acid, as a catalyst. Alternatively, a hydrohalide or a hydrosulfonic acid salt of amine m can be used.
Scheme 1 N02
R
RI N H H2N-A-X-R5
HCHO
I I R6
R
2
R
3 Compounds of Formula I can be prepared by reaction of compounds of Formula IV with an amine of Formula V as shown in Scheme 2. Typically, compounds of Formula IV are combined with 1-20 molar equivalents of an amine of Formula V in a suitable solvent at temperatures ranging from 0-100 Scheme 2 reactions typically require 6 to 48 h for completion, however longer reaction times may sometimes be required. Suitable solvents include but are not limited to, alcohols such as rethanol, ethanol and isopropanol; water; acetonitrile; dimethyl formamide and dimethyl acetamide. Amines of Formula V can also be used as hydrochloride salts; in these cases I I---I I~-mYL-- WO 95/21846 PCT/US95/01616 6 an equivalent amount of a base (such as sodium hydroxide) is added to the reaction mixtures.
Scheme 2
NO
2
RI
R2
R
3
NH
2 10 II X a suitable leaving group such as halogen, SCH 3 or OC 6
H
5 Alternatively, compounds of Formula II can be prepared by the reaction of Formula VI compounds with amines of Formula VII as depicted in Scheme 3 using conditions that are completely analogous to those described in Scheme 2.
Scheme 3
NO,
R3.
H
M
R
1
R
2 NH I IT
VII
Compounds of Formula IV can be prepared employing processes known in the art that involve reaction of nitroethene compounds of Formula VIII with amines of Formula VII (Scheme Compounds of Formula VI can be prepared by procedures which are analogous to those for compounds of Formula IV. Typical reaction conditions involve tih combination of equimolar amounts of compounds of Formulas VII and VIII in a suitable solvent or solvent mixture at temperatures in the range of about 0-100 °C.
Scheme 4 reactions typically require 6 to 48 h for completion. Suitable solvents typically have sufficient polarity to effect solution of compounds of Formulas VII and VIII, and include alcohols such as methanol, ethanol and isopropanol; ethers such as diethyl ether, tetrahydrofuran and dioxane; esters such as ethyl acetate; polar aprotic solvents such as dimethylformamide and dimethylacetamide; and water, as well as mixtures of solvents.
Scheme 4 N02XI
R
1
R
2 NH go IV VIII
V
i 1 i i I~ll WO 95/21846 PCT/US95/01616 7 Alternatively, compounds of Formula I can be prepared by the reaction of tetrahydropyrimidines of Formula IX with amines of Formula VII as depicted in Scheme 5 under conditions analogous to those described in Scheme 2. Preparation of compounds of Formula I by the reactions depicted in Scheme 5 are advantageous when either R 1 and/or R 2 are equal to H.
Scheme R4 02N A-X-R R6
RR
2 NH
I
X N)
I
R3 IX vI Compounds of Formula IX can be prepared by the reaction of Formula Il amines with compounds of Formula VI in the presence of formaldehyde as shown in Scheme 6 using procedures analogous to those described in Scheme 1.
Scheme 6
NO
2 R6
H
VI 1 Alternatively, as shown in Scheme 7, compounds of Formula I (where R 1 is other than H) can be prepared by the reaction of compounds of Formula I (where R 1 is H) with an alkylating agent of Formula X in the presence of a proton acceptor in a suitable solvent. Typical proton acceptors include NaH, KH, K 2 C0 3 NaHCO 3 and Cs 2
CO
3 and suitable solvents include DMF, THF, acetonitrile and water. In some cases, Scheme 7 reactions are carried out under phase transfer conditions using solvents that include toluene, dichloromethane, dichloroethane, ether, hexanes, benzene and the like and an aqueous base, including NaOH, KOH, NaHC0 3 Na 2
CO
3
K
2 C0 3 among others.
Typical phase transfer catalysts include tetrasubstituted ammonium halide salts, such as tetrabutylammonium iodide, benzyl triethyl ammonium bromide and the like. Reactions are typically carried out at temperatures ranging from 20-150 °C and are completed in 1 h to 3 days; however, 6 to 24 h is usually preferred.
i -F lpl llllslll~ I WO 95/21846 PCT/US95/01616 8 Scheme 7 R4
I
02Nr A-X R5 2 N X- 5 proton R| R6 R--X 2 aceptr (Rl is other NRIN than H) 2 IR3 I X2= a suitable leaving group
R
1 =H such as halogen, tosylate, methanesulfonate, or trifluoromethanesulfonate.
Alternatively, compounds of Formula I (where R 3 is other than H) can be prepared as shown in Scheme 8 using procedures that are completely analogous to those described for Scheme 7 reactions.
Scheme 8 R4
A-X-R
S R6 R3-X2 cceptor I (R 3 is other RI XN than H) 11 R2 H
XI
I
X
2 a suitable
R
3 H leaving group.
The formation of compounds of Formula II (where R 2 and R 3 are taken together to form a 5-or 6-membered ring and R 1 is other than H) is depicted in Scheme 9.
Conditions for carrying out Scheme 9 reactions are analogous to those described for Scheme 7.
Scheme 9 N0 2 NI proton NH RIX2 acceptor n(R is other SX than H) B X II X 2 is asuitable leaving group.
R =H B R 2 and R 3 taken together to forma 5- or 6- menbered ring.
-e s WO 95/21846 PCT/US95/01616 9 Alternatively, compounds of Formula II (where R 2 and R 3 are taken together to form a 5- or 6-membered ring) can be prepared as shown in Scheme 10. Typical reactions involve the combination of equimolar amounts of Formula XII and VIII compounds in a suitable solvent or solvent mixture at temperatures in the range of about 0-100 °C for a time ranging from 2 to 48 h. Suitable solvents typically have sufficient polarity to effect solution of Formula XII and VIII compounds and include alcohols such as methanol, ethanol and isopropanol; ethers such as diethyl ether, tetrahydrofuran and dioxane; esters such as ethyl acetate; polar aprotic solvents such as dimethylformamide and dimethylacetamide; and water, as well as mixtures of solvents.
Scherme
NO
2 R1--NH NH2N/ Rl N+ I (R 2 and R 3 taken together) B
X
1 X1 XII VIm B R 2 and R 3 taken together. X 1 =a suitable leaving group.
Diamines of Formula XII can be formed by reaction of Formula X compounds wth a stoichiometric excess of amines of Formula XIII as depicted in Scheme 11. Typical reactions involve the use of 1.5-10 equivalents of Formula Xm compounds in solvents such as methanol, ethanol, isopropanol, THF, water or acetonitrile, among others.
Scheme 11 reactions are sometimes carried out in the absence of solvent. Typical reaction times for Scheme 11 reactions range from 30 min to several days, with 6 to 24 h being generally preferred.
Scheme 11 RI X 2
H
2 N N XII
B
X Xll
X
2 a suitable B=R 2 and R 3 leaving group. taken together.
Alternatively, Formula XII diamines where B is an optionally substituted CH 2
CH
2 group can be prepared by the two-step procedure depicted in Scheme 12. In Step i of Scheme 12, amines of Formula XIV are treated with potassium cyanide and compounds of Formula XV in the presence of zero to three equivalents of acid to form aminonitriles of Formula XVI. One skilled in the art will recognize that compounds of Formula XV i ~P I WO 95/21846 PCT/US95/01616 can be formaldehyde, acetaldehyde or acetone. Other cyanide salts as well as HCN can be used in the procedure as well as hydrohalide and other acid salts of Formula XIV.
Suitable solvents include methanol, ethanol, isopropanol and water, as well as combinations of solvents. Scheme 12 reactions are usually complete with 24 h.
Alternative procedures for the preparation of amino nitriles such as XVI can be found in the literature (see, Synth. Commun., (1985), 15, 157; Synthesis, (1979), 127).
In Step ii of Scheme 12, aminonitriles of Formula XVI are reduced to form diamines of Formula XII. This reduction can usually be achieved using lithium aluminum hydride or borane in amounts ranging from 0.75 to 3 molar equivalents, in a solvent such as diethyl ether or THF. Reactions are carried out at temperatures ranging from -20 °C to the reflux temperature of the solvent for times ranging from 0.5 h to 2 days.
Alternatively, the reduction of compounds of Formula XVI to compounds of Formula XII can be achieved using catalytic hydrogenation over a catalyst such as palladium on carbon or Raney nickel. The addition of ammonia to the hydrogenation reaction is sometimes useful to maximize the yield of diamines of Formula XII.
Scheme 12 Step i
RI--NH
2
R
12 R3C(0) KCN HN CN H+ R 12R2X R13 XIV XV XVI R2 and R 13 are independently H or CH 3 Step ii XVI 2 (R 12 andR 13 are RI2 independently H or CH 3 R13
XII
An alternative procedure for the preparation of diamines of Formula XII where B is an optionally substituted CH 2
CH
2 group is depicted in Scheme 13. In Step i of Scheme 13, amino amides of Formula XVII are treated with 1 to 2 molar equivalents of acid chlorides of Formula XVIII in the presence of 1 to 3 molar equivalents of a base such as NaOH, KOH, K 2
CO
3 NaHC0 3 pyridine or triethylamine. Suitable solvents include THF, CH 2 Cl 2 water or pyridine. The products (compounds of Formula XIX) can be isolated by extraction or, more conveniently, by removal of solvent, and are usually suitable for use in Step ii of Scheme 13 in crude form. Amides of Formula XVII can be used either in neutral form as depicted or as the salt form (typically as the HCI or I WO 95/21846 PCTIUS95/01616 11
CF
3
CO
2 H salt, among others). When the salt form of XVII i J, an additional one equivalent of base is used in Step i of Scheme 13.
In Step ii of Scheme 13, the amide of Formula XIX is converted to the diamine of Formula XII by treatment with a reducing agent such as LiAlH 4 BH3-THF or BH3-SMe 2 in a solvent such as THF or Et 2 O at temperatures ranging from 0 °C to the reflux temperature of the solvent. Typical reaction times range from 0.5 h to 2 days.
Analogous procedures are well-known in the literature (see Synthesis, (1981), 441).
When R 12 is CH 3 and R 13 is H, then XVII is alanine amide. The use of either the D- or the L- form of alanine amide of Formula XVII or its salt provides a convenient means of obtaining enantiomerically enriched forms of diamines of Formula XII. When compounds of Formula II are prepared as described for Scheme 10 reactions using enantiomerically enriched forms of compounds of Formula XII, the compounds of Formula II are obtained in enantiomerically enriched form. When compounds of Formula I are prepared as described for Scheme 1 reactions using enantiomerically enriched forms of compounds of Formula II, the compounds of Formula I are obtained in enantiomerically enriched form.
Scheme 13 Step i 0
H
2 N ,C(
O
)NH2 base RI14N C(0)NH RI2>(RI3 RR 4 C(O) -R1 XVII XVm XIX Step ii
[H]
XX XII
R
14
CH
3
SCH
2 3-pyridyl, 6choro-3-pyridyl, or 5,6-dichloro-3-pyridyl.
Alternatively, diamines of Formula XII can be obtained in enantiomerically enriched forms by resolution with enantiomeric acids, such as tartaric acid. Such resolutions are well-known to one skilled in the art (see Synthesis, (1991), 789 for a related example).
Amines of Formula I can be prepared by the reaction of a silyl halide or germanyl halide of Formula XX with an excess of ammonia as shown in Scheme 14. These transformations typically involve the addition of compounds of Formula XX to anhydrous, liquid ammonia (2 to 100 equivalents) at temperatures ranging from -78 to I_ L~ WO 95/21846 PCT/US95/01616 12 100 OC. In cases where temperatures greater than -33 °C are required, the reactions are carried out in a sealed, high pressure apparatus. Usually no solvent is required; however, solvents such as THF or diethyl ether are sometimes used. Reactions generally require h to 72 h for completion. Typical work-up procedures usually involve the evaporation of excess ammonia, precipitation of ammonium halide by addition of ether, and removal of solvent. One skilled in the art will recognize that there are many alternative methods for converting halides of Formula XX to primary amines of Formula II. References for a variety of procedures can be found in March, Adv. Org.
Chem., 4th Ed., pp 1276-7.
Scheme 14 R6 I NH 3 X2-A-X-R m
I
R4
XX
X
2 is a suitable leaving group.
Silanes and germanes of Formula XX can be prepared by the reaction of organolithium or Grignard reagents of Formula XXI with chlorosilanes or chlorogermanes of Formula XXII as depicted in Scheme 15. These reactions typically involve the mixture of equimolar amounts of compounds of Formulas XXI and XXII in organic solvents such as pentane, hexane, THF, ether and the like at temperatures ranging from -78 to 25 °C for times typically ranging from 2 h to 4 days.
Scheme R6
I
R
4 -M X- A-X-a
XX
R
XXI XXII M i, MgCI, X 2 is a suitable MgBrorMgI. leaving group.
Chlorosilanes and chlorogremanes of Formula XXII can be prepared by treatment of dichlorides of Formula XXIII with one molar equivalent of an organometallic reagent of Formula XXIV as depicted in Scheme 16. Conditions for Scheme 16 reactions are analogous to those described for Scheme 15 reactions. The preparation of compounds a WO 95/21846 PCTIUS95/01616 13 of Formula XX where R 4 is equal to R 5 can be achieved by the use of two equivalents of compounds of Formula XXIV in procedures depicted in Scheme 16.
Schenr, 16
X
2
R
5 -M xi
XXIII
XNXIV
X
2 is as suitable leaving group.
M 1,MgQ], MgBrorMgl.
Compounds of Formula XX where R 4
R
5 and R 6 are identical can be prepared by the reaction of trichiorides of Formula XXV with three equivalents of organometallic compounds of Formula)XXIV as shown in Scheme 17. Conditions for Scheme 17 reactions are analogous to those described for Scheme 15 reactions.
Scheme 17
X
2 A-Xa 3 3R 5 -M -~XX (R 4
=R
5
R
6 xxv XXIV
X
2 =a suitable leaving group.
M U, MgQ1, MgBr or MgI Compounds of Formula XX where R 4 is an alkoxy or phenoxy group can be prepared by the reaction of an alcohol or phenol of Formula XXVI with a chiorosilane or chiorogermane, of Formula XXII in the presence of a base such as triethylamine, pyridine or Nail as depicted in Scheme 18.
Scheffr 18 RI 5 0H XXOM XX (10=alkoxy orphenoxy) xxVI RI 5 C, -CIO aI or C 6
H
WO 95/21846 PCTI/US95/01616i 14 Procedures for the formation of ethers XX (R 4 is alkoxy or phenoxy) are well-known to one skilled in the art (see, Org. Synth., 69, 96; J. Chem. Soc. Chem.
Commun. (1988) 802; J. Organomet. Chem., (1970), 22, 599.) Silanes and germanes of Formula XX where R 4 and R 5 are alkoxy or phenoxy can be prepared by the reaction of dichlorides of Formula XXIII with two equivalents of alcohols of Formula XXVI in the presence of a base using procedures analogous to those described for Scheme 18 reactions. Similarly, compounds of Formula XX where R 4
R
and R 6 are alkoxy or phenoxy can be prepared by the reaction of trichlorosilanes or trichlorogermanes of Formula XXV with three equivalents of an alcohol of Formula XXVI In the presence of a base using procedures analogous to those described for Scheme 18 reactions.
One skilled in the art will recognize that a wide variety of alternative procedures for the preparation of compounds of Formulae XX, XXII, XXIII and XXV are known in the art. Leading references concerning silanes include, Fleming, Organosilicon Chemistry, in Comprehensive Organic Chemistry, (1979), 3, 541; Colvin, Silicon in Organic Synthesis, Butterworths, Boston, (1981); and Pawlenko, Organosilicon Chemistry, Walter de Gruyter, New York, (1986). Leading references for germanes include, Rivibre, et, al., Germanium, In Comprehensive Organometallic Chemistry, (1982), 2, 399; Lesbre, et. al, The Organic Compounds of Germanium, Wiley, London, (1971).
It is recognized that some reagents and reaction conditions described above for preparing compounds of Formula I may not be compatible with certain functionalities present in the intermediates. In these instances, the incorporation of protection/deprotection sequences into the synthesis will aid in obtaining the desired products. The use and choice of the protecting group will be apparent to one skilled in chemical synthesis.
EXAMPLE 1 Step A: Methyl N-[(6-chloro-3-pyridinyl)carbonyll-alanine A solution of 50.5 g (0.29 mol) of 6-chloronicotinyl chloride and 290 mL of
CH
2 C12 was added to a solution of 60 g (0.43 mol) of DL-alanine methyl ester hydrochloride and 290 mL of saturated aqueous sodium bicarbonate solution. Then, mL of aliquat 336 (Aldrich) was added and the resulting two-phase mixture was stirred rapidly at 25 0 C for 24 h. The resulting mixture was partitioned between CH 2
CI
2 and saturated NaHC0 3 The aqueous layer was extracted with three portions of CH 2 C2.
The combined organics were washed twice with saturated NaHCOI, dried over MgSO 4 and concentrated to give 56.1 g of the title compound as a viscous yellow oil. 1 H NMR (300 MHz, CDC1 3 8 8.82 (d,J=2.4Hz,lH), 8.10 (dd,lH), 7.41 7.10 (br d,lH), 4.78 (quintet,1H), 3.80 1.53 (d,3H).
Ir ir I_ ~R WO 95/21846 PCT/US95/01616 Step B: 6-Chloro-N-[ 1 -(aminocarbonvl)-ethyll-3-pyridine carboxamide A solution of 50.5 g (0.21 mol) of the product from Step A and 150 mL of anhydrous MeOH was added to 575 mL of 15% anhydrous ammonia in anhydrous methanol. The resulting solution was stirred at room temperature for 48 h. The solid product was removed by filtration, washed with ethanol and dried under vacuum to give 43.5 g of the title compound as a white solid; m.p. >220 1 H NMR (400 MHz,
(CH
3 2 SO-d 6 6 8.87 (apparent s,lH), 8.79 8.29 7.65 7.45 (br s,lH), 7.03 (br s,lH), 4.41 (quintet,lH), 1.33 (d,3H).
Step C: N 2 -[(6-chloro-3-pyridinyl)-methyl]-1,2-propanediamine Borane-methyl sulfide complex (18.7 mL, 0.19 mol) was added dropwise to a mechanically stirred mixture of 8.5 g (0.04 mol) of the product from Step B and 112 mL of THF at 50-60°C. The resulting orange-yellow suspension was refluxed for 2 h, cooled to room temperature and quenched by the careful dropwise addition of 62 mL of 6 N HC1. The resulting pale yellow mixture was stirred at room temperature for 24 h and then was washed with three portions of ether. The aqueous layer was basified with mL of 50% NaOH (added with cooling) and extracted with 3 x 150 mL of 2:1 methylene chloride-chloroform solution. Combined organic layers were dried (K 2
CO
3 and concentrated to give 3.5 g of the title compound as a yellow oil. 1 H NMR (400 MHz,CDCl 3 6 8.33 (apparent s,lH), 7.69 7.30 3.78 (ABq,2H), 2.75 2.63 (dd,lH), 2.53 (dd,1H), ca. 1.50 (br s,3H); 1.07 (d,3H).
Step D: 2-Chloro-5-r[5-methyl-2-(nitromethylene)- -imidazolidinvllmethyllpyridine A suspension of 2.5 g (0.013 mol) of the product from Step C, 1.6 g (0.009 mol) of 1,l-bis(methylthio)-2-nitroethylene and 63 mL of anhydrous EtOH was heated at reflux for 3 h and was then allowed to stand at 24 0 C for 72 h. The resulting mixture was concentrated and chromatographed on silica gel using 15:1:0.1 CH 2
CI
2
NH
4 0H to give 0.70 g of the title compound as a yellow solid; m.p. 127-131 0
C.
IH NMR (400 MHz,CDCl 3 8 8.70 (br s,lH), 8.27 7.56 7.35 (d,1H), 6.56 4.33 (ABq,2H), 3.95-3.85 3.45-3.35 1.33 (d,3H).
Step E: 1-r(6-Chloro-3-pyridinvl)methvll-1.2.3.5.6.7-hexahvdro-2-methvl-8-nitro-6r(trimethvlsilyl)methvllimidazo[ 1.2-c]pyrimidine (Compound 1) A mixture of 0.5 g (1.9 mmol) of the product from Step D, 0.31 mL (4.1 mmol) of 37% aqueous formaldehyde, 0.21 g (2.1 mmol) of trimethylsilyl methylamine and 4 mL of ethanol was stirred at room temperature for 18 h. The resulting mixture was concentrated and the yellow residue was triturated with diethyl ether and filtered to give 0.32 g of the title compound as a yellow solid, m.p. 112-115 oC. 1 H NMR (300 MHz,CDC13) 6 8.30 7.81 7.30 5.04 (1/2ABq,lH), 3.98-3.68 3.23 (dd,HI), 1.94 1.26 0.08 (s,9H).
i i WO 95/21846 PCTIUS95/01616 16 EXAMPLE 2 Step A: 2-Nitromethylene-imidazolidine A suspension of 1,l-bis(methylthio)-2-nitroethylene (125 g, 0.76 mol), ethylenediamine (50.6 mL, 0.76 mol) and ethanol (757 mL) was heated at reflex for 4 h.
The resulting mixture was cooled to 5°C and filtered. The solids were washed with cold ethanol and dried under vacuum to yield 102.5 g of a tan solid. 1 H NMR (200 MHz, Me 2 SO-d 6 5 8.27 (br s,2H), 6.33 3.58 (s,4H).
Step B: 1,2.3.5.6.7-Hexahvdro-8-nitro-6-[(trimethylsilvl)methyl1imidazorl .2-clpyrimidine A suspension of 0.98 g (7.6 mmol) of the product from Step A, 1.26 mL (16.7 mmol) of 37% aqueous formaldehyde and 15 mL of ethanol was treated with 1.11 mL (8.3 mmol) of trimethylsilyl methylamine at room temperature. After 18 h, the resulting solution was concentrated to give 1.85 g of a yellow solid. 1 H NMR (400 MHz,CDC13) 8 8.33 (br s,lH), 4.00 3.80 (overlapping t, 2H and s,2H), 3.66 2.14 0.10 (s,9H).
Step C: 1-1(6-Chloro-3-pyridinyl)methyll- 1.2.35,6,7-hexahydro-8-nitro-6- [(trimethylsilyl)methyl-imidazo[ .2-c]pyrimidine A mixture of 0.5 g (2.0 mmol) of the product from Step B, 0.8 g (3.9 mmol) of 6chloro-3-chloromethyl-pyridine hydrochloride, 0.004 g (0.1 mmol) of tetra-n-butyl ammonium iodide, 6.4 mL of 50% aqueous KOH and 8.4 mL of methylene chloride was stirred vigorously for 24h. The resulting mixture was poured into water and extracted with 3 portions of methylene chloride. The combined organic layers were washed with saturated aqueous sodium bicarbonate, dried (K 2
CO
3 and concentrated. The crude product was triturated with diethyl ether and filtered to give 0.34 g of the title compound as a yellow solid, m.p. 145.5-147.0 C. 1H NMR (400 MHz,CDC13) 6 8.35 7.90 (dd,lH), 7.33 4.86 3.90 3.77 3.68-3.55 2.02 0.10 (s,9H).
By the general procedures described herein, or obvious modifications thereof, the compounds of Tables 1-16 and Index Tables A-D can be prepared. The compounds of Table 1, line 1 can be referred to as 1-1, 1-2, 1-3 and 1-4 (as designated by line and column). All the other specific compounds covered in these Tables can be designated in an analogous fashion. In Tables 1-16 and Index Tables A-D, the following notations have been used: i PCTIUS$95101616 WO 95/21846 a-P mPhp-Ph- 0o 0 Me CH 3 Et CH 2
CH
3 n-Pr (CH 2 2
CH
3 i-Pr CH(CH 3 2 n-Bu (CH 2 3
CH
3 i-Bu CH 2
CH(CH
3 2 s-Bu CH(CH 3
)CH
2
CH
3 t-Bu C(CH 3 3 Ac C(O)CH 3 n-pentyl (CH 2 4
CH
3 n-hexyI (CH 2 5
CH
3 c -Pr= c-Bu C-Pentyl c-hexyl =0 (CH2) 2 Ne 3 1 CH 2
CH
2 NMe 3 1
CH
2 (2-Cl-Ph) =1
CH
2 (4-Cl-Ph) CH 2-ci 2-pyr 0 O 3-pyr =0 4-pyr 0 2-CH 2 -pyr H-0 3-CH 2 -pyr N N Ci 2-CH 2 -6-al-pyr 3-H -6C -p r CH2a N a 6--3-pyr =0 6-F-3-pyr E1
F
CH23-aPh)= WO 95/21846 WO 9521846PCTIUS951016l6 6-Br-3-pyr 6-Me-3-pyr 6-OMe-3-pyr 3C 2 0 E 0Me aQOMe a-1N
N
2 a N F
CH
2 N Br
C
2 N Me N e r=
I
C
2
CH
2 al 'yr Q
C
3-CH 2 -6-F-pyr 2 &6Br-riyr 3-CH 2 -6Me-pyr 3-CH 2 -6-OMe-py, 2-CH 2 -3-Me-pyrazyl Me 2-C,-S-Me-pyrazyl QI
M
C'12,- (Me 2-CH 2 -6-Me-pyrazyl
Q
C2NY 2-CH 2 -5--pyzy Q 3-CH 2 -pyridazyl CH 2
N-N
3-CH 2 -6-a-pyridazy] CH 2 (3)
N
2-CH 2 -pyrindyl CH 2 0D 4-CH 2 -pyrinidyl CH 2 (3)N 5- C H -p y ini yl C M 2 7
N
5-Ci2pyiridl 0>2 -Me
N
5-CH 2 -2-M-pyrndyl CH2Q >m ,s CH2 2 thiazolyl 2-ai 2 -pymzyl WO 95/21846 5-Oi-2-Me- thiazolyl 2 -2-Cl- thiazolyl 2 -2-Br- thiazolyl 2-01H2- thienyl 2-CH 2 -5-Br-thienyl- 2.'H 2 -furYl 2-CH 2 -2-pyirolyl 54CH 2 -3-Me-isommzly] S CH 2 Cl s
CI
Br-
N
a12--'
S
C12' Q Br 0 CH2-
H
PCTfUS9S/01616 al
\N
0H 5-GH 2 -3-CQ-isoxazolyl 2 -3-Br-isoxazolyl 42-adiazyra 5-e2-thiadiazlyl 2-CH 2 -tiniadiazlyl=
N-N
Me
NHIN
'Al ~s M Table I
QN
RI-N""
RI=
~Z~i 12 COLUMN 31
H
Me Et n-Pr i-Pr n-Bu Ph
CH
2 Ph 2-Cl-Ph 3-Cl-Ph 4-Cl-Ph
CH
2 (c-Pr) 2-CH 2 -5-CF 3 -thienyl
NCCH
2
CH
2 AcNHCH 2 AcNHCH 2
CH
2
CH
2 NMe 3
I
C
2
CH
2 Ne 3 l
CH
2 (3,4-di-CI-Ph) 2-CH 2 -6-CI-pyr 3-CH 2 -6-CI-pyr 4-CH 2 -6-CI-pyr 2-CH 2 2-CH 2 -4-Cl-pyr WO 95/21946 WO 95/ 1846PCTIUS95/01616 s-Bu i-Bu c-Pr
HCCCH
2
NCCH
2 2-pyr 3-pyr 4-pyr AcSCH 2 Et 2
NCH
2 c-Bu c-pentyl c-hexyl 6-F-2-pyr 6-Me-3-pyr 6-Br-3-pyr 6-F-3-pyr 6-QMe-3-pyr 6-Me-2-pyr 6-Br-2-pyr 5-CI-2-pyr 5-Me-2-pyr 5-Br-2-pyr 5-F-2-pyr 6-OMe-2-pyr 2-thiadiazolyl MeSCH 2 6-CI-2-pyr 6-CI-3-pyr 6-CI-4-pyr 2-CH 2 -pyr 3-CH 2 -Pyr 4-CH 2 -Pyr 5-CH 2 -isoxazolyl Me 2
NCH
2
CH
2 (c-Bu)
CH
2 (c-pentyl)
CH
2 (c-hexyl) 5-CH 2 -2-Me-thiazolyl 5-CH 2 -2-Br-thiazolyl 2-CH 2 -5-Me-thi enyl 3-CH 2 -pyrazolyl 4-CH 2 -pyrazolyl 5-CH 2 -pyrazolyl 2-CH 2 -5-CI-thienyl 2-CH 2 -5-Me-thienyl 3-CH 2 -6-Me-pyr 3-CH 2 -6-OMe-pyr 3-CH 2 -6-Br-pyr 2-CH 2 -6-CF 3 -pyr 3-CH 2 -6-F-pyr 3-CHi 2 -6-CF 3 -pyr 3-CH 2 -6-QCF 3 -Pyr 2-CH 2 -6-Me-pyr 2-CH 2 -6-OMe-pyr 2-CH 2 -6-Br-pyr 2-CH 2 -6-F-pyr 5-CH 2 -pyrimidyl 2-CH 2 -pyrimidyl
CH
2 (2-CI-Ph)
CH
2 (3-CI-Ph)
CH
2 (4-CI-Ph)
CH
2 C(Me)CH 2
HCCCH
2
CH
2
CH
2
CHCH
2 MeSCH 2
CH
2 AcSCH 2
CH
2 2-CH 2 -furyl 5,6-di-CI-3-pyr 5-OMe-2-pyr 2-CH 2 -pyrrolyl 3-CH 2 -Pyrrolyl 3-CH 2 -1I-Me-pyrazolyl 4.-CH 2 -1-Me-pyrazolyl 5-CH 2 -1-Me-pyrazolyl 2-CH 2 -pyrazlyl 2-CH 2 -3-Me-pyrazlyl 2-CH2)-5-Me-pyrazyl 2-CH 2 -6-Me-pyrazyl 3-CH 2 -Pyridazy] 3-CH 2 -6-Me-pyridazyl 3-CH 2 -6-CI-pyridazyl 4-C11 2 -pyriniidyl 5-CH 2 -2-Me-pyriMdyl 2-CH 2 -5-CF 3 -thiadiazyl 2-CH 2 -5-Br-thienyl 5-CH 2 -3-Me-isoxazolyl 5-CH 2 -3-F-isoxazolyl 2-CH 2 -3-CI-pyr 2-CH 2 -5,6-di-CI-pyr 3-C11 2 3-CH 2 -4-CI-pyr 3-CH 2 -2-CI-pyr 3-CH 2 -5,6-di-CI-pyr 4-CH 2 -2,6-di-CI-pyr 5-CH 2 -2-Cl-thiazolyl
CH
2
CHCH
2
CH
2
CH
2 C(Me)CH 2
CH
2
CH
3
CHCHCH
2
CH
3
CHCHCH
2
CH
2 Et 2
NCH
2
CH
2 Me 2
NCH
2
CH
2 2-CH 2 1-Me-pyrrolyl 3-CH 2 -1-Me-pyrrolyl 5-CH 2 -thiazolyl 2-CH 2 -thienyl 5-CH 2 -2-Cl-pyrimidyl 2-CH 2 2-CH 2 -6-OCF 3 -pyr 2-CH 2 -thiadiazyl 5-Me-2-thiadiazyl 5-CI-2-thiadiazyl 5-CF 2 -2-thiadiazyl 2-CH 2 2-CH 2 5-CH 2 -3-Cl-isoxazolyl 5-CH 2 -3-Br-isoxazolyl I L WO 95/21846 WO 95/1846 CTfUS95/01616 21 Table 2
R=
COLUMN
H
Me Et n-Pr i-Pr n-Bu s-Bu i-Bu c-Pr
HCCCH
2
NCCH
2 2-pyr 3-pyr 4-pyr AcSCH 2 Et 2
NCH
2 c-Bu C-pentyl c-hexyl 6-F-2-pyr 6-Me-3-pyr 6-Br-3-pyr 6-F-3-pyr 6-OMe-3-pyr 6-Me-2-pyr 6-Br-2-pyr 5-CI-2-pyr 5-Me-2-pyr 5-Br-2-pyr Ph
CH
2 Ph 2-Cl-Ph 3-Cl-Ph 4-Cl-Ph
CH
2 (c-Pr) 2-CH 2 -pyr 3-CH 2 -pyr 4-CH 2 -pyr 5-CH 2 -isoxazolyl Me 2
NCH
2
CH
2 (c-Bu)
CH
2 (c-pentyl)
CH
2 (c-hexyl) 5-CH 2 -2-Me-thiazolyl 5-CH 2 -2-Br-thiazolyl 2-CH 2 -5-Me-thienyl 3-CH 2 -PyrazolYl 4-CH 2 -pyrazolyl 5-CH 2 -pyrazolyl 2-CH 2 -5-Cl-thienyl 2-CH 2 -5-Me-thienyl 3-CH 2 -6-Me-pyr 3-CH 2 -6-OMe-pyr 3-CH 2 -6-Br-pyr 2-CH 2 -6-CF 3 -pyr 3-CH 2 -6-F-pyr 3-CH 2 -6-CF 3 -pyr 3-CH 2 -6-OCF 3 -pyr 2-Cf1 2 -5-CF 3 -thienyl
NCCH
2
CH
2
ACNHCH',
AcNHCH 2
CH
2
CH
2 NMe 3 l
C
2
CH
2 Ne 3 l
CH
2 (2-CI-Ph)
CH
2 (3-Cl-Ph)
CH
2 C(Me)CH 2
HCCCH
2
CH-
2
CH
2
CHCH
2 MeSCH 2
CH
2 AcSCH 2
CH
2 2-CH 2 -furyl 5,6-di-CI-3-pyr 5-OMe-2-pyr 2-CH 2 -pyrrolyl 3-CH 2 -Pyrrolyl 3-CH 2 -1-Me-pyrazolyl 4-CH 2 1-Me-pyrazolyl 5-CH 2 1-Me-pyrazolyl 2-CH 2 -pyrazlyl 2-CH 2 -3-Me-pyrazlyl 2-CH 2 -5-Me-pyrazyl 2-CH 2 -6-Me-pyrazyl 3-CH 2 -pyridazyl 3-CH-,-6-Me-pyridazyl 3-CH 2 -6-CI-pyridazyl
CH
2 (3,4-di-CI-Ph) 2-CH 2 -6-Cl-pyr 3-CH 2 -6-CI-pyr 4-CH 2 -6-CI-pyr 2-CH 2 2-CH 2 -4-CI-pyr 2-CH 2 -3-Cl-pyr 2-CH 2 -5,6-di-C1-pyr 3-CH 2 3-CH 2 -4-Cl-pyr 3-CH 2 -2-CI-pyr 3-CH 2 -5,6-di-CI-pyr 4-CH 2 -2,6-di-CI-pyr 5-CH 2 -2-CI-thiazolyl
CH
2
CHCH
2
CH
2
CH
2 C(Me)CH 2
CH
2
CH
3
CHCHCH
2
CH
3
CHCHCH
2
CH
2 Et 2
NCH
2
CH
2 Me 2
NCH
2
CH
2 2-CH 2 -1-Me-pyrroly! 3-CH 2 -1-Me-pyrrolyl 5-CH 2 -thiazolyl 2-CH 2 -thienyl 5-CH 2 -2-CI-pyrim*idyl 2-CH 2 2-CH 2 -6-OCF 3 -pyr 2-CH 2 -thiadiazyl 5-Me-2-thiadiazyl WO 95/21846 WO 95/ 1846PCr[US9S/01616 5-F-2-pyr 6-OMe-2-pyr 2-thiadiazolyl MeSCH 2 6-CI-2-pyr 6-CI-3-pyr 6-C l-4-ovr 2-CH 2 -6-Me-pyr 2-CH 2 -6-OMe-pyr 2-CH 2 -6-Br-pyr 2-CH 2 -6-F-pyr 5-CH 2 -pyrimidyl 2-CH 2 -Pyrimidyl 4-CH 2 -pyrimidyl 5-CH 2 -2-Me-pyrimidyl 2-CH 2 -5-CF 3 -thiadiazyl 2-CH 2 -5-Br-thienyl 5-CH 2 -3-Me-isoxazolyl 5-CH 2 -3-F-isoxazolyl 5-CI-2-thiadiazy] 5-CF 2 -2-thiadiazyl 2-CH 2 2-CH 2 5-CHZ-3-CI-isoxazolyl 5-CH 2 -3-Br-isoxazolyl Table 3 0 2 N K~"SiMe 3 .Ii 2 COLUMN I_ 4
H
Me Et n-Pr i-Pr n-Bu s-Bu i-Bu c-Pr
HCCCH
2
NCCH
2 2-pyr 3-pyr 4-pyr AcSCH 2 Et 2
NCH
2 c-Bu c-pentyl c-hexyl 6-F-2-pyr 6-Me-3-pyr Ph
CH
2 Ph 2-Cl-Ph 3-Cl-Ph 4-Cl-Ph
CH
2 (c-Pr) 2-CH 2 -pyr 3-CH 2 -pyr 4-CH 2 -pyr 5-CH 2 -isoxazolyl Me 2
NCH
2
CH
2 (c-Bu)
CH
2 (c-pentyl)
CH
2 (c-hexyl) 5-CH 2 -2-Me-thiazolyl 5-CH 2 -2-Br-thiazolyl 2-CH 2 -5-Me-thienyl 3-CH 2 -pyrazolyl 4-CH 2 -pyrazolyl 5-CH 2 -pyrazolyl 2-CH 2 -5-Cl-thienyl 2-CH 2 -5-CF 3 -thienyl
NCCH
2
CH
2 AcNHCH 2 AcNHCH 2
CH
2
CH
2 NMe 3
I
CH
2
CH
2 NMe 3
I
CH
2 (2-CI-Ph)
CH
2 (3-CI-Ph)
CH
2 (4-CI-Ph)
CH
2 C(Me)CH 2
HCCCH
2
CH
2
C
2
CHCH
2 MeSCH 2
CH
2 AcSCH 2
CH
2 2-CH 2 -furyl 5,6-di-CI-3-pyr 5-OMe-2-pyr 2-CH 2 -pyr-rolyl 3-CH 2 -pyrrolyl 3-CH 2 -1I-Me-pyrazolyl 4-CH 2 1-Me-,pyrazolyl
CH-
2 (3,4-d-i-CI-Ph) 2-CH 2 -6-CI-pyr 3-CH 2 -6-CI-pyr 4-CH 2 -6-CI-pyr
.CH
2 2-CH 2 -4-CI-pyr 2-CH 2 -3-CI-pyr 2-CH 2 -5,6-di-CI-pyr 3-CH 2 3-CH 2 -4-CI-pyr 3-CH 2 -2-CI-pyr 3-CH 2 -5,.6-di-CI-pyr 4-CH 2 -2,6-di-Cl-pyr 5-CH 2 -2-CI-thiazolyl
CH
2
CHCH
2
CH
2
C
2 C(Me)CH 2
CH
2
CH
3
CHCHCH
2
CH
3
CHCHCH
2
CH
2 E-t 2
NCH
2
CH
2 Me 2
NCH
2
CH
2 2-CH 2 1-Me-pyrrolyl WO 95/21846 WO 9521846PCTtUS95/O 1616 6-Br-3-pyr 6-F- 3-pyr 6-OMe-3-pyr 6-Me-2-pyr 6-Br-2-pyr 5-CI-2-pyr 5-Me-2-pyr 5-Br-2-pyr 5-F-2-pyr 6-OMe-2-pyr 2-thiadiazolyl MeSCH 2 6-CI-2-pyr 6-CI-3-pyr 6-CI-4-pyr 2-CH 2 -5-Me-thienyl 3-CH 2 -6-Me-pyr 3-CH 2 -6-OMe-pyr 3-CH 2 -6-Br-pyr 2-CH 2 -6-CF 3 -pyr 3-CH 2 -6-F-pyr 3-CH 2 -6-CF 3 -pyr 3-CH 2 -6-OCF 3 -pyr 2-CH 2 -6-Me-pyr 2-CH 2 -6-OMe-pyr 2-CH 2 -6-Br-pyr 2-CH 2 -6-F-pyr 5-CH 2 -pyrimidy) 2-CH 2 -pyrimidyl 5-CH2-1I-Me-pyrazolyl 2-Ci!h-pyrazlyl 2-CH 2 -3-Me-pyrazlyl 2.CH 2 -5-Me-pyrazy! 2-CH 2 -6-Me-pyrazyl 3-.CH 2 -pyridazyl 3-CH 2 -6-Me-pyridazyl 3-CH 2 -6-Ci-pyridazyl 4-CH 2 -Pyrimidyl 5-CH 2 -2-Me-pyrimidyl 2-CH 2 -5-CF 3 -thiadiazyl 2-CH 2 -5-Br-thienyl 5-CH 2 -3-Me-isoxazolyl 5-CH 2 -3-F-isoxazolyl 3-CH 2 -1 -Me-pyrrolyl 5-CH2)-thiazolyl 2-CH 2 -thienyl 5-CH 2 -2-CI-pyfimidyl 2-CH 2 2-CH 2 -6-OCF 3 -pyr 2-CH 2 -thiadiazyl 5-Me-2-thiadiazyl 5-CI-2-thiadiazyi 5-CF 2 -2-thiadiazyl 2-CH 2 2-CH 2 5-CH 2 -3-CI-isoxazolyl 5-CH 2 -3-Br-isoxazolyl I L I Table 4 02N SiMe 3
R
1 11.
N
H
3
C'-
R=
COLUMN
1 2 ::T3 1
H
Me Et n-Pr i-Pr n-Bu s-Bu i-Bu c-Pr
HCCCH
2
NCCH
2 2-pyr Ph
C
2 Ph 2-Cl-Ph 3-Cl-Ph 4-Cl-Ph
CH{
2 (c-Pr) 2-CH 2 -pyr 3-CH 2 -pyr 4-CH 2 -pyr 5-CH,2-isoxazolyl M(1 2
NCH
2
C
2 (c-Bu) 2-CH 2 -5-CF 3 -thienyl
NCCH
2
CH
2 AcNHCH 2 AcNHCH 2
CH
2
CH
2 NMe 3
I
CH
2 (2NI-Ph
CH
2 (2-CI-Ph)
CH
2 (4-CI-Ph)
CH
2 C(Me)CH 2
HCCCH
2
CH-
2
CH
2
CHCH
2
C
2 (3,4-diCl-Ph) 2-CH 2 -6-CI-Pyr 3-CH 2 -6-CI-pyr 4-CH 2 -6.CI-pyr 2-CH 2 2-CH 2 -4-CI-pyr 2-CH 2 -3-CI-pyr 2-CH 2 -5,6-di-CI-pyr 3-CH 2 3-CH 2 -4-Cl-pyr 3-CH 2 -2-CI-pyr 3-CH 2 -5,6-di-CI-pyr WO 95/21846 WO 9521846PCTUS9S/01616 3-pyr 4..pyr AcSCH 2 Et 2
NCH
2 c-Bu c-pentyl c-hexyl 6-F-2-pyr 6-Me-3-pyr 6-Br-3-pyr 6-F-3-pyr 6-OMe-3-pyr 6-Me-2-pyr 6-Br-2-pyr 5.CI-2-pyr 5-Me-2-pyr 5-Br-2-pyr 5-F-2-pyr 6-OMe-2-pyr 2-thiadiazolyl MeSCH 2 6-CI-2-pyr 6-CI-3-pyr 6-CI-4-ovr
CH
2 (c-pentyl)
CH
2 (c-hexyl) 5-CH 2 -2-Me-thiazoly] 5-CH 2 -2-Br-thiazolyl 2-CH 2 -5-Me-thienyl 3-CH 2 -PYraZOlYl 4-CH 2 -pyrazolyl 5-CH 2 -pyrazolyl 2-CH 2 -5-Cl-thienyl 2-CH 2 -5-Me-thienyl 3-CH 2 -6-Me-pyr 3-CH 2 -6-OMe-pyr 3-CH 2 -6-Br-pyr 2-CH 2 -6-CF 3 -pyr 3-CH 2 -6-F-pyr 3-CH 2 -6-CF 3 -pyr 3-CH 2 -6-OCF 3 -pyr 2-CH 2 -6-Me-pyr 2-CH 2 -6-QMe-pyr 2-CH 2 -6-Br-pyr 2-CH 2 -6-F-pyr 5-CH 2 -pyrimidyl 2-CH 2 -pyrimidyl MeSCH 2
CH
2 AcSCH 2
CH
2 2-CH 2 -furyl 5,6-di-CI-3-pyr 5-QMe-2-pyr 2-CH 2 -pyrrolyl 3-CH 2 -PyffOlyl 3-CH 2 1-Me-pyrazolyl 4-CH 2 -1I-Me-pyrazolyl 5-CH 2 -1 -M.--pyrazolyl 2-CH 2 -pyrazlyl 2-CH 2 -3-Me-pyrazlyl 2-CH 2 -5-Me-pyrazyl 2-CH 2 -6-Me-pyrazyl 3-CH 2 -pyridazyl 3-CH 2 -6-Me-pyridazyl 3-CH 2 -6-CI..pyridazy] 4-CH 2 -pyrimidyl 5-CH 2 -2-Me-pyrimidyl 2-CH 2 -5-CF 3 -thiadiazyl 2-CH 2 -5-Br-thienyl 5-CH 2 -3-Me-isoxazolyl 5-CH 2 -3-F-isoxazolyl 4-CH 2 -2,6-di-CI-pyr 5-CH 2 -2-CI-thiazolyl
CH
2
CHCH
2
CH
2
CH
2 C(Me)CH 2
CH
2
CH
3
CHCHCH
2
CH
3
CHCHCH
2 r.H 2 EtINCH 2
CH
2 Me 9
)NCH
2
)CH
2 2-CH 2 -1I-Me-pyrrolyl 3-CH 2 1-Me-pyrrolyl 5-CH 2 -thiazolyl 2-CH 2 -thienyl 5-CH 2 -2-Cl-pyfimidyl 2-CH 2 2-CH 2 -6-OCF 3 -pyr 2-CH 2 -thiadiazyl 5-Me-2-thiadiazyl 5-CI-2-thiadiazyl 5-CF 2 -2-thiadiazyl 2-CH 2 2-CH 2 5-CH 2 -3-Cl-isoxazolyl 5-CH2)-3-Br-isoxazolyl Table 0 2 N i We 3
RII
ii 2 1 4 Ph
CI-
2 Ph 2-Cl-Ph 3-Cl-Ph 4-Cl-Ph 2-CH 2 -5-CF 3 -thienyl
NCCH
2
CH
2 AcNHCH 2 AcNHCH2CH 2
CH
2 (3,4-di-Ci-Ph) 2-CH 2 -6-CI-pyr 3-CH 2 -6-CI-pyr 4-CH 2 -6-CI-pyr 2-CH 2 WO 95/21846 WO 9521846PCT1JS95101616 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 n-Bu s-Bu i-Bu c-Pr
H-CCCH
2
NCCH
2 2-pyr 3-pyr 4-pyr AcSCH 2 Et 2
NCH
2 c-Bu c-pentyl c-hexyl 6-F-2-pyr 6-Me-3-pyr 6-Br-3-pyr 6-F-3-pyr 6-OMe-3-pyr 6-Me-2-pyr 6-Br-2-pyr 5-CI-2-pyr 5-Me-2-pyr 5-Br-2-pyr 5-F-2-pyr 6-OMe-'2-pyr 2-thiadiazolyl MeSCH 2 6-CI-2-pyr 6-CI-3-pyr 6-CI-4-pyr
CH
2 (c-Pr) 2-CH 2 -pyr 3-CH 2 -pyr 4-CH 2 -pyr 5-CH 2 -isoxazolyl Me 2
NCH
2 012(c-Bu)
C
2 (c-pentyI)
CH
2 (c-hexyl) 5-CH 2 -2-Me-thiazolyl 5-CH2-2-Br-thiazolyl 2-CH 2 -5-Me-thienyl 3-CH 2 7pyrazolyl 4-CH 2 -pyrazoly] 5-CH 2 -pyrazolyl 2-CH 2 -5-Cl-thienyl 2-CH 2 -5-Me-thienyl 3-CH 2 -6-Me-pyr 3-CH 2 -6-OMe-pyr 3-CH 2 -6-Br-pyr 2-CH 2 -6-CF 3 -pyr 3-CH 2 -6-F-pyr 3-CH 2 -6-CF 3 -pyr 3-CH 2 -6-OCF 3 -pyr 2-CH 2 -6-Me-pyr 2-CH 2 -6-QMe-pyr 2-CH 2 -6-Br-pyr 2-CH 2 -6-F-pyr 5-CH 2 -pyrim-idyl 2-CH 2 -pyrimidyl
CH
2
CH
2 )NMe, 3
I
CH
2 (2-CI-Ph)
CH
2 (3-CI-Ph)
CH
2 (4-CI-Ph)
CH
2 C(Me)CH 2
HCCCH
2
CH',
TH2CHCH 2 MeSCH 2
CH
2 ACSCH-,CH2 2-CH 2 -furyl 5,6-di-CI-3-pyr 5-OMe-2-pyr 2-CH 2 -pyrrolyl 3-CH 2 -pyrrolyl 3-CH 2 -1-Me-pyrazolyl 4-CH 2 -1 -Me-pyrazolyl 5-CH 2 -1-Me-pyrazolyl 2-CH2-pyrazlyl 2-CH 2 -3-Me-pyrazlyl 2-CH 2 -5-Me-pyrazyl 2-CH 2 -6-Me-pyrazyl 3-CH 2 -pyridazyl 3-CH 2 -6-Me-pyridazyl 3-CH 2 -6-CI-pyridazyl 4-CH 2 7pyrimidy1 5-CH 2 -2-Me-pyrimidyl 2-CH 2 -5-CF 3 -thiadiazyl 2-CH 2 -5-Br-diienyl 5-CH 2 -3-Me-isoxazolyl 5-CH 2 -3-F-isoxazolyl 2-CH 2 -4-Cl-pyr 2-CH 2 -3-CI-pyr 2-CH 2 -5,6-di-CI-pyr 3-CH 2 3-CH 2 -4-Cl-pyr 3-CH 2 -2-CI-pyr 3-CH 2 -5,6-di-CI-pyr 4-CH 2 -2,6-di-CI-pyr 5-CH 2 -2-CI-thiazolyl
CH
2 CHCHiCH 2
C
2 C(Me)CH 2
CH
2
CH
3
CHCHCH
2
CH
3
CHCHCH
2
CH
2 Et 2
NCH
2
CH
2 Me 2
NCH
2
CH
2 2-CH 2 1 -Me-pyrrolyl 3-CH 2 1-Me.-pyrrolyl 5-CH 2 -thiazolyl 2-CH 2 -thienyl 5-CH 2 -2-CI-pyrimidyl 2-CH 2 2-CH 2 -6-OCF 3 -pyr 2-CH 2 -thiadiazyl 5-Me-2-thiadiazyl 5-CI-2-thiadiazyl 5-CF 2 -2-thiadiazy] 2-CH 2 2-CH 2 5-CH 2 -3-CI-isoxazolyl 5-CH 2 -3-Br-isoxazolyl
I
L WO 95/21846 PCT[US95/01616 26 Table 6
CH
3 3 2 ~COLUMN 4_ 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 19 t.
197 198 199 200 201 202 203 204 205 206 207 208 209
H
Me Et n-Pr i-Pr n-Bu s-Bu i-Bu c-Pr
HCCCH
2
NCCH
2 2-pyr 3-pyr 4-pyr AcSCH 2 Et 2
NCH
2 c-Bu c-pentyl c-hexyl 6-F-2-pyr 6-Me-3-pyr 6-Br-3-pyr 6-F-3-pyr 6-OMe-3-pyr 6-Me-2-pyr 6-Br.2-pyr 5-CI-2-pyr 5-Me-2-pyr 5-Br-2-pyr Ph
CH
2 Ph 2-Cl-Ph 3-Cl-Ph 4-Cl-Ph
CH
2 (c-Pr) 2-CH 2 -pyr 3-CH 2 -pyr 4-CH 2 -pyr 5-CH 2 -isoxazolyl Me 2
NCH
2
C
2 (c-Bu)
CH
2 (c-pentyl)
C
2 (c-hexyl) 5-CH 2 -2-Me-thiazolyl 5-CH 2 -2-Br-thiazolyl 2-CH 2 -5-Me-thienyl 3-CH 2 -pyrazolyl 4-CH 2 -pyrazolyl 5-CH 2 -pyrazolyl 2-CH 2 -5-CI-thienyl 2-CH 2 -5-Me-thienyl 3-CH 2 -6-Me-pyr 3-CH 2 -6-OMe-pyr 3-CH 2 -6-Br-pyr 2-CH 2 -6-CF 3 -Pyr 3-CH 2 -6-F-pyr 3-CH 2 -6-CF 3 -pyr 3-CH 2 -6-OCF 3 -pyr 2-CH 2 -5-CF 3 -thienyl
NCCH
2
CH
2
ACNHCH
2 AcNHCH 2
CH
2
CH
2 NMe 3
I
CR
2
CH
2 NMe 3
I
CH
2 (2-CI-Ph)
C
2 (3-CIPh)
CH
2 (4-CI-Ph)
C
2 CMe)CH 2
HCCCH
2
CH
2
CH
2
CHCH
2 MeSCH 2
CH
2 AcSCH 2
CH
2 2-CH 2 -furyl 5,6-di-CI-3-pyr 5-OMe-2-pyr 2-CH 2 -Pyrrolyl 3-CH 2 -pyrrolyl 3-CH 2 -1lMe-pyazolyl 4-CH 2 1-Me-pyrazolyl 5-CH 2 -1-Me-pyrazolyl 2-CH 2 -Pyrazlyl 2-CH 2 -3-Me-pyrazlyl 2-CH 2 -5-Me-pyra-.yl 2-CH 2 -6-Me-pyrazyl 3-CH 2 -pyridazyl 3-CH 2 -6-Me-pyridazyl 3-CH 2 -6-CI-pyridazyl
CH
2 (3,4-di-CI-Ph) 2-CH 2 -&-CL-pyr 3-CH 2 -6-CI-pyr 4-CH 2 -6-CI-pyr 2-CH 2 2-CH 2 -4-CI-pyr 2-CH 2 -3-CI-pyr 2-CH 2 -5,6-di-Cl-pyr 3-CH 2 3-CH 2 -4-CI-pyr 3-CH 2 -2-CI-pyr 3-CH 2 -5,6-di-CI-pyr 4-CH 2 -2,6-di-CI-pyr 5-CHZ-2-CI-thiazolyl
CH
2
CHCH
2
CH
2
CH
2 C(Me)CH 2
CH
2
CH
3
CHCHCH
2
CH
3
CHCHCH
2
CH
2 Et 2
NCH
2
CH
2 Me 2
NCH
2
CH
2 2-CH 2 -1-Me-pyrrolyl 3-CH 2 -1-Me-pyrrolyl 5-CH 2 -thiazolyl 2-CH 2 -thienyl 5-CH4 2 -2-CI-pyrimidyl 2-CH 2 Cl-pyrazyl 2-CH 2 -6&OCF 3 -pyr 2-CH4 2 -thiadiazy] 5-.Me-2-thiadiazyl WO 95/21846 WO 9521846PCTUS95/01616 5-F-2-pyr 6-OMe-2-pyr 2-thiadiazolyl MeSCH 2 6-CI-2-pyr 6-CI-3-pyr 6-CI-4-pyr 2-CH 2 -6-Me-pyr 2-CH 2 -6-OMe-pyr 2-CH 2 )-6-Br-pyr 2-CH 2 -6-F-pyr 5-CH 2 -pyrimidyl 2-CH 2 -Pyrimidyl 4-CH 2 -pyrimidyl 5-CH 2 -2-Me-pyrimidyl 2-CH 2 -5-CF 3 -thiadiazyl 2-CH 2 -5-Br-thienyl ,5-CH 2 -3-Me-isoxazolyl 5-CH 2 )-3-F-is oxazolyl 5-CI-2-thiadiazyl 5-CF 2 -2-thiadiazyl 2-CH 2 2-CH 2 5-CH 2 -3-CI-isoxazolyl 5-CH 2 -3-Br-isoxazolyl Table 7 02N N' SMe 3
RI.
CH
3
RI
11 2 1 3 I4
H
Me Et n-Pr i-Pr n-Bu s-Bu i-Bu c-Pr
HCCCH
2
NCCH
2 2-pyr 3-pyr 4-pyr AcSCH 2 Et 2
NCH
2 c-Bu c-pentyl c-hexyl 6-F-2-pyr 6-Me-3-pyr Ph
C
2 Ph 2-Cl-Ph 3-Cl-Ph 4-Cl-Ph 2CH 2 -Pr 3-CH 2 -pyr 4-CH 2 -Pyr 5-CH 2 -isoxazolyl Me 2
NCH
2
CH
2 (c-Bu)
CH
2 (c-pentyl)
CH
2 (c-hexyl) 5-CH 2 -2-Me-thiazoly]
S-CH
2 -2-Br-thiazolyl 2-CH 2 -5-Me-thienyl 3-CH 2 -pyrazolyl 4-CH 2 -Pyrazolyl 5-CH 2 7pyrazolyl 2-CH 2 -5-CI-thienyl 2-CH 2 -5-CF 3 -thienyl
NCCH
2
CH
2 AcNHCH 2 AcNHCH 2
CH
2
CH
2 NMe 3
I
CH
2
CH
2 NMe 3
I
CH
2 (2-CI-Ph)
CH
2 (3-Cl-Ph)
CH
2 C(Me)CH 2
HCCCH
2
CH
2
CH
2
CHCH
2 MeSCH 2
CH
2 AcSCH 2
CH
2 2-CH 2 -furyl 5,6-di-CI-3-pyr 5-OMe-2-pyr 2-CH 2 -pyrrolyl 3-CH 2 -pyrrolyl 3-CH 2 -1-Me-pyrazolyl 4-CH 2 1-Me-pyrazolyl Cl 2 (3,4-di-Cl-Ph) 2-CH 2 -6CI-pyr 3-CH 2 -6-Cl-pyr 4-CH 2 -6-CI-pyr 2-CH 2 2-CH 2 -4-CI-pyr 2-CH 2 -3-CI-pyr 2-CHZ-5,6-di-CI-pyr 3-CH 2 3-CH 2 -4-CI-pyr 3-CH 2 -2-CI-pyr 3-CH 2 -5,6-di-Cl-pyr 4-CH 2 -2,6-di-CI-pyr 5-CH 2 -2-Cl-thiazolyl CH4 2
CHCH
2
CH
2
CH
2 C(Me)CH 2 CH2)
CH
3
CHCHCH
2
CH
3
CHCHCH
2
CH
2 Et 2
NCH
2
CH
2 Me 2
NCH
2
CH
2 2-CH 2 -1-Me-pyrrolyl WO 95121846 WO 9521846PCTIUS95/01616 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 6-Br-3-pyr 6-F-3-pyr 6-OMe-3-pyr 6-Me-2-pyr 6-Br-2-pyr 5-CI-2-pyr 5-Me-2-pyr 5-Br-2-pyr 5-F-2-pyr 6-OMe-2-pyr 2-thiadiazolyl MeSCH 2 6-CI-2-pyr 6-CI-3-pyr 6-CI-4-ipvr 2-CH 2 -5-Me-thienyl 3-CH 2 -6-Me-pyr 3-CH 2 -6-OMe-pyr 3-CH 2 -6-Br-pyr 2-CH 2 -6-CF 3 -pyr 3-CH 2 -6-F-pyr 3-CH 2 -6-CF 3 -pyr 3-CH 2 -6-OCF 3 -pyr 2-CH 2 -6-Me-pyr 2-CH 2 -6-O~le-pyr 2-CH 2 -6-Br-pyr 2-CH 2 -6-F-pyr 5-CH 2 -pyrimiddyl 2-CH 2 -pyrimidyl 5-CH 2 1-Me-pyrazoly] 2-CH 2 -PYraz]l 2-CH 2 -3-Me-pyrazlyl 2-CH 2 -5-Me-pyrazyl 2-CH 2 -6-Me-pyrazyl 3-CH 2 -pyridazyl 3-CH 2 -6-Me-pyridazyl 3-CH 2 -6-CI-pyridazyl 4-CH 2 -pyrimaidyl 5-CH 2 -2-Me-pyrimidyl 2-CH 2 -5-CF 3 -thiadiazyl 2-CH 2 -5-Br-thienyl 5-CH 2 -3-Me-isoxazolyl 5-CH 2 -3-F-isoxazolyl 3-CH- 2 1-Me-pyrrolyl 5-CH 2 -thiazolyl 2-CH 2 -thienyl 5-CH 2 -2-Cl-pyrimidyl 2-CH 2 2-CH 2 -6-OCF 3 -pyr 2-CH 2 -thiadiazy] 5-Me-2-thiad~azyl 5-C1-2-thiad~azyl 5-CF 2 -2-thiadiazyl 2-CH 2 2-CH 2 5-CH 2 -3-CI-isoxazolyl 5-CH 2 -3-Br-isoxazolyl Table 8 0 2 NS~e
CH
3
K
CH
3 COLUMN I2 1 2 4
H
Me Et n-Pr i-Pr n-Bu s-Bu i-Bu c-Pr
HCCCH
2
NCCH
2 2-pyr 3-pyr Ph
C
2 Ph 2-Cl-Ph 3-Cl-Ph 4-Cl-Ph
CH
2 (c-Pr) 2-CH 2 -pyr 3-CH 2 -pyr 4-CH 2 pyr 5-CH 2 -isoxazolyl Me 2
NCH
2
CH
2 (c-Bu)
CH
2 (c-pentyl) 2-CH 2 -5-CF 3 -thienyl
NCCH
2
CH
2 AcNHCH 2 AcNHCH 2
CH
2
CH
2 NMe 3
I
CH
2
CH
2 NMe 3 l
CH
2 (2-CI-Ph)
CH
2 (3-Cl-Ph)
CH
2 Cl-Ph)
CH
2 C(Me,)CH 2
HCCCH
2
CH
2
C
2
CHCH
2 MeSCH 2
CH
2 2CH 2 ,--C-Pyr 3-CH 2 -6-Cl-jpyr 4-CH 2 -6-Cl-pyr 2-CH 2 2-CH 2 -4-CI-pyr 2-CH 2 -4-CI-pyr 2-CH 2 -5,6-di-CI-pyr 3-CH 2 3-CH 2 -4-CI-pyr 3-CH 2 -2-Cl-pyr 3-CH4 2 -5,6-di-CI-pyr 4-CH 2 -2,6-di-CI-pyr WO 95/21846 WO 9521846PCTIUS95/01616 4-pyr
ACSCH
2 Et 2
NCH
2 c-Bu c-pentyl c-hexyl 6-F-2-pyr 6-Me-3-pyr 6-Br-3-pyr 6-F-3-pyr 6-OMe-3-pyr 6-Me-2-pyr 6-Br-2-pyr 5-CI-2-pyr 5-Me-2-pyr 5-Br-2-pyr 5-F-2-pyr 6-OMe-2-pyr 2-thiadiazolyl MeSCH 2 6-Cl-2-pyr 6-CI-3-pyr 6-CI-4-pyr
CH
2 (c-hexyl) 5-CHZ-2-Me-thiazolyl 5-CH 2 -2-Br-thiazolyl 2-CH 2 -5-Me-thienyl 3-CH 2 -pyrazolyl 4-CH 2 -PylazOlyl 5-CH 2 -Pyrazolyl 2-CH 2 -5-Cl-thienyl 2-CH 2 -5-Me-thienyl 3-CI- 2 -6-Me-pyr 3-CH 2 -6-OMe-pyr 3-CH 2 -6--Br-pyr 2-CH 2 -6-CF 3 -pyr 3-CH 2 -6-F-pyr 3-CH 2 -6-CF 3 -pyr 3-CH 2 -6-OCF 3 -pyr 2-CH 2 -6-Me-pyr 2-CH 2 -6-OMe-pyr 2-CH 2 -6-Br-pyr 2-CH 2 -6-F-pyr 5-CH 2 -pyrimidyl 2-CH 2 -pyrimidyl AcSCH 2
CH
2 2-CH 2 -furyl 5,6-di-CI-3-pyr 5-OMe-2-pyr 2-CH 2 -Pyrrolyl 3-CH 2 -Pyrrolyl 3-CH 2 -1I-Me-pyrazolyvl 4-CH 2 -1 -Me-pyrazolyl 5-CH 2 -1I-Me-pyrazolyl 2-CH 2 -pyrazlyl 2-CH 2 -3-Me-pyrazlyl 2-CH 2 -5-Me-pyrazyl 2-CH 2 -6-Me-pyrazy] 3-CH 2 -pyridazyl 3-CH 2 -6-Me-pyridazyl 3-CH 2 -6-CI-pyridazy] 4-CH 2 -pyrimi dyl 5-CH 2 -2-Me-pyrimidyl 2-CH 2 -5-CF 3 -thiadiazyl 2-CH 2 -5-Br-thienyl 5-CH 2 -3-Me-isoxazolyl 5-CH 2 -3-F-isoxazolyl 5-CH 2 -2-CI-thiazolyl
CH
2
CHCH
2
)CH
2
CH
2 C(Me)CH 2 CH2
CH
3
CHCHCH
2
CH
3
CHCHCH
2 CHi Et 2
NCH
2
CH
2 Me 2
NCH
2
CH
2 2-CH 2 -1-Me-pyrrolyl 3-CH 2 -1-Me-pyrrolyl 5-CH 2 -thiazolyl 2-CH 2 -thieny'l 5-CH 2 -2-CI-pyrimidyl 2-CH 2 2-CH 2 -6-OCF 3 -pyr 2-CH 2 -thiadiazyl 5-Me-2-thiadiazyl 5-CI-2-thiadiazyl 5-CFZ-2-thiadiazyl 2-CH 2 2-CH 2 5-CH 2 -3-CI-isoxazolyl 5-CH 2 -3-Br-isoxazolyl.
Table 9 C' N~SiMe 3 2=
H
Me Et n-Pr i-Pr n-Bu Ph
C
2 Ph 2-Cl-Ph 3-Cl-Ph 4-Cl-Ph
C
2 (c-pr) 2-CH 2 -5-CF 3 -thienyl
NCCH
2
CH
2 AcNHCH- 2 AcNH-CH 2 CH2
CH
2 NMe 3
I
C
2
CH
2 Ne 3
I
CH
2 (3,4-di-CI-Ph) 2-CH 2 -6-CI-pyr 3-CH 2 -6-CI-pyr 4-CH 2 -6-CI-pyr 2-CH 2 2-CH 2 -4-CI-pyr WO 95/21846 WO 9521846PCT/US95/01616 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 .316 317 318 319 320 321 322 323 324 s-Bu i-Bu c-Pr
HCCCH
2
NCCH
2 2-pyr 3-pyr 4-pyr AcSCH 2 Et 2
NCH
2 c-Bu c-pentyl c-hexyl 6-F-2-pyr 6-Me-3-pyr 6-Br-3-pyr 6-F-3-pyr 6-OMe-3-pyr 6-Me-2-pyr 6-Br-2-pyr 5-CI-2-pyr 5-Mve-2-pyr 5-Br-2-pyr 5-F-2-pyr 6-OMe-2-pyr 2-thiadiazolyl MeSCH 2 6-CI-2-pyr 6-CI-3-pyr 6-CI-4-pyr 2-CH 2 -pyr 3-CH 2 -pyr 4-CH 2 -pyr 5-CH 2 isoxazolyl Me 2
NCH
2
CH
2 (c-Bu)
CH
2 (c-pentyl)
C
2 (chexyl) 5-CH 2 -2-Me-thiazolyl 5-CH 2 -2-Br-thiazolyl 2-CH 2 -5-Me-thienyl 3-CH 2 -pyrazolyl 4-CH 2 -pyrazolyl 5-CH 2 -pyrazolyl 2-CH 2 -5-CI-thienyl 2-CH 2 -5-Me-thienyl 3-CH 2 -6-Me-pyr 3-CH 2 -6-OMe-pyr 3-CH 2 -6-Br-pyr 2-CH 2 -6-CF 3 -pyr 3-CH 2 -6-F-pyr 3-CH 2 -6-CF 3 -pyr 3-CH 2 -6-OCF 3 -pyr 2-CH 2 -6-Me-pyr 2-CH 2 -6-OMe-pyr 2-CH 2 -6-Br-pyr 2-CH 2 -6-F-pyr 5-CH 2 -pyimidyl 2-CH 2 -pyriniidyl
CH
2 (2-CI-Ph)
CH
2 (3-CI-Ph)
CH
2 (4-CI-Ph)
CH
2 C(Me)CH 2
HCCCH
2
CH
2
CH
2
CHCH
2 MeSCH 2
CH
2
ACSCH
2 CH4 2 2-CH 2 -furyl 5,6-di-CI-3-pyr 5-OMe-2-pyr 2-CH 2 -pyrrolyl 3-CH 2 -Pyrrolyl 3-CH 2 -1 -Me-pyrazolyl 4-CH 2 -1-Me-pyrazolyl 5-CI-1 2 -l-Me-pyrazolyl 2-CH 2 -pyrazlyl 2-CH 2 -3-Me-pyrazlyl 2-CH 2 -5-Me-pyrazyl 2-CH 2 -6-Me-pyrazyl 3-CH 2 -Pyridazyl 3-CH 2 -6-Me-pyridazyl 3-CH 2 -&-CI-pyridazyl 4-CH 2 -Pyrirnidyl 5-CH 2 -2-Me-pyrimidyl 2-CH 2 -5-CF 3 ;-thiadiazyl 2-CH 2 -5-Br-thienyl 5-CH 2 -3-Me-isoxazolyl 5-CH 2 -3-F-isoxazolyl 2-CH 2 -3-CI-pyr 2-CH 2 -5,6-di-CI-pyr 3-CH 2 3-CH 2 -4-CI-pyr 3-CH 2 -2-CI-pyr 3-CH 2 -5,6-di-CI-pyr 4-CH 2 -2,6-di-CI-pyr 5-CH 2 -2-CI-thiazolyl
CH
2
CEICH
2
CH
2
CH
2 C(Me)CH,2CH 2
CH
3
CHCHCH
2
CH
3
CHCHCH
2
CH
2 Et 2 NCH9CH 2 Me 2 NCfl-1CH 2 2-CH 2 -1I-M(--pynfolyI 3-CH 2 -1-MC.-PyrrolyI 5-CH 2 -thiaz DIYI 2-CH 2 -thienyl 5-CH 2 -2-CI-pyrimidyl 2-CH 2 2-CH 2 -6-OCF 3 -pyr 2-CH 2 -thiadiazyl 5-Me-2-thiadiazy] 5-CI-2-thiadiazyl 5-CF 2 -2-thiadiazyl 2-CH 2 2-CH 2 5-CH 2 -3-Cl-isoxazolyl 5-CH 2 -3-Br-isoxazolyl
I
Table 0 2 N Nr'K SiWe 3
H
3
C,:
H
R
3 WO 95/21846 WO 9521846PCTIUS95/01616 R3 S~~~~COLUMN 32 1 3 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360
H
Me Et n-Pr i-Pr n-Bu s-Bu i-Bu c-Pr
HCCCH
2
NCCH
2 2-pyr 3-pyr 4-pyr AcSCH 2 Et 2
NCH
2 c-Bu c-pentyl c-hexyl 6-F-2-pyr 6-Me-3-pyr 6-Br-3-pyr 6-F-3-pyr &-OMe-3-pyr 6-Me-2-pyr 6-Br-2-pyr 5-CI-2-pyr 5-Me-2-pyr 5-Br-2-pyr 5-F-2-pyr 6-OMe-2-pyr 2-thiadiazolyl MeSCH 2 6-CI-2-pyr 6-CI-3-pyr 6-CI-4-pyr Ph
C
2 Ph 2-Cl-Ph 3-Cl-Ph 4-Cl-Ph
CH
2 (c-Pr) 2-CH 2 -pyr 3-CH 2 -pyr 4-CH 2 -Pyr 5-CH 2 -isoxazolyl Me2NCH 2
CH
2 (c-pentyl)
C
2 (chexyl) 5-CH 2 -2-Me-thiazolyl 5-CH 2 -2-Br-thiazolyl 2-CH 2 -5-Me-thienyl 3-CH 2 -pyr-azolyl 4-CH 2 -pyrazolyl 5-CH 2 -pyrazolyl 2-CH 1 )-5-CI-thienyl 2-CH 2 -5-Me-thienyl 3-CH 2 -6-Me-pyr 3-CH 2 -6-OMe-pyr 3-CH 2 -6-Br-pyr 2-CH 2 -6-CF 3 -pyr 3-CH 2 -6-F-pyr 3-CH 2 -6-CF 3 -pyr 3-CH 2 -6-OCF 3 -pyr 2-CH 2 -6-Me-pyr 2-CH 2 -6-OMe-pyr 2-CHZ-6-Br-pyr 2-CH 2 -6-F-pyr 5-CH 2 -Pyrimidyl 2-CH 2 -pyrin-ddyl 2-CH 2 -5-CF 3 -thienyl
NCCH
2
CH
2 AcNHCH 2
ACNHCH
2
CH
2
CH
2 NMe 3
I
CH
2
CH
2 NMe 3
I
CH
2 (2-CI-Ph)
C
2 (3-Cl-Ph)
C
2 (4-Cl-Ph)
CH
2 C(Me)CH 2
HCCCH
2
CH
2
CH
2
CHCH
2 MeSCH 2
CH
2 AcSCH 2
CH
2 2-CH 2 -furyl 5,6-di-CI-3-pyr 5-OMe-2-pyr 2-CH 2 -Pyrrolyl 3-CH 2 -pyrrolyl 3-CH 2 -1 -Me-pyrzolyl 4-CH 2 -1I-Me-pyrazolyl 5-CH 2 -1I-Me-pyrazolyl 2-CH 2 -pyrazlyl 2-CH 2 -3-Me-pyrazlyl 2-CH 2 -5-Mt-pyrazy] 2-CH 2 -6-Me-pyrazyl 3-CH 2 -pyridazyl 3-CH 2 -6-Me-pyridazyl 3-CH 2 -6-CI-pyridazyl 4-CH 2 -pyrimidyl 5-CH 2 -2-Me-pyrimidyl 2-CH 2 -5-CF 3 -thiadiazyl 2-CH 2 -5-Br-thienyl 5-CH 2 -3-Me-isoxazolyl 5-CH 2 -3-F-isoxazolyl
CH
2 (3,4-di-CI-Ph) 2-CH 2 -6-CI-pyr 3-CH 2 -6-CI-pyr 4-CH 2 -6-CI-pyr 2-CH 2 2-CH 2 -4-CI-pyr 2-CH 2 -3-CI-pyr 2-CH 2 -5,6-di-CI-pyr 3-CH 2 3-CH 2 -4-CI-pyr 3-CH 2 -2-CI-pyr 3-CH2-5,6-di-CI-pyr 4-CH 2 -2,6-di-CI-pyr 5-CH 2 -2-CI-thiazolyl
C
2
CHCH
2
CH
2
C.H
2 C(Me)CH 2
CH
2
CH
3
CHCHCH
2
CH
3
CHCHCH
2
CH
2 Et 2
NCH
2
CH
2 Me 2
NCH
2
CH
2 2-CH 2 -1I-Me-Pyrrolyl 3-CU 2 I -Me-pyrrolyl 5-CH 2 -thiazolyl 2-CH 2 -thienyl 5-CH 2 -2-CI-pyrimidyl 2-CH 2 2-CH 2 -6-OCF 3 -pyr 2-CH 2 -thiadiazy] 5-Me-2-thiadiazyl 5-CI-2-thiadiazyl 5-CF 2 -2-thiadiazyl 2-CH 2 -5-C1-thiadiazyl 5-CH 2 -3-CI-isoxazolyl 5-CH 2 -3-Br-isoxazolyl WO 95/21846 WO 95/ 1846PCTIUS95/01616 32 Table I11 0 2 N SiMe 3 H
RZ
3 I~i [2COLUMN 1 [3 4_
H
Me Et n-Pr i-Pr n-Bu s-Bu i-Bu c-Pr
HCCCH
2
NCCH
2 2-pyr 3-pyr 4-pyr AcSCH 2 Et 2
NCH
2 c-Bu c-pentyl c-hexyl 6-F-2-pyr 6-Me-3-pyr 6-Br-3-pyr 6-F-3-pyr 6-OMe-CI-pyr 6-Me-2-pyr 6-Br-2-pyr 5-CI-2-pyr 5-Me-2-pyr 5-Br-2-pyr 5-F-2-pyr Ph
C
2 Ph 2-Cl-Ph 3-Cl-Ph 4-Cl-Ph C11 2 (c-Pr) 2-CH 2 -pyr 3-CH 2 -pyr 4-CH 2 -pyr 5-CH 2 -isoxazolyl Me 2
NCH
2
CH
2 (c-Bu)
CH
2 (c-pentyl)
CH
2 (c-hexyl) 5-CH 2 -2-Me-thiazolyl 5-CH 2 -2-Br-thiazolyl 2-CH-,-5-Me-thi enyl 3-CH 2 -pyrazolyl 4-CH 2 -PyrazOlYl 5-CH 2 -pyrazolyl 2-CH 2 -5-CI-thienyl 2-CH 2 -5-Me-thienyl 3-CH 2 -6-Me-ppr 3-CH 2 -6-OMe-pyr 3-CH 2 -6-Br-pyr 2-CH 2 -6-CF 3 -pyr 3-CH 2 -6-F-pyr 3-CH 2 -6-CF 3 -pyr 3-CH 2 -6-OCF 3 -pyr 2-CH 2 -6-Me-pyr 2-CH 2 -5-CF 3 -thienyl
NCCH
2
CH
2 AcNHCH 2 AcNHCH 2
CH
2
CH
2 NMe 3
I
CH
2
CH
2 NMe 3
I
CH
2 (2-CI-Ph)
CH
2 (3-CI-Ph)
CH
2 C(Me)CH 2
HCCCH
2
CH
2
C
2
CHCH
2 MeSCH 2
CH
2 AcSCH2)CH 2 2-CH 2 -furyl 5,6-di-CI-3-pyr 5-OMe-2-pyr 2-CH 2 -pyrrolyl 3-CH 2 -PYrrOlYl 3-CH 2 -1 -Me-pyrazolyl 4-CH 2 -1 -Me-pyrazolyl 5-CH 2 1-Me-Pyrazly' 2-CH 2 -Pyrazlyl 2-CH 2 -3-Me-pyrazlyl 2-CH 2 -5-Me-pyrazyl 2-CH 2 -6-Me-pyrazyl 3-CH 2 -pyridazyl 3-CH 2 -6-Me-pyridazyl 3-CH 2 -6-CI-pyiidazyl 4-CH 2 -Pyrimidyl
CH
2 (3,4-di-CI-Ph) 2-CH 2 -6-Cl-pyr 3-CH 2 -6-CI-pyr 4-CH 2 -6-CI-pyr 2-CH 2 2-CH 2 -4-Cl-pyr 2-CH 2 -3-Cl-pyr 2-CH 2 -5,6-di-CI-pyr 3-CH 2 3-CH 2 -4-Cl-pyr 3-CH 2 -,2-Cl-pyr 3-CH 2 -5.6-di-CI-pyr 4-CH 2 -2,6-di-CI-pyr 5-CH 2 -2-CI-thiazolyl
CH
2
CHCH
2
CH
2
CH
2 C(Me)CH 2
CH
2
CH
3
CHCHCH
2
CH
3
CHCHCH
2
CH
2 Et 2
NCH
2
CH
2 Me 2
NCH
2
CH
2 2-CH 2 -I-Me-pyrrolyl 3-CH 2 1-Me-pyrrolyl 5-CH 2 -thiazolyl 2-CH 2 -thienyl 5-CH 2 -2-Cl-pyfimi dyl 2-CH 2 2-CH 2 -6-OCF 3 -pyr 2-CH 2 -thiadiazyl 5-Me-2-thiadiazyl 5-Cl-2-thiadiazyl WO 951846CTIUS95/01616 WO 95/21846 6-OMe-2-pyr 2-thiadiazolyl MeSCH 2 6-Cl-2-pyr 6-CI-3-pyr 2-CH 2 -6-OMe-pyr 2-CH 2 -6-Br-pyr 2-CH 2 -6-F-pyr 5-CH 2 -PYrimidyl 2-CH 2 -PYrimidyl 5-CH 2 -2-Me-pyrimidyl 2-CH 2 -5-CF 3 -thiadiazyi 2-CH 2 -5-Br-thienyl 5-CH 2 -3-Me-isoxazolyl 5-CH 2 -3-r--isoxazolyl 5-CF 2 -2-thiadiazy] 2-CH 2 2-CH 2 5-CH 2 -3-CI-isoxazolyl 5-CH 2 -3-Br-isoxazolyl Table 12 N~SiMe3
H
3
C,,
Cf! 3
R
3
R
3 COLUMN I 2 3_ 114
H
Me Et n-Pr i-Pr n-Bu s-Bu i-Bu c-Pr
HCCCH
2
NCCH
2 2-pyr 3-pyr A-pyr AcSCH 2 Et 2
NCH
2 c-Bu c-pentyl c-hexyl 6-F-2-pyr 6-Me-3-pyr 6-Br-3-pyr 6-F-3-pyr 6-OMe-3-pyr 6-Me-2-pyr Ph
CH
2 Ph 2-Cl-Ph 3-Cl-Ph 4-Cl-Ph
CH
2 (c-Pr) 2-CH 2 -pyr 3-CH 2 -pyr 4-CH 2 -pyr 5-CH 2 -isoxazolyl Me 2
NCH
2
CH
2 (c-Bu)
C
2 (c-pentyl) CI1 2 (c-hexyl) 5-CH 2 -2-Me-thiazolyl 5-CH 2 -2-Br-thiazolyl 2-CH 2 -5-Me-thienyl 3-CH 2 -pyrazolyl 4-CH 2 -pyrazolyl 5-CH 2 -pyrazolyl 2-CH 2 -5-CI-thienyl 2-CH 2 -5-Me-thienyl 3-CH 2 -6-Me-pyr 3-CH 2 -6-OMe-pyr 3-CH 2 -6-Br-pyr 2-CHZ-5-CF 3 -thienyl
NCCH
2
CH
2 AcNHCH 2 AcNHCH 2
CH
2
CH
2 NMe 3 l
CH
2
CH
2 NMe 3
I
C
2 (2-Cl-Ph)
CH
2 (3-CI-Ph)
C
2 (4-Cl-Ph)
C
2 C(Me)CH 2
HCCCH
2
CH
2
CH
2
CHCH
2 MeSCH 2
CH
2 AcSCH 2
CH
2 2-CH 2 -furyl 5,6-di-Cl-3-pyr 5-OMe-2-pyr 2-CH 2 -pyrrolyl 3-CH 2 -pyrrolyl 3-CH 2 1-Me-pyrazolyl 4-CH 2 -1I-Me-pyrazolyl 5-CH 2 1-Me-pyrazolyl 2-CH 2 -Pyrazlyl 2-CH 2 -3-Me-pyrazlyl 2-CH 2 -5-Me-pyrazy]
CH
2 (3,4-di-CI-Ph) 2-CH 2 -6-Cl-pyr 3-CH 2 -6-CI-pyr 4-CH 2 -6-Cl-pyr 2-CH 2 2-CH 2 -4-Cl-pyr 2-CH 2 -3-CI-pyr 2-CH 2 -5,6-di-CI-pyr 3-CH 2 3-CH 2 -4-CI-pyr 3-CH 2 -2-CI-pyr 3-CHI-5,6-di-CI-pyr 4-CH 2 -2,6-di-CI-pyr 5-CH 2 -2-Cl-i.iazolyl
CH
2 CHCH2CA'2
C
2 C(Me)CH 2
CH
2
CH
3
CHCHCH
2
CH
3
CHCHCH
2
CH
2 Et 2
NCH
2
CH
2 Me 2
NCH
2
CH
2 2-CH 2 -1-Me-PYrrOlYl 3-CH 2 -1 Me-pyrrolyl 5-CH 2 -thiazolyl 2-CfH 2 -thieaiyl 5-CH 2 -2-Cl-pyrin-ddyl WO 95/21846 WO 9521846PCTIUS95/01616 422 423 424 425 426 427 428 429 430 431 6-Br-2-pyr 5-CI-2-pyr 5-Me-2-pyr 5-Br-2-pyr 5-F-2-pyr 6-OMe-2-pyr 2-thiadiazolyl MeSCH 2 6-CI-2-pyr 6-CI-3-pyr 6-CI-4-ovr 2-CH 2 -6-CF 3 -pyr 3-CH 2 -6-F-pyr 3-CH 2 -6-CF 3 -pyr 3-CH 2 -6-OCF 3 -pyr 2-CH 2 -6-Me-pyr 2-C11 2 -6-OMe-pyr 2-CH 2 -6-Br-pyr 2-CH 2 -6-F-pyr 5-CH 2 -pyrimidyl 2-CH 2 -Pyrimidyl 2-CH 2 -6-Me-pyrazyl 3-CH 2 -pyridazyl 3-CH 2 -6-Me-pyridazyl 3-CH 2 -6-CI-pyridazyl 4-CH 2 -Pyrimidyl 5-CH2-2-Me-pyrimiddyl 2-CH 2 -5-CF 3 -thiadiazyl 2-CH 2 -5-Br-thienyl 5-CH 2 -3-Me-isoxazolyl 5-CH 2 -3-F-isoxazolyl 2-CH 2 2-CH 2 -6-OCF 3 -pyr 2-CH 2 )-thiadiazyl 5-Me-2-thiadiazy] 5-CI-2-thiadiazyl 5-CF 2 -2-thiadiazyl 2-CH 2 2-CH 2 5-CH 2 -3-Ci-isoxazo]l 5-CH 2 -3-Br-isoxazolyl Table 13 0N N SiMe 3
CH
3
R
3 COLUMN_ 2II J3
H
Me Et n-Pr i-Pr n-Bu s-Ru i-Ru c-Pr
HCCCH
2
NCCH
2 2-pyr 3-pyr 4-pyr AcSCH 2 Et 2
NCH
2 c-Ru c-pentyl c-hexyl Ph
CH
2 Ph 2-Cl-Ph 3-Cl-Ph 4-Cl-Ph
CH
2 (c-Pr) 2-CH 2 7pyr 3-CH 2 -pyr 4-CH 2 -pyr 5-CH 2 -isoxazolyl Me 2
NCH
2
CH
2 (c-Ru)
C
2 (cpentyl)
C
2 (chexyI) 5-CH 2 -2-Me-thiazolyl 5-CH 2 -2-Br-thiazolyl 2-CH 2 -5-Me-thienyl 3-CH 2 -Pyrazolyl 4-CH 2 -pyrazolyl 2-CH 2 -5-CF 3 -thienyl
NCCH
2
CH
2
ACNHCH
2 AcNHCH 2
CH
2
CH
2 NMe 3
I
CH
2
CH
2 NMe 3
I
CH
2 (3-CI-Ph)
CH
2 (4-CI-Ph)
CH
2 C(Me)CH 2
HCCCH
2
CH
2
C
2
CHCH
2 MeSCH 2
CH
2 AcSCH 2
CH
2 2-CH 2 -furyl 5,6-di-CI-3-pyr 5-OMe-2-pyr 2-CH 2 -Pyrrolyl 3-CH 2 -Pyrrolyl
CH
2 (3,4-di-CI-Ph) 2-CH 2 -6-CI-pyr 3-CH 2 -6-CI-pyr 4-CH 2 -6-Cl-pyr 2-CH 2 2-CH 2 -4-CI-pyr 2-CH 2 -3-CI-pyr 2-CH 2 -5,6-di-CI-pyr 3-CH 2 3-CH 2 -4-CI-pyr 3-CH 2 -2-CI-pyr 3-CH 2 -5,6-di-CI-pyr 4-CH 2 -2.6-di-CI-pyr 5-CH 2 -2-CI-thiazolyl
CH
2
CHCH
2
CH
2
CH
2 C(Me)CH 2
CH-,
CH
3
CHCHCH
2
CH
3
CHCHCH
2
CH,)
Et 2
NCH
2
CH.,
WO 95/21846 PTU9/11 PCTfUS95/01616 6-F-2-pyr 6-Me-3-pyr 6-Br-3-pyr 6-F-3-pyr 6-OMe-3-pyr 6-Me-2-pyr 6-Br-2-pyr 5-Cl-2-pyr 5-Me-2-pyr 5-Br-2-pyr 5-F-2-pyr 6-OMe-2-pyr 2-thiadiazolyl MeSCH 2 6-Cl-2-pyr 6-Cl-3-pyr 6-CI-4-pyr 5-CH 2 -pyrazolyl 2-CH 2 -5-CI-thienyl 2-CH 2 -5-Me-thienyl 3-CH 2 -6-Me-pyr 3-CH 2 -6-OMe-pyr 3-CH 2 -6-Br-pyr 2-CH 2 -6-CF 3 -pyr 3-CH 2 -6-F-pyr 3-CH 2 -6-CF 3 -pyr 3-CH 2 -6-OCF 3 -pyr 2-CH 2 -6-Me-pyr 2-CH 2 76-OMe-pyr 2-CH 2 -6-Br-pyr 2-CH 2 -6-F-pyr 5-CH 2 -pyrimidyl 2-CH 2 -pyrimidyl 3-CH 2 1-Me-pyrazolyl 4-CH 2 1-Me-pyrazolyl 5-CH 2 -1I-Me-pyrazolyl 2-CH 2 -Pyrazlyl 2-CH 2 -3-Me-pyrazlyl 2-CH 2 -5-Me-pyrazy] 2-CH 2 -6-Me-pyrazyl 3-CH 2 -pyridazyl 3-CH 2 -6-Me-pyridazyl 3-CH 2 -6-C1-pyridazyl 4-CH 2 -pyrimidyl 5-CH 2 -2-Me-pyrimidyl 2-CH 2 -5-CF 3 -thiadiazyl 2-CH 2 -5-Br-thieriyl 5-CH 2 -3-Me-isoxazolyl 5-CH 2 -3-F-isoxazolyl Me 2
NCH
2
CH
2 2-CH 2 -I -Me-pyrrolyl 3-CH 2 -1 -Me-pyrrolyl 5-CH 2 -thiazolyl 2-CH2)-thienyl 5-CH 2 -2-Cl-pyrimidyl 2-CH 2 2-CH 2 -6-OCF 3 -pyr 2-CH 2 -thiadiazyl 5-Me-2-thiadiazy] 5-Cl-2-thiadiazyl 5-CF 2 -2-thiadiazy] 2-CH 2 2-CH 2 5-CH 2 -3-CI-isoxazolyl 5-CH 2 -3-Br-isoxazolyl Table 14 0 2 N N'SiWe 3
H
3 cK- :x CH 3
R
R
3 COLUMNj 1 2 T 3
H
Me Et n-Pr i-Pr n-Bu s-Bu i-Bu c-Pr
HCCCH
2
NCCH
2 2-pyr Ph
CH
2 Ph 2-Cl-Ph 3-Cl-Ph 4-Cl-Ph
CH
2 (c-Pr) 2-CH 2 -Pyr 3-CH 2 -pyr 4.CH 2 -pyr 5-CH 2 -isoxazolyl Me 2
NCH
2
CH
2 (C-Bu) 2-CH 2 -5-CF 3 -thienyl
NCCH
2
CH
2 AcNHCH 2 AcNHCH 2
CH
2
CH
2 NMe 3
I
CH
2
CH
2 NMe 3 l
CH
2 (2-CI-Ph)
CH
2 (4-CI-Ph)
CH
2 C(Me)CH 2
HCCCH
2
CH
2
CH
2
CHCH
2
CH
2 ,-i-Cl-Pyr 3-CH- 2 -6-Cl-pyr 4-CH 2 -6-Cl-pyr 2-CH 2 2-CH 2 -4-Cl-pyr 2-CH 2 -3-Cl-pyr 2-CH 2 -5,6-di-CI-pyr 3-CH 2 3-CU 2 -4-Cl-pyr 3-CH 2 -2-CI-pyr 3-CH 2 -5,6-di-CI-pyr WO 95/21846 WO 9521846PCTfUS95/01616 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 3-pyr 4-pyr AcSCH 2 Et 2
NCH
2 c-.Bu c-pentyl c-hexyl 6-F-2-pyr 6-Me-3-pyr 6.Br-3-pyr 6-F-3-pyr 6-OMe-3-pyr 6-Me-2-pyr 6-Br-2-pyr 5-CI-2-pyr 5-Me-2-pyr 5-Br-2-pyr 5-F-2-pyr 6-OMe-2-pyr 2-thiadiazolyl MeSCH 2 6-CI-2-pyr 6-CI-3-pyr 6-CI.4-pyr
CH
2 (c-pentyl)
CH
2 (c-hexyl) 5-CH 2 -2-Me-thiazolyl 5-CH 2 -2-Br-thiazolyl 2-CH 2 -5-Me-thienyl 3-CH 2 -pyrazolyl 4-CH 2 -Pyrazo,'yl 5-CH 2 -Pyrazolyl 2-CH- 2 -5-CI-thienyl 2-CH 2 -5-Me-thienyl 3-CH 2 -6-Me-pyr 3-CH 2 -6-OMe-pyr 3-CH 2 -6-Br-pyr 2-CH 2 -6-CF 3 -pyr 3-CH 2 -6-F-pyr 3-CI1 2 -6-CF 3 -pyr 3-CH 2 -6-OCF 3 -pyr 2-CH 2 -6-Me-pyr 2-CH 2 -6-OMe-pyr 2-CH 2 -6-Br-pyr 2-CH 2 -6-F-pyr 5-CH 2 -pyrimidyl 2-CH 2 -pyrimidyl MeSCH 2
CH
2 AcSCHICH 2 2-CH 2 -furyl 5,6-di-CI-3-pyr 5-OMe-2-pyr 2-CH 2 -pyrrolyl 3-CH 2 -pyrrolyl 3-CH 2 -1I-Me-pyrazolyl 1 -Me-pyrazolyl 5-CH 2 1-Me-pyrazolyl 2-CH 2 -pyrazlyl 2-CH 2 -3-Me-pyrazlyl 2-CH 2 -5-Me-pyrazyl 2-CH 2 -6-Me-pyrazyl 3-CH 2 -pyridazy] 3-CH 2 -6-Me-pyridazyl 3-CH 2 -6-CI-pyridazy] 4-CH 2 -pyrimidyl 5-CH 2 -2-Me-pyrimidyl 2-CH 2 -5-CF 3 -thiadiazyl 2-CH 2 -5-Br-thienyl 5-CH 2 -3-Me-isoxazolyl 5-CH 2 -3-F-isoxazolyl 4-CH 2 -2,6-di-CI-pyr 5-CH 2 -2-CI-thiazolyl CHnCHCH 2
CH,)
C'
2 C(Me)CH 2
)CH
2
CH
3
CHCHCH
2
CH
3
CHCHCH
2
CH
2 Et 2
NCH
2
CH
2 Me 2
NCH
2
CH
2 2-CH 2 1-Me-pyrrolyl 3-CH- 2 -1I-Me-pyrrolyl 5-CH 2 -thiazolyl 2-CH 2 -thienyl 5-CH 2 -2-CI-pyrimidyl 2-CH 2 2-CH 2 -6-OCF 3 -pyr 2-CH 2 -thiadiazyl 5-Me-2-thiadiazy] 5-CI-2-thiadiazyl 5-CF 2 -2-thiadiazy] 2-CH 2 2-CH 2 5-CH 2 -3-CI-isoxazolyl 5-CH 2 -3-Br-isoxazolyl 1 L I The following additional notations have been used to represent various embodiments of Q in Tables 15 and 16: Q-1 6-C1-3-pyridyl, Q-2 5,6-dichloro-3-pyridyl, Q-3= Q-4 3-chloro-5-isoxazolyl and Q-5 CH 3
SCH
2 Table 0 2
NI
k 2
R
3 WO 95/21846 PcTJUS95/01616 37
COLUMN
1 2 3 4 505 A=direct band; R 2
R
3 =Me; R 4 =Me; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 506 A=direct bond; R 2
R
3 =Me; R 4 =t-Bu; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 507 A=direct bond; R 2
R
3 -Me; R4-Ph; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 508 A=direct bond; R 2
R
3 =Me; R 4 =i-Pr; R 5 =i-Pr; R 6 =i-Pr; Q-1 Q-2 Q-3 Q-4 509 A=direct bond; R 2
R
3
R
4 =t-Bu; R 5 =Ph; R 6 Q-1 Q-2 Q-3 Q-4 510 A=direct bond; R 2
R
3
R
4 =Ph; R 5 =Ph; R 6 =Ph; Q-1 Q-2 Q-3 Q-4 511 A=CH 2
R
2
R
3 -Me; R 4 =t-Bu; R 5 -Me; R 6 -Me; Q-1 Q-2 Q-3 Q-4 512 A=CH 2
R
2
R
3
R
4 =Ph; R 5 -Me; R 6 -Me; Q-1 Q-2 Q-3 Q-4 513 A--CH 2
R
2
R
3 -Me; R 4 =i-Pr; R 5 =i-Pr; R 6 =i-Pr; Q-1 Q-2 Q-3 Q-4 514 A=CH 2
R
2
R
3 =Me; R 4 =t-Bu; R 5 =Ph; R 6 =Ph; Q-1 Q-2 Q-3 QA 515 A--CH 2
R
2
R
3 =Me; R$-Ph; R 5 =Ph; R 6 Q-1 Q-2 Q-3 Q-4 516 A--CH 2
R
2
R
3 -Me; R 4 =Et; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 517 A=Cfl 2
R
2
R
3 -Me; R 4
CH
2 CH; R 5 =Me; R 6 =Me; Q-1 (Q-2 Q-3 Q-4 518 A--CH 2
R
2
R
3 =Me; R 4
=CH
2
CHCH
2
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 519 A=CH 2
R
2
R
3 =Me; R 4 =EtO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 512 A=CH 2
R
2
R
3 =Me; R 4 =i-PrO; R 5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 513 A--CH 2
R
2
R
3 -Me; R 4 =EtO; R 5 -Eto; R 6 =Me; Q-1 Q-2 Q-3 Q-4 514 A=-CH 2
R
2
=H;,R
3 =Me; R -i-PrO; R 5 =i-ThrO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 515 A=CH 2
R
2
R
3 =Me; R 4 -EtO; R 5 =EtO; R 6 -=EtO; Q-1 Q-2 Q-3 Q-4 516 A--CH 2
R
2
R
3 =Me; R 4 =i-PrO; R 5 =i-PrO; R 6 -i-PrO; Q-1 Q-2 Q-3 Q.-4 517 A=-CH 2
R
2
R
3 -Me; R 4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 518 A=CH 2
R
2
R
3 -Me; R 4
R
5 -Et; R 6 -Et; Q-1 Q-2 Q-3 Q-4 519 A=-CH 2
CH
2
R
2
R
3 =Me; R 4 =Me; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 520 A=(CH 2 3
R
2
R
3 -Me; 1$-Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 521 A--CH 2 CHCH; R 2
R
3 =Me; R 4 -Me; R 5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 522 A--CH 2 CC& R 2
R
3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 523 A=CH 2
CH
2 CHCH; R 2
R
3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 524 A=-CH 2
CH
2 CC; R 2
R
3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 525 A=o-Ph; R* 2
R
3 -Me; R 4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 526 A~m-Ph; R 2
R
3 -Me; R$=Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 527 A=p-Ph; R 2
R
3 =Me; R 4 =Mle; Rb-Me; p 6 -Me, Q-1I Q-2 Q-3 Q-4 528 A~direct bond; R 2 =Me;
R
4 =Me; R 5 =Me; R 6 =Me, Q-1 Q-2 Q-3 Q-4 529 A=direct bond; R 2 =Me; R 3 =Me; R 4
R
5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 530 A=direct bond; R 2 =Me; R 3 =Me; R 4
R
5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 531 A=direct bond; R 2 =Me; R 3 =Me; R 4 =i-Pr; R 5 =i-Pr; R 6 =i-Pr; Q-1 Q-2 Q-3 Q-4 WO 95121846 PCTIUS95/01616 38 532 A=direct bond; R 2 =Me; R 3 =Me. R 4
R
5
R
6 Q-1 Q-2 Q-3 Q-4 533 A=direct bond; R 2 =Me; R 3 =Me; R 4 -Ph; R 5 =Ph; R 6 =Ph; Q-1 Q-2 Q-3 Q-4 534 A=direct bond;, R 2
R
3 =Me; R 4 =Me; R 5 =Ph; R 6 Ph; Q.1 Q-2 Q-3 Q-4 535 A=CH 2
R
2
R
3
R
4 =Me; R 5
R
6 Q-i Q-2 Q-3 Q-4 536 A--CH 2
R
2 -Me; R 3
R
4 =Me; R 5
R
6 Q-1 Q-2 Q-3 Q-4 537 A=-CH 2
R
2 =Me, R 3 =Or: R4W-3u; R 5 =Me; R 6 =Me; Q-1 Q-.2 Q-~3 Q-4 538 A=-CH 2 RL-Me; R 3 =ile: R'"Ii R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 539 A=-CH 2
R
2 Me; R 3 =Me; R 4 -i-Pr; R 5 =i-Pr; R 6 =i-pr; Q-1 Q-2 Q-3 Q-4 540 A=-CH 2
R
2 =Me; R 3 =Me; R 4
R
5 =Ph; R 6 =ph; Q-1 Q-2 Q-3 Q-4 541 A=-CH 2
R
2 -Me; R 3 -Me; R 4 =Ph; R 5 =Ph; R 6 Q.1 Q-2 Q-3 Q-4 542 A--CH 2
R
2 =Me; R 3 =Me; R 4 =Et; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 543 A--CH 2 R2ZMe: R 3 =Me; R 4
=-CH
2 CH,; R 5
R
6 Q-1 Q-2 Q-3 Q-4 544 A=-CH 2
R
2 =Me; R 3
R
4
-CH
2
CHCH
2
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 545 A=-CH 2
R
2
R
3
R
4 =EtO;, R 5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 546 A=-CH 2
R
2 =Me; R 3 r.
4 =i-PrO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 547 A--CH 2
R
2 =Me, R 3 =Me; R 4 =EtO; R 5 =EtO; R 6 Q-1 Q-2 Q-3 Q-4 548 A=-CH 2
R
2
R
3 =Me; R 4 =i-PrO; R 5 =i-PrO; R 6 Q-1 Q-2 Q-3 Q-4 549 A=-CH 2
R
2 =Me; R 3 =Mc; R 4 =EtO; R 5 =EtO; R 6 =EtO; Q-1 Q-2 Q-3 Q-4 550 A--CH 2
R
2 -Me; R 3 -Me; R 4 =MeO; R 5 =MeO; R 6 =MeO; Q-1 Q-2 Q-3 Q-4 551 A=-CH 2
R
2 Me; R 3 =Me; R 4 =MeO; R 5 =MeO; R 6 Q-1 Q-2 Q-3 Q4 552 A=-CH 2
R
2 =Me; R 3 =Me; R 4 =MeO; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 553 A=-CH 2
R
2 =Me; R 3 =Me- R 4
R
5 =Me; R 6 =Me; Q- 1 Q-2 Q-3 Q-.4 554 A=-CH 2
R
2 =Me; R 3
R
4
R
5
R
6 Q-1 Q-2 Q-3 Q-4 555 A=-CH 2
CH
2
R
2 =Me; R 3 =Me; R 4 =Me; R 5 -Me; R 6 Me; Q-1 Q-2 Q-3 Q-4 556 A--(CH2) 3
R
2 =Me; R 3 =Me; R 4
R
5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 557 A=-CH 2 CHCH; R 2 =Me; R 3 =Me; R 4 =Me; R 5 =Me; R 6 Q-1 Q-2 Q-.3 QA 558 A--CH 2 CC; R 2 =Me; R 3 =Me: R 4 =Me; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 559 A=-CH 2
CH
2 CHCH; R 2 =Me; R 3
R
4 =Me, R 5
R
6 =Me; Q-1 Q-2 Q-3 Q 4 560 A=-CH 2
CH
2 CC; R 2
R
3 =Me; R 4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 561 A=o-Ph,; R 2
R
3 =Me, R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 562 A=m-Ph;, R 2
R
3 =Me; R 4 =Me; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 563 A=p-Ph; R 2 =Me; R 3 =Me; R 4 =Me; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q.4 564 A=-CH 2
R
2
R
3 -Me; R 4 =MeQ; R 5 =MeQ; R 6 =MeO-; Q-1 Q-2 Q-3 Q-4 565 A--CH 2
R
2
R
3 =Me; R 4 =MeO; R 5 =MeO; R 6 Q-1 Q-2 Q-3 Q-4 566 A--CH 2
R
2
R
3 =Me; R 4 =MeO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 567 A=direct bond; R 2
R
3 =Me; R 4 =Me, R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 568 A=direct bond; R 2 =Et; R 3 =Mc' R 4 =t-Bu; R 5 =Me; R 6 =Me; Q-1 Q-2 'Q-3 Q4 569 A-direct bond; R 2
R
3 =Me; R 4
R
5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 WO 95/21846 pCTlus9s/o16l6 39 570 A=direct bond;, R 2 Et; R 3 =Me; R 4 =i-Pr; R 5 =i-Pr; R 6 =i-Pr; Q-1 Q-2 Q-3 Q-4 571 A=direct bond; R 2
R
3 =Me; R 4 =t-BU; R 5 =Ph; R 6 Q-1 Q-2 Q-3 Q-4 572 A=direct bond; R 2 -Et; R 3
R
4 =Ph; R 5 =Ph; R 6 =Ph, Q-1 Q-2 Q-3 Q-4 573 A=direct bond; R 2 =Et; R 3 -Me; R 4 -Me; R 5 =Ph; R 6 Q-1 Q-2 Q-3 Q-4 574 A--CH 2
R
2
R
3 =Me; R 4 =Me; R 5
R
6 =Ph; Q-1 Q-2 Q-3 Q-4 575 A--CH 2
R
2 Et; R 3 -Me; R 4 -t-Bu; R 5 =Me: R 6 Q-1 Q-2 Q-3 Q.4 576 A=-CH 2
R
2 =Et; R 3 =Me; R 4 =Ph; R 5 =Me* R 6 -Me; Q-1 Q-2 Q-3 Q-4 577 A=-CH 2
R
2
R
3 =Me; R 4 =i-Pr; R 5 =i-Pr; R 6 =i-Pr; Q-1 Q-2 Q-3 Q-4 578 A--CH 2
R
2 =Et; R 3 =Me; R 4 =t-Bu; R 5 =Ph; R 6 =Ph; Q-1 Q-2 Q-.3 Q-4 579 A=-CH 2
R
2
R
3 =Me; R 4 Ph; R 5
R
6 =Ph; Q-1 Q-2 Q-3 Q-4 580 A--CH 2
R
2 =Et; R 3 =Me; R 4 -Et; R 5 -Me; R 6 Q-1 Q-2 Q-3 Q-4 581 A--CH 2 R2=Et; R 3 =Me; R 4
=-CH
2 CH; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 582 A--CH 2
R
2 =Et; R 3 =Me; R 4
=CH
2
CHCH
2
R
5 =Me; R 6 -Me; Q-1 Q-2 Q-3 Q-4 583 A=-CH 2
R
2 =Et; R 3 =Me; R 4 =EtO; R 5 =Me; R 6 =Me; Q-.1 Q-2 Q-3 Q-4 584 A=-CH 2
R
2
R
3 =Me; R 4 =i-PrO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 585 A--CH 2
R
2 Et; R 3 =lMe; R 4 =EtO; R 5 =EtO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 586 A=-CH 2
R
2 =Et; R 3 Me; R 4 =i-PrO; R 5 =i-PrO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 587 A=CH 2
R
2 -Et; R 3 -Me; R 4 =EtO; R 5 =EtO; R 6 =EtO; Q-1 Q-2 Q-3 Q-4 588 A--CH 2
R
2 =Et; R 3 =Me; R 4 =MeO; R 5 =MeO; R 6 =MeO; Q-1 Q-2 Q-3 Q-4 589 A=-CH 2
R
2 =Et; R 3 =Me; R 4 =MeO; R 5 =MeO; R 6 Q-1 Q-2 Q-3 Q-4 590 A-=CH 2
R
2
R
3 =Me; R 4 =MeO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 591 A=CH 2
R
2 =Et; R 3 =Me; R 4
R
5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 592 A=-CH 2
R
2
R
3 =Me; R 4 5 E;R=t Q-1 Q-2 Q-3 Q-4 593 A=-CH 2
CH
2
R
2 -Et; 3 =Me; R 4 =Me; R 5 =Me; R 6 Me; Q-.1 Q-2 Q-3 Q-4 594 A=(CH 2 3
R
2
R
3 =Me; R 4 =Me; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 595 A=-CH 2 CHCH; R 2 =Et; R 3 =Me; R 4 =Me; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 596 A--CH 2 CC; R 2 =Et; R 3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-I Q-2 Q-3 Q-4 597 A--CH 2
CH
2 CHCH; R 2 =Et; R 3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 598 A--CfH 2
CH
2 CC; R 2 =Et; R 3 -Me; R 4 -Me; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 599 At-o-Ph; R 2 =Et; R 3 =Me; R 4 =Me; R 5 =Me; R 6 Q-1 Q.-2 Q-3 Q-4 600 A=m-Ph, R 2 -Et; R 3
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 601 Amp-Ph;, R 2 =Et; R 3 =Me; R 4 =Me; R 5 =Me; R 6 Q-.1 Q-2 Q-3 Q-4 602 A=direct bond; R 2
+R
3
=-CH
2
CH
2
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 603 A=direct bond; R 2
+R
3
=-CH
2
CH
2 Rd;4--Bu; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 604 A=direct bond; R 2
+R
3
-CH
2
CH
2
R
4
R
5 =Me; R 6 =me; Q-1 Q-2 Q-3 Q-4 605 A=direct bond; R 2
+R
3
=-CH
2
CH
2
R
4
R
5 =i-Pr; R 6 =i-Pr; Q-1 Q-2 Q-3 Q-4 606 A-direct bond; R 2
+R
3
=-CH
2
CH
2
R
4 =t-Bu; R 5 =Ph; R 6 Q-1 Q-2 Q-3 Q4 607 A-direct bond; R 2
+R
3
-CH
2
CH
2
R
4 =Ph; R 5 =Ph; R 6 Q-1 Q-2 Q-3 Q-4 WO095/21846 PCT(US9S101616 608 Adirect bond; R 2
+R
3
=-CH
2
CH
2
R
4 =Me; R 5 =Ph; R 6 Q-1 Q-2 Q-3 Q-4 609 A-CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =Me; R 5 -Ph; R 6 -Ph; Q-1 Q-2 Q-3 Q-4 610 A=CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =t-Bu; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 611 A=-CH 2
R
2
+R
3
=-CH
2
CH
2
R
4
R
5 -Me; R 6 -Me; Q-1 Q-2 Q-3 Q-4 612 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =i-Pr; R 5 =i-Pr; R 6 =i-Pr; Q-1 Q-2 Q-3 Q-4 613 A--CH 2
R
2
+R
3
-CH
2
CH
2
R
4
R
5 =Ph; R 6 =Ph; Q-1 Q-2 Q-3 Q-4 614 A--CH 2
R
2
+R
3
=-CH
2 CF1 2
R
4
R
5 -Ph; R 6 Q-1 Q-2 Q-3 Q-4 615 A-CH 2
R
2
+R
3
-CH
2
CH
2
R
4 =Et; R 5 -Me, R 6 -Me; Q-1 Q-2 Q-3 Q-.4 616 A--CH 2
R
2 -iR 3
=-CH
2
CH
2
R
4
-CH
2 CH; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 617 A-CH 2
R
2
+R
3
=-CH
2
CH
2
R
4
CH
2
CHCH
2
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3' Q-4 618 A-CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =EtQ; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 619 A=-CH 2
R
2
+R
3
=-CH
2
CH
2 7; R 4 =i-PrO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 620 A=-CH 2
R
2
+R
3
=-CH
2 CHi 2
R
4 =-EtO; R 5 =EtQ; R 6 =Me; Q-1 Q-2 Q-3 Q-4 621 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =i-PrO; R 5 =i-PrO; R 6 Q-1 Q-2 Q-3 Q-4 622 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =EtO; R 5 =EtQ; R 6 =EtO; Q-1 Q-2 Q-3 Q-4 623 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =MeO; R 5 =MeO; R 6 =MeQ; Q-1 Q-2 Q-3 Q-4 624 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 -MeQ; R 5 =MeO;, R 6 Q-1 Q-2 Q-3 Q-4 625 A=H 2
R
2
R
3
-C
2
C
2
-;R
4 Me; 5 6 =e;Q-1 Q-2 Q-3 Q4 Q-5 626 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =He; R 5 =Me; R 6 =Me 627 A--CH 2
R
2
-+R
3
=-CH
2
CH
2
R
4
R
5 Met; R 6 Met; Q-1 Q-2 Q-3 Q-4 628 A-C
H
2H 2
R
2
+R
3
-CC
H
2- R 4
R
5 R R 6 e; Q-1 Q-2 Q-3 Q-4 629 A=(CH2 C3
R
2
+R
3
-CH
2
CH
2
R
4 =Me; R 5 =Me, R 6 =Me; Q-1 Q-2 Q-3 Q-4 630 A=(CH 2 CHC; R 2
+R
3
-CH
2
CH
2
R
4 Me; R 5 Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 631 A--CH 2 CC; R 2
+R
3
-CH
2
CH
2
R
4 =Me R 5 =Me R 6 =Me; Q-1 Q-2 Q-3 Q-4 632 A--HC;R=3=
CH;R
2
+R
3
-C
2
CH
2 R=Me; R6=Me; Q-1 Q-2 Q-3 Q-4
R
6 =me; 633 A=CH 2
CH
2 CC; R 2
+R
3
=-CH
2
CH
2
R
4 =Me; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 634 A=o-Ph; R 2
+R
3
=-CH
2
CH
2
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 635 A=m-Ph; R 2
+R
3
=-CH
2
CH
2
R
4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 636 A-p.Ph; R 2
+R
3
=-CH
2
CH
2
R
4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q.3 Q.4 637 A=direct bond; R 2
+R
3 =-CH(Me)CH2-;
R
4 =Me; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 638 A=direct bond; R 2
+R
3 =-CH(Me)CH 2
R
4 =t-Bu; R 5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =Me; 639 A=direct bond; R 2
+R
3 =-CH(Me)CH 2
R
4 =Ph; R 5 =Me; R 6 Me; Q-1 Q-2 Q-3 Q-4 640 A=direct bond; R 2
+R
3 =-CH(Me)CH 2
R
4 =i-Pr; R 5 =i-Pr; Q-1 Q-2 Q-3 Q-4
R
6 =i-Pr; 641 A=direct 'bond;, R 2
+R
3 =-CH(Me)CH 2
R
4 =t-Bu; R 5 -Ph; R 6 =Ph; Q-1 Q-2 Q-3 Q-4 642 A=direct bond,, R 2
+R
3 -CH(Me)CH2-;
R
4 =Ph; R 5 =Ph; R 6 =Ph; Q-1 Q-2 Q-3 Q-4 WO 95/21846 PCT[US9S/01616 41 643 A=direct bond; R 2
+R
3 =-CH(Me)CH 2
R
4 -Me; R 5 =Ph; R 6 =Ph; Q-1 Q-2 Q-3 Q-4 644 A-CH 2
R
2
+R
3 CH(Me)CH 2
R
4 =Me; R 5 =Ph; R 6 Ph; Q-1 Q-2 Q-3 Q-4 645 A-CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 -t-Bu; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 646 A=CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =Ph; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 647 A=CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =i-Pr; R 5 =i-Pr; R 6 Q-1 Q-2 Q-3 Q-4 648 A=CH 2
R
2
+R
3
R
4 =t-Bu; R 5 =Ph, R 6 =Ph; Q-1 Q-2 Q-3 Q-4 649 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =Ph; R 5 =Ph; R 6 =Ph; Q-1 Q.-2 Q-3 Q-4 650 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =Et; R 5 =Me; R 6 =Me, Q-1 Q-2 Q-3 Q-4 651 A=CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4
-CI-
2 CH; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 652 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4
CH
2
CHCH
2
R
5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =Me; 653 A=CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 -Eto; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 654 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =i-PrO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 655 A=CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =EtO;, R 5 =EtO; R 6 =Me, Q-1 Q-2 Q-3 Q-4 656 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =i-PrO; R 5 =i-PrO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 657 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =EtQ; R 5 =EtO: R 6 =EtO; Q-1 Q-2 Q-3 Q-4 658 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =MeO; R 5 =MeO; R 6 =-MeO; Q-1 Q-2 Q-3 Q-4 659 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =MeO; R 5 =MeO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 660 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =MeO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 661 A-CH 2
R
2
+R
3 =-CH-(Me)CH 2
R
4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 662 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4
R
5 =rEt; R 6 Et; Q-1 Q-2 Q-3 Q-4 663 A--CH 2
CH
2
R
2
+R
3 =-CH(Me)CH2-;
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 664 A=(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 665 A--CH 2 CHCH, R 2
+R
3 =-CH(Me)CH 2
R
4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 666 A--CH 2 CC; R 2
+R
3 =-CH(Me)CH2-;
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 667 A=CH 2
CH
2 CHCH; R 2
+R
3 =-CH(Me)CH 2
R
4 =Me; R 5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =Me; 668 A--CH 2
CH
2 CC; R 2
+R
3 =-CH(Me)CH 2
R
4 =Me; R 5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =Me; 669 A=o-Ph; R 2
+R
3 =-CH(Me)CH2-;,
R
4 =Me; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 670 A=m-Ph; R 2
+R
3 =-CH(Me)CH 2
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 671 A=p-Ph; R 2
+R
3 =-CH(Me)CH 2
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 672 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 =Et; R 5 =Et; R 6 =Et; Q-1 Q-2 Q-3 Q-4 673 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 =iPr; R 5 =iPr; R 6 =iPr; Q-1 Q-2 Q-3 Q-4 674 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 675 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 =tBu; R 5 =Me; R 6 =Me; Q-1 Q.-2 Q-3 Q-4 676 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 =Eto; R 5 =EtO; R 6 =EtO; Q-1 Q-2 Q-3 Q-4 677 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 =MeO; R 5 =MeO; R 6 =MeO; Q-1 Q-2 Q-3 Q-4 WO 95/21846 PCTIUS95/01616 42 678 A=(CH 2 3
R
2
-+R
3
-CH
2
CH
2
R
4 -EtO, R 5 =EtO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 679 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 =EtO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 680 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 =n-PrO; R 5 =n-PrO; R 6 Q-1 Q-2 Q-3 Q-4 PrO; 681 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 =i-PrO; R 5 =i-PrO; R 6 =i-PrO; Q-1 Q-2 Q-3 Q-4 682 A=(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4 =Et; R 5 =Et; R 6 =Et; Q-1I Q-2 Q-3 Q-4 683 A=(CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 -iPr; R 5 -iPr; R 6 =iPr; Q-1 Q-2 Q-3 Q-4 684 A=(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4 -Ph; R 5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 685 A=(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4 -tBu; R 5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 686 A=(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4 -EtO; R 5 -EtO; R 6 =-EtO; Q-1 Q-2 Q-3 Q-4 687 A=(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4
R
5 =MeO; Q-1 Q-2 Q-3 Q-4
R
6 =MeO; 688 A--(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4 =Eto; R 5 =EtO; R 6 Q-1 Q-2 Q-3 Q-4 689 A=(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4 =EtO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 690 A=(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4 =-n-PrO; R 5 =n-PrO; R 6 Q-1 Q-2 Q-3 Q-4 PrO; 691 A=(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4 =-PrO; R 5 =-PrO; R 6 Q-1 Q-2 Q-3 Q-4 PrO; 692 A=(CH 2 4
R
2
+R
3
=-CH
2
CH
2
R
4 =Et; R 5 =Et; R 6 =Et; Q-1 Q-2 Q-3 Q-4 693 A=(CH 2 4
R
2
+R
3
=-CH
2
CH
2
R
4 =EtQ; R 5 =EtO; R 6 =EtO; Q-1 Q-2 Q-3 Q-4 694 A=(CH 2 4
R
2
+R
3
=-CH
2
CH
2
R
4 =MeO; R 5 -MeO;, R 6 =MeO; Q-1 Q-2 Q-3 Q-4 695 A=(CH 2 4
R
2
+R
3
=-CH
2
CH
2
R
4 =EtO; R 5 =EtO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 696 A=(CH 2 4
R
2
+R
3 =-CH(Me)CH 2
R
4 =Et; R 5
R
6 =Et; Q-1 Q-2 Q-3 Q-4 697 A=(CH 2 4
R
2
+R
3 =-CH(Me)CH 2
R
4 =EtO; R 5 =EtO; R 6 =-EtO; Q-1 Q-2 Q-3 Q-4 698 A=(CH 2 4
R
2
+R
3 =-CH(Me)CH2-;
R
4 =MeQ; R 5 =MeO; Q-1 Q-2 Q-3 Q-4
R
6 =MeO; 699 A=(CH 2 4
R
2
+R
3 =-CH(Me)CH 2
R
4 =EtO; R 5 =EtO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 700 A--CH 2
R
2
+R
3
=-(CH
2 3
R
4 =Me; R 5 -Ph; R 6 -Ph; Q-1 Q-2 Q-3 Q-4 701 A--CH 2
R
2
+R
3
=-(CH
2 3
R
4 =t-Bu; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 702 A=CH 2
R
2
+R
3
=-(CH
2 3
R
4 =Ph; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 703 A--CH 2
R
2
+R
3
=-(CH
2 3
R
4 =i-Pr; R 5 =i-Pr; R 6 =i-Pr. Q-1 Q-2 Q-3 Q-4 704 A=CH 2
R
2
+R
3
=-(CH
2 3
R
4 =t-Bu; R 5
R
6 =Ph; Q-1 Q-2 Q-3 Q-4 705 A=CH 2
R
2
+R
3
=-(CH
2 3
R
4 =Ph; R 5 =Ph; R 6 =Ph: Q-1 Q-2 Q-3 Q-4 706 A=CH 2
R
2
+R
3
=-(CH
2 3
R
4 =Et; R 5 -Me; R 6 -Me; Q-1 Q-2 Q-3 Q-4 707 A-CH 2
R
2
+R
3
=-(CH
2 3
R
4
=-CH
2 CH; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 708 A--CH 2
R
2
+R
3
=-(CH
2
R
4
=-CH
2
CHCH
2
R
5 -Me; R 6 -Me; Q-1 Q-2 Q-3 Q-4 709 A--CH 2
R
2
+R
3
=-(CH
2 3
R
4 =EtO; R 5
R
6 =Me; Q-1 Q-2' Q-3 Q-4 710 A=CH 2
R
2
+R
3
=-(CH
2
R
4 =i-PrO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 m WO095/21846 PC'r/Us95I01616 43 711 A--CH 2
R
2
+R
3
=-(CH
2 3
R
4 =EtQ;, R 5 =EtO; R 6 =Me: Q-1 Q-2 Q-3 Q-4 712 A=CH 2
R
2
+R
3
=-(CH
2 3
R
4 =i-Pr0; R 5 =-i-PrO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 713 A=-CH 2
R
2
+R
3
=-(CH
2 3
R
4 =EtO; R 5 =EtO; R 6 =EtO; Q-1 Q-2 Q-3 Q-4 714 A=-CH 2
R
2
+R
3
=-(CH
2 3
R
4 =MeO; R 5 =MeO; R 6 =MeO; Q-1 Q-2 Q-3 Q-4 715 A=CH 2
R
2
+R
3
=-(CH
2 3
R
4 =MeO; R 5 =MeO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 716 A=-CH 2
R
2
+R
3
=-(CH
2 3
R
4 =Meo; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 717 A--CH 2
R
2
+R
3
=-(CH
2 3
R
4
R
5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 718 A=CH 2
R
2
+R
3
=-(CH
2 3
R
4
R
5
R
6 =Et; Q-1 Q-2 Q-3 Q-4 719 A=CH 2
CH
2
R
2
+R
3
=-(CH
2 3
R
4 =Me; R 5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 720 A=(CH 2 3
R
2
+R
3 =-t'CH 2 3
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 721 A--CH 2 CHCH; R 2
+R
3
=-(CH
2 3
R
4 -Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 722 A--CH 2 CC; R 2
+R
3
=-(CH
2 3
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 723 A--CH 2
CH
2 CHCH; R 2
+R
3
=-(CH
2 3
R
4 =Me; R 5
R
6 =Me; Q-1 Q-2 Q-3 *Q-4 724 A--CH 2
CH
2 CC; R 2
+R
3
=-(CH
2 3
R
4 =Me; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 725 A=a-Ph; R 2
+R
3
=-(CH
2 3
R
4 =Me; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 726 A=m-Ph; R 2
+R
3
=-(CH
2 3
R
4 =Me; R 5
R
6 Q-1 Q-2 Q-3 Q-4 727 A=p-Ph; R 2
+R
3
=-(CH
2 3
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 728 A=(CH 2 3
R
2
+R
3 =-(C11 2 3
R
4 =Et; R 5 =Et; R 6 Et; Q-1 Q-2 Q-3 Q-4 729 A=(CH 2 3
R
2
+R
3
=-(CH
2 3
R
4 =iPr; R 5 =iPr; R 6 =iPr; Q-1 Q-2 Q-3 Q-4 730 A=(CH 2 3
R
2
+R
3
=-(CH
2 3
R
4 =ph; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 731 A=(CH 2 3
R
2
+R
3
=-(CH
2 3
R
4 =tBu; R 5 -Me; R 6 Q-1 Q-2 Q-3 Q-4 732 A=(CH 2 3
R
2
+R
3
=-(CH
2 3
R
4 =EtQ;, R 5 =EtO; R 6 =EtO; Q-1 Q-2 Q-3 Q-4 733 A=(CH 2 3
R
2
+R
3
=-(CH
2 3
R
4 =MeO; R 5 =MeO; R 6 =MeO; Q-1 Q-2 Q-3 Q-4 734 A=(CH 2 3
R
2
+R
3
=-(CH
2
R
4 =EtQ; R 5 =EtO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 735 A=(CH 2 3
R
2
+R
3
=-(CH
2 3
R
4 EtO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 736 A=(CH 2 3
R
2
+R
3
=-(CH
2 3
R
4 =n-PrO; R 5 =n-PrO; R 6 =n-PrO; Q-1 Q-2 Q-3 Q-4 737 A=(CH 2 3
R
2
+R
3
=-(CH
2 3
R
4 =i-PrO; R 5 =i-PrO; R 6 =i-PrO; Q-1 Q-2 Q-3 Q-4 738 A=(CH 2 4
R
2
+R
3
=-(CH
2 3
R
4 =Et, R 5 =Et; R 6 =Et; Q-1 Q-2 Q-3 Q-4 739 A=(CH 2 4
R
2
+R
3
=-(CH
2 3
R
4 =EtO; R 5 =EtO; R 6 =EtO; Q-1 Q-2 Q-3 Q-4 740 A=(CH 2 4
R
2
+R
3
=-(CH
2 3
R
4 =MeO; R 5 =MeO; R 6 =-MeO; Q-1 Q-2 Q-3 Q-4 741 A=(CH 2 4
R
2
+R
3
=-(CH
2
R
4 =EtO; R 5 =Eto; R 6 =Me; Q-1 Q-2 Q-3 -Q-4 742 A=(CH 2 3
R
2 =Me; R 3 =Me; R 4
R
5
R
6 =Et; Q-1 Q-2 Q-3 Q-4 743 A=(CH 2 3
R
2 =Me; R 3 =Me; R 4 =Ph; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 744 A=(CH, 2 3
R
2 =Me; R 3 =Me; R 4 =tBu; R 5 -Me, R 6 =Me; Q-1 Q-2 Q-3 Q-4 745 A=(CH 2 3
R
2 -Me; R 3
R
4 -EtO; R 5 =EtO; R 6 =EtO, Q-1 Q-2 Q-3 Q-4 746 A=(CH 2 3
R
2 -Me; R 3 -Me; R 4 =MaO; R 5 =MeO;, R 6 =MeO; Q-1 Q-2 Q-3 Q-4 747 A=(CH 2 3
R
2 =Et; R 3 =Me; R 4 -Et- R 5 =Et; R 6 =Et; Q-1 Q-2 -Q-3 Q-4 748 A=(Ci1 2 3
R
2 =Et; R 3 =Me; R 4 =Ph; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 WO 95/21846 pCTUS95S/01616 44 749 A=(CH 2 3
R
2 =Et; R 3 =Me; R 4 =tBu; R 5 -Me; R 6 -Me; Q-1 Q-2 Q-3 Q-4 750 A=(CH 2 3
R
2 Et; R 3 =Me; R 4 =EtO; R 5 -EtO; R 6 =EtO; Q-1 Q-2 Q-3 Q-4 751 A=(CH 2 3
R
2 -Et; R 3 -Me; R 4 =MeO; R 5 =MeO; R 6 =MeO; Q-1 Q-2 Q-3 Q-4 752 A=(CH 2 4
R
2 =Me; R 3 =Me; R 4 =Ph; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 753 A=(CH 2 4
R
2 =Me; R 3 =Me; R 4 =tBu; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 754 A=(CH 2 4
R
2 =Et; R 3 =Me; R 4 =Ph; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 755 A=(CH 2 4
R
2 -Et; R 3 -Me; R 4 =tBu; R 5 -Me; R 6 -Me; Q-1 Q-2 Q-3 Q-4 756 A=(CH 2 4
R
2
+R
3
=CH
2
CH
2
R
4 =Me 3 Si; R 5 =Me 3 Si; R 6 sMe 3 Si; Q-1 Q-2 Q-3 Q-4 757 A=(CH 2 3
R
2
+R
3
CH
2
CH
2
R
4 =Me 3 Si; R 5 =Me 3 Si; R 6 =Me 3 Si; Q-1 Q-2 Q-3 Q-4 758 A=(CH2)3; R 2
+R
3
CH
2
CH
2
R
4 =Me; R 5
R
6 =Me 3 SiCH 2 Q-1 Q-2 Q-3 Q-4 759 A=(CH 2 3
R
2
+R
3
-CH
2
CH
2
R
4 =Me; R 5 =Me; R 6 =Me 3 SiCH 2 O; Q-1 Q-2 Q-3 Q-4 760 A=(CH 2 3
R
2
+R
3
CH
2 CH 1; R 4 =Me; R 5 =Me;
R
6 =-Me 3 SiCH 2 CH2O; 761 A=(CH 2 3
R
2
+R
3
CH
2
CH
2
R
4 =Me; R 5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =Me 3 SiCH 2
CH
2
S;
762 A=(CH 2 3
R
2
+R
3
=CH
2
CH
2
R
4 =Me 3 SiCH 2 O; Q-1 Q-2 Q-3 Q-4
R
5 =Me 3 SiCH 2 O; R 6 =Me 3 SiCH 2
O;
763 A=(CH 2 3
R
2
+R
3
CH
2
CH
2
R
4 =Me 3 Si(CH 2 2 0; Q-1 Q-2 Q-3 Q-4
R
5 =Me 3 Si(CH 2 2 0; R6=-Me 3 Si(CH 2 2 0; 764 A=(CH 2 3
R
2
+R
3
CH
2
CH
2
R
4 =MeS; R5=MeS; R 6 -McS; Q-1 Q-2 Q-3 Q-4 765 A=(CH 2 3
R
2
+R
3
CH
2
CH
2
R
4 =Ph; R 5 =Ph; R 6 Q-1 Q-2 Q-3 -Q4 766 A=(CH 2 3
R
2
+R
3
CH
2
CH
2
R
4 =nBu; R 5 =nBu; R 6 =nBu; Q-1 Q-2 Q-3 Q-4 767 A=(CH 2 3
R
2
+R
3
-CH
2
CH
2
R
4 =Me; R 5 =Me 3 SiCH 2 Q-1 Q-2 Q-3 Q-4
R
6 =Me 3 SiCH 2 768 A-CH 2
R
2
R
3 =Me; R 4 Me; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 769 A=-CH 2
R
2 =Me; R 3 =Me; R 4 =Me; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 770 A=-CH 2
R
2 -Et; R 3 -Et; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 'Q-4 771 A--CH 2 R24R 3
=-CH
2
CH
2
R
4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 772 A=-CH 2
R
2
+R
3 -CH(Me)CH2-;,
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 PCT[US95/01616 WO 95/21846 Table 16 ~I COLUMN Q1 Q2 Q3 Q4 773 774 775 776 777 778 779 512 513 514 515 516 517 518 519 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 A=direct bond; R 2
R
3 =Me; R 4 =Me; R 5 =Me; R 6 Me; A=direct bond; R 2
R
3 =Me; R 4 =t-Bu; R 5 =Me; R 6 =Me; A-direct bond; R 2
R
3 =Me; R 4 =Ph; R 5 =Me; R 6 =Me; A=direct bond; R 2
R
3 =Me; R 4 =i-Pr; R 5 =i-Pr; R 6 =i-Pr; A=direct bond; R 2
R
3 =Me; R 4 =t-Bu; R 5 =Ph; R 6 =Ph; A-direct bond, R 2
R
3 =Me; R 4
R
5 =Ph; R 6 =Ph;
A=-CH
2
R
2
R
3 -Me; R 4
R
5 =Me; R 6 =Me;
A=-CH
2
R
2
R
3 -Me; R 4 =Ph; R 5 =Me; R 6 =Me;
A-CH
2
R
2
R
3 =Me; R 4 =i-Pr; R 5 =i-Pr; RO 6 =i-Pr;
A=-CH
2
R
2
R
3 =Me; R 4
R
5 =Ph; R 6 =Ph;
A--CH
2
R
2
R
3 -Me; R 4 =Ph; R 5 =Ph; R 6 =Ph;
A=-CH
2
R
2
R
3 =Me; R 4 =Et; R 5 =Me; R 6 =-Me;
A=-CH
2
R
2
R
3 Me; R 4
CH
2 CH; R 5 =Me; R 6 =Me;, r%=CH 2
R
2
R
3 =Me; R 4
=-CH
2
CHCH
2
R
5 =Me; R 6 =Me;,
A--CH
2
R
2
R
3 =Me; R 4 =EtQ; R 5 =Me; R 6 =Me;
A=-CH
2
R
2
R
3 =Me; R 4 =i-PrO; R 5 =Me; R 6 =Me,
A=-CH
2
R
2
R
3 =Me; R 4 -EtO; r 5 EtO., R 6 -Me-,
A--CH
2
R
2
R
3 =Me; R 4 =i-PrO; R 5 =i-pro; R 6 =Me;
A=-CH
2
R
2
R
3 =Me; R 4 =EtO; R 5 =EtO; R 6 =Eto;
A=-CH
2
R
2
R
3 -Me; R 4 =i-pro; R 5 =i-PrO; R 6 =i-pro;
A-CH
2
R
2
R
3 =Me; R 4
R
5 =Me; R 6 =Me;
A--CH
2
R
2
R
3 =Me; R 4
R
5 =Et; R 6 =Et;
A=-CH
2
CH
2
R
2
R
3 =Me; R 4 =Me; R 5 =Me; R 6 =Me;
A=(CH
2 3
R
2
R
3 =Me; R 4 =Me; R 5
R
6 -Me;
A--CH
2 CHCH;, R 2
R
3 -Me; R 4 -Me; R 5 =Me; R 6 =Me;
A=-CH
2 CC; R 2
R
3 -Me; R 4 -Me; R 5 =Me; R 6 =Me;
A--CH
2
CH
2 CHCH; R 2
R
3 =Me; R 4 =Me; R 5 =Me; R' 6 =Me;,
A=-CH
2
CH
2 CC; R 2
R
3 -Me; R 4 -Me; R 5 =Me; RO=Me; A=o-Ph; R 2
R
3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; A=m-Ph; R 2
R
3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; A-Ph; R 2
R
3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-1 Q-1 Q-1 Q-1 Q-1 Q-1 Q-1 Q-1 Q-1 Q- 1 Q. 1 Q-1 Q-1 Q-1 Q-1 Q..1 Q-1 Q-1I Q-1 Q-1 Q-1 Q-1 Q-1 Q-1 Q-1 Q-1 Q-1 Q-1 Q-1 Q-2 Q-3 Q-2 Q-3 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-2 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-3 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 Q-4 WO 95/21846 PCTIUS95/01616 46 796 A=direct bond; R2=Me; R 3 -Me; R 4 -Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 797 A=direct bond; R 2 =Me; R 3
R
4 =t-Bu; R 5 =Me; R 6 Q- 1 Q-2 Q-3 Q-4 798 A=direct bond; R 2 =Me; R 3 -Me; R 4 -Ph; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 799 A=direct bond; R 2 =Me; R 3 -Me; R$-i-Pr; R 5 =i-Pr; R 6 =i-Pr; Q-1 Q-2 Q-3 Q-4 800 A=direct bond; R 2 =Me; R 3
R
4
R
5 =Ph; R 6 Q-1 Q-2 Q-3 Q-4 801 A=direct bond; R 2 =Me; R 3 -Me; R 4 -Ph; R 5 =Ph; R 6 Q-1 Q-2 Q-3 Q-4 802 A=direct bond; R 2
R
3 =Me; R 4 =Me; R 5 =Ph; R 6 =Ph; Q-1 Q-2 Q-3 Q-4 803 A--CH 2
R
2
R
3 =Me; R 4 =Me; R 5 =Ph; R 6 Q-1 Q-2 Q-3 Q-4 804 A=-CH 2
R
2 =Me; R 3 =Me; R 4 =Me; R 5 -Ph; R 6 -Ph; Q-1 Q-2 Q-3 Q-4 805 A-CH 2
R
2 -Me; R 3 =Me; R 4 =t-Bu; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 806 A--CH 2
R
2 =Me; RL-Me; R 4 =Ph; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 807 A=-CH 2
R
2 =Me; R 3 =Me; R4$-i-Pr; R 5 =i-Pr; R 6 =i-Pr; Q-1 Q-2 Q-3 Q-4 808 A--CH 2
R
2 =Me; R 3 =Me; R 4
R
5 -Ph; R 6 -Ph; Q-1 Q-2 Q-3 Q-4 809 A--CH 2
R
2 =Me; R 3 =Me; R 4 =Ph; R 5 -Ph; R 6 -Ph; Q- 1 Q-2 Q-3 Q-4 810 A=-CH 2
R
2
R
3 =Me; R 4 -Et; R 5 -Me; R 6 =Me; Q-1 Q-2 Q -3 Q-4 811 A=-CH 2
R
2 =Me; R 3 =Me; R 4
=-CH
2 CH; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 812 A=-CH 2
R
2 =Me; R 3 =Me; R 4
=CH
2
CHCH-
2
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 813 A=CH 2
R
2 =Me; R 3 =Me; R 4 =EtO; R 5 -Me; R 6 -Me; Q-1 Q-2 Q-3 Q-4 814 A--CH 2
R
2
R
3 =Me; R 4 =i-PrO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 815 A--CH 2
R
2 =Mle; R 3 =Me; R 4 =EtO; R 5 =EtO; R 6 Me; Q-1 Q-2 Q-3 Q-4 816 A=-CH 2
R
2 =Me; R 3 =Me; R 4 =i-PrO; R 5 =i-PrO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 817 A--CH 2
R
2 =Me; R 3 =Me; R 4 =EtO; R 5 =EtO; R 6 EtO; Q-1 Q-2 Q-3 Q-4 818 A--CH 2
R
2 =Me; R 3 =Me; R 4 =MeO; R 5 =MeO; R 6 =Meo; Q-1 Q-2 Q-3 Q-4 819 A--CH 2
R
2 =Me; R 3 =Me; R 4 =MeO; R 5 =MeQ; R 6 =Me; Q-1 Q-2 Q-3 Q-4 820 A-CH 2 R2=Me; R 3 =Me; R 4 =MeO; R 5 -Me; R 6 -Me; Q-1 Q-2 Q-3 Q-4 821 A=-CH 2
R
2 =Me; R 3 =Me; R 4
R
5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 822 A--CH 2
R
2
R
3 =Me; R 4
R
5 =Et; R 6 =Et; Q-1 Q-2 Q-3 Q-4 823 A=-CH 2
CH
2
R
2
R
3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 824 A--(CH 2 3
R
2 -Me; R 3 -Me; R 4 =Me; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 825 A=-CH 2 CHCH; R 2 =Me; R 3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 826 A=-CH 2 CC; R 2 =Me; R 3 =Me; R 4 =Me; R 5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 827 A--CH 2
CI-
2 CHCH; R 2
R
3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 828 A=-CH 2
CH
2 CC; R 2 =Me; R 3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 829 A=o-Ph; R 2 =Me; R 3 =Me; R 4 =Me; R 5 =Me; R 6 =Me* Q-1 Q-2 Q-3 Q-4 830 A=m-Ph; RZ=Me; R 3 -Me; R 4 =Me; R 5 -Me; R 6 -Me; Q-1 Q-2 Q-.3 Q-4 831 A=p-Ph; R 2 =Me; R 3 =Me; R 4 =Me; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 832 A=-CH 2
R
2
R
3 =Me; R 4 =MeO; R 5 =MeO; R 6 =MeO; Q-1 Q-2 Q73 Q-4 833 A--CH 2
R
2
R
3 -Me; R 4 =MeO; R 5 =MeO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 834 A=-CH 2
R
2
R
3 =Me; R 4 =MeQ; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 835 A=direct bond; R 2 =Et; R 3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 836 A=direct bond; R 2 =Et; R 3 =Me; R 4 =t-Bu; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 WO 95/21846 PCT/1S95/01616 47 837 Adirect bond; R 2
R
3 =Me; R 4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 838 A=direct bond; R 2 =Et; R 3 =Me; R 4 =i-Pr; R 5 =i-Pr; R 6 =i-Pr; Q-1 Q-2 Q-3 Q-4 839 A=direct bond; R 2 =Et; R 3 =Me; R 4 =t-Bu; R 5 =Ph; R 6 =ph; Q-1 Q-2 Q-3 Q-4 840 A=direct bond;, R 2 =Et; R 3 =Me; R 4 =Ph; R 5
R
6 Q-1 Q-2 Q-3 Q-4 841 A=direct bond; R 2 =Et; R 3 =Me; R 4 =Me; R 5 =Ph; R 6 =Ph; Q-1 Q-2 Q-3 Q-4 842 A-CH 2
R
2 -Et; R 3 =Me; R 4 =Me; R 5 -Phv R 6 -Ph; Q-1 Q-2 Q-3 Q-4 843 A--CH 2
R
2 =Et; R 3 =Me; R 4 =t-Bu; R 5 -Me; R 6 -Me; Q-1 Q-2 Q-3 Q-4 844 A=CH 2
R
2 =Et; R 3 =Me; R 4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 845 A--CH 2
R
2 =Et; R 3 =Me; R 4 -i-Pr; R 5 =i-Pr; R 6 =i-Pr; Q-1 Q-2 Q-3 Q-4 846 A=-CH 2
R
2 =Et; R 3 =Me; R 4 -t-Bu- R 5 -Ph; R 6 -Ph; Q-1 Q-2 Q-3 Q-4 847 A--CH 2
R
2
R
3 =Me; R 4 =Ph; R 5 =Ph; R 6 Ph; Q-1 Q-2 Q-3 Q-4 848 A--CH 2
R
2
R
3 -Me* R 4 -Et; R 5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 849 A--CH 2
R
2 -Et; R 3 -Me; R 4
=-CH
2 CH; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 850 A--CH 2
R
2 -Et; R 3 -Me; R 4
-CH
2
CHCH
2
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 851 A--CH 2
R
2 =Et; R 3
R
4 =EtO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 852 A--CH 2
R
2 =Et; R 3 =Me; R 4 =i-PrO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 853 A--CH 2
R
2 =Et; R 3 =Me; R 4 =EtQ; R 5 =EtQ; R 6 Q-1 Q-2 Q-3 Q-4 854 A=-CH 2 R9-Et; R 3 =Me; R 4 =i-PrO; R 5 =i-PrO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 855 A=CH 2
R
2 -Et; R 3 -Me; R 4 =EtO; R 5 -EtO; R 6 -EtO, Q-1 Q-2 Q-3 Q -4 856 A--CH 2
R
2 =Et; R 3 -Me; R 4 =MeO; R 5 =MeO; R 6 =MeO; Q-1 Q-2 Q-3 Q-4 857 A--CH 2
R
2 -Et; R 3 -Me; R 4 =MeQ; R 5 =MeO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 858 A=-CH 2
R
2 -Et; R 3 -Me; R 4 =MeO; R 5 =Me, R 6 =Me; Q-1 Q-2 Q-3 Q-4 859 A=-CH 2
R
2 =Et; R 3 =Me; R 4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 860 A=CH 2
R
2 =Et; R 3 =Me; R 4
R
5 -Et; R 6 =Et; Q-1 Q-2 Q-3 Q-4 861 A=-CH 2
CH
2
R
2
R
3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 862 A=(CH 2 3
R
2 -Et; R 3 -Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 863 A=CH 2 CHCH; R 2 =Et; R 3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 864 A=-CH 2 CC;, R 2 =Et; R 3 =Me; R 4 =Me; R 5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 865 A--CH 2
CH
2 CHCH; R 2 =Et; R 3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q.-2 Q-3 Q-4 866 A--CH 2 )CH-CC; R 2 =Et; R 3 =Me; R 4 =Me; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 867 A=o-Ph, R 2
R
3 =Me; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-3 Q-4 868 A=m-Ph; R 2 =Et; R 3 =Me; R 4 =Me; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 869 A=p-Ph, R=Et,, R 3 Me 4 M~ 5 me; R 6 -Me; Q-1 Q-2 Q-3 Q-4 870~~ AdR2c bond
R
2
+R
3 -CHCH R=e 5 M;R=e .4 Q.
871 A=direct bond; R 2
+R
3
=-CH
2
CH
2
R
4 -t-Bu R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 872 A~direct bond; R 2
+R
3
=-CH
2
CH
2
R
4 =Ph;u R 5 =Me; R 6 =Me, Q-1 Q-2 Q-3 'Q-4 873 A=direct bond; R 2
+R
3
=-CH
2
CH
2
R
4 =iP; R 5
R
6 Q-1 Q-2 Q-3 Q-.4 874 A=direct bond; R 2
+R
3
=-CH
2
CH
2
R
4
R
5
R
6 =iP; Q I Q-2 Q-3 Q-4 875 A=direct bond; R 2
+R
3
=~-CH
2
CH
2
R
4 =PhB; R 5 =Ph; R 6 =Ph; Q,1 Q-2 Q-3 Q-4 876 A=direct bond; R 2
+R
3
=-CH
2
CH
2
R
4
R
5 =Ph; R 6 =Ph; Q-1 Q-2 Q-3 Q-4 877 A=drcH 2 n; R 2
+R
3
=-CH
2
CH
2
R
4 =Me; R 5 =ph; R 6 =Ph Q-1 Q-2 Q-3 Q.-4 WO 95/21846 PCT[JS9S101616 48 878 A=-CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =t-B3u; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 879 A-CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =Ph; R 5 -Me; R 6 -Me; Q-1 Q-2 Q-3 Q-4 880 A=CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =i-Pr; R 5 =i-Pr; R 6 =i-Pr; Q-1 Q-2 Q-3 Q-4 881 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =t-Bu; R 5 -Ph; R 6 -Ph; Q-1 Q-2 Q-3 Q-4 882 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =Ph; R 5 =Ph; R 6 =Ph; Q-1 Q-2 Q-3 Q-4 883 A=CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =Et; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 884 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4
-CH
2 CH; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 885 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4
-CH
2
CHCH
2
R
5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =Me; 886 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =EtO; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 887 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =i-PrO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 888 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =EtO; R 5 -EtQ; R 6 =Me; Q-1 Q-2 Q-3 Q-4 889 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =i-PrO; R 5 =i-pro; R 6 =Me; Q-1 Q-2 Q-3 Q-4 890 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =EtO; R 5 =EtO; R 6 =EtO; Q-1 Q-2 Q-3 Q-4 891 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =MeO; R 5 =MeO; R 6 MeO; Q-1 Q-2 Q-3 Q-4 892 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =MeQ; R 5 =MeO;, R 6 =Me; Q-1 Q-2 Q-3 Q-4 893 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 -MeO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 894 A=CH 2
R
2
+R
3
=-CH
2
CH
2
R
4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 895 A--CH 2
R
2
+R
3
=-CH
2
CH
2
R
4
R
5 =Et; R 6 =Et; Q-1 Q-2 Q-3 Q-4 896 A--CH 2
CH
2
R
2
+R
3
=-CH
2
CH
2
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 897 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 898 A--CH 2 CHCH; R 2
+R
3
=-CH
2
CH
2
R
4 -Me; R 5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 899 A--CH 2 CC; R 2
+R
3
=-CH
2 CH2-; R 4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 900 A--CH 2
CH
2 CHCH; R 2
+R
3
=-CH
2
CH
2
R
4 =Me; R 5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =Me; 901 A--CH 2
CH
2 CC; R 2
+R
3
=-CH
2
CH
2
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 902 A~o-Ph; R 2
+R
3
=-CH
2
CH
2
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 903 A=m-Ph; R 2
+R
3
=-CH
2
CH
2
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 904 A=p-Ph; R 2
+R
3
=-CH
2
CH
2
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 905 A=direct bond; R 2
+R
3 =-CH(Me)CH 2
R
4 -Me; R 5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =Me; 906 A=direct bond; R 2
+R
3 =-CH(Me)CH2-;
R
4
R
5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =Me; 907 A=direct bond; R 2
+R
3 =-CH(Me)CH 2
R
4
R
5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =Me; 908 A~direct bond; R 2
+R
3 =-CH(Me)CH2-,
R
4 =i-Pr; R 5 =i-Pr; Q-1 Q-2 Q-3 Q-4
R
6 -i-Pr; 909 A=direct bond; R 2
+R
3 -CH(Me)CH2-
R
4 =t-Bu; R 5 =Ph; Q-1 Q-2 Q-3 Q-4
R
6 =Ph; 910 A=direct bond; R 2
+R
3 CH(Me)CH2-;
R
4 =Ph; R 5 =Ph; R 6 Q-1 Q-2 Q-3 Q-4 WO 95/21846 pCTfi'S95101 616 911 A=direct bond; R 2
+R
3 =-CH(Me)CH 2
R
4 =Me; R 5 =Ph; Q-1 Q-2 Q-3 Q-4
R
6 =Ph; 912 A--CH 2
R
2
+R
3 =-CH(Me)CH2-;
R
4 -Me; R 5 =Ph; R 6 =Ph; Q-1 Q-2 Q-3 Q-4 913 A=CH- 2
R
2
+R
3 =-CH(M~e)CH 2
R
4
R
5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 914 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 915 A-CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =i-Pr; R 5 =i-Pr; R 6 =i-Pr; Q-1 Q-2 Q-3 Q-4 916 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =t-Bu; R 5 =Ph; R 6 Q-1 Q-2 Q-3 Q-4 917 A-CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 -Ph; R 5 =Ph; R 6 =Ph; Q-1 Q-2 Q-3 Q-4 918 A=CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 -Et; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 919 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4
-CH
2 CH; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 920 A-CH 2
R
2
+R
3 CH(Me)CH 2
R
4
CH
2
CHCH
2
R
5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =me; 921 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 -EtQ; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 922 A=CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =i-PrO; R 5 =Me; R 6 -Me; Q-1 Q-2 Q-3 Q-4 923 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 -EtQ; R 5 =EtO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 924 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =i-PrO; R 5 =i-PrO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 925 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =EtO; R 5 =Eto; R 6 =EtO; Q-1 Q-2 Q-3 Q-4 926 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =MeO; R 5 =MeO; Q-1 Q-2 Q-3 Q-4
R
6 =MeO; 927 A--CH 2 RZ2+p 3 .(Me)CH 2
R
4 =MeO; R 5 =MeQ; R 6 =Me; Q-1 Q-2 Q-3 Q-4 928 A=CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4 =MeO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 929 A--CH 2
R
2
+R
3 =-CH(Me)CH2-,
R
4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 930 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4
R
5 =Et; R 6 =Et; Q-1 Q-2 Q-3 Q-4 931 A--CH 2
CH
2
R
2
+R
3 =-CH(Me)CH 2
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 932 A=(CH 2 3
R
2
+R
3 CH(Me)CH 2
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 933 A--CH 2 CHCH; R 2
+R
3 =-CH(Me)CH 2
R
4 =Me; R 5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =Me; 934 A--CH 2 CC; R 2
+R
3 =-CH(Me)CH2-;
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 935 A--CH 2
CH
2 CHCH; R 2
+R
3 =-CH(Me)CH 2
R
4 -Me; R 5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =Me; 936 A--CH 2
CH
2 CC, R 2
+R
3 =-CH(Me)CH 2
R
4 =Me; R 5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =Me; 937 A=o-Ph; R 2
+R
3 =-CH(Me)CH2-;
R
4 =Me; R 5 =me; R 6 -me; Q-1 Q-2 Q-3 Q-4 938 A=m-Ph;, R 2
,+R
3 =-CH(Me)CH 2
R
4 -Me; R 5 -Me; R 6 =me; Q-1 Q-2 Q-3 Q-4 939 A=p-Ph; R 2
+R
3 =-CH(Me)CH2-;
R
4 -Me; R 5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 940 A=(CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =Et; R 5 =Et; R 6 =Et; Q-1 Q-2 Q-3 Q-4 941 A=(CH 2 3
R
2
+R
3
=-CH
2
)CH
2
R
4 =iPr; R 5 =iPr; R 6 =iPr; Q-1 Q-2 Q-3 Q-4 942 A=(CH 2 3
R
2 3
=-CH
2
CH
2 R=Ph; R 5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 943 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 -tBu; R 5 -Me; R 6 Q-1 Q-2 Q-3 Q-4 944 A=(CH 2 3
R
2
+R
3
-CH
2
CH
2
R
4 =EtO; R 5 -Eto; R 6 =EtO; Q-1 Q-2 Q-3 Q-4 945 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 =MeO; R 5 =MeO; R 6 =MeO; Q-1 Q-2 Q-3 Q-4 WO095/21846 1'CT[US9S/01616 946 A=(CH 2 3
R
2
+R
3
=-CH
2 C11 2
R
4 =EtO; R 5 =Eto; R 6 =Me; Q-1 Q-2 Q-3 Q-4 947 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 -EtO; R 5
R
6 =Me; Q-1 Q.-2 Q-3 Q-4 948 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 -n-PrO; R 5 =n-PrO; R 6 Q-1 Q-2 Q-3 Q-4 PrO; 949 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 =i-PrO; R 5 =i-PrO; R 6 Q-1 Q-2 Q-3 Q-4 Pro; 950 A=(CH 2 3
R
2 -iR 3 =-CH(Me)CH 2
R
4 =Et; R 5 =Et; R 6 =Et; Q-1 Q-2 Q-3 Q-4 951 A=(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4 =iPr; R 5 =iPr; R 6 =iPr; Q-1 Q-9- Q-3 Q-4 952 A=(CH 2 3
R
2
+R
3 CH(Me)CH 2
R
4 =Ph; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 953 A=(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4 =tBu; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 954 A=(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4 =EtO; R 5 =EtO; Q-1 Q-2 Q-3 Q-4
R
6 =EtO; 955 A=(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4 =MeO; R 5 =MeO; Q-1 Q-2 Q-3 Q-4 956 =CH 2 +R-C(eC -REt;R=t;R-e Q- Q2 Q3 Q4 957 A=(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4 =Eto; R 5 =MEt; R 6 =Me, Q-1 Q-2 Q-3 Q-4 958 A=(CH 2 3
R
2
+R
3 =-CH(Me)CH 2
R
4 =EtPO; R 5 Q-1 Q-2 Q-3 Q-4 959 A=(CH 2 3
R
2
+R
3 CH(Me)CH 2
R
4 =i-PrO; R 5 z=i-PrO; Q-1 Q-2 Q-3 Q-4
R
6 =n-PrO; 960 A=(CH 2
R
2
+R
3
CH
2
MCH
2
R
4 r 5 O; R 6 ,=Etpr; Q-1 Q-2 Q-3 Q-4 961 A=(CH 2 4
R
2
+R
3
=-CH
2
CH
2
R
4 -Et; R 5 Et; R 6 =Et; Q-1 Q-2 Q-3 Q-4 962 A=(CH 2 4
R
2
+R
3
=-CH
2
CH
2
R
4 =MEO; R 5 =MEO; R 6 =MEO; Q-1 Q-2 Q-3 Q-4 963 A=(CH 2 4
R
2
+R
3
=-CH
2
CH
2
R
4 =MEto; R 5 =eto; R 6 =Me; Q-1 Q-2 Q-3 Q-4 964 A=(CH 2 4
R
2
+R
3
=-CH(MCH
2
R
4 Et; R 5 Et; R 6 =Me; Q-1 Q-2 Q-3 Q-4 965 A=(CH 2 4
R
2
+R
3 =-CH(Me)CH2-;
R
4 =Et; R 5 =EtO 6; Q.-1 Q-2 Q-3 Q-4
R
6 =EtO; 966 A=(CH 2 4
R
2
+R
3 =-CH(Me)CH 2
R
4 =MeO; R 5 =Meo; Q-1 Q-2 Q-3 Q-4
R
6 =MeO; 967 A=(CH 2 4
R
2
+R
3 =-CH(Me)CH2-;
R
4 -EtO; R 5 =EtO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 968 A--CH 2
R
2
+R
3
=-(CH
2 3
R
4 =Me; R 5 =Ph; R 6 Ph; Q-1 Q-2 Q-3 Q-4 969 A--CH 2
R
2
+R
3
=-(CH
2
R
4
R
5 =Me; R 6 =Me; Q- 1 Q-2 Q-3 Q-4 970 A--CH 2
R
2
+R
3
=-(CH
2
R
4 =Ph; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 971 A=CH 2
R
2
+R
3
=-(CH
2 3
R
4 =i-Pr; R 5
R
6 =i-Pr; Q-1 Q-2 Q-3 Q-4 972 A--GH 2
R
2
+R
3
=-(CH
2
R
4 =t-Bu; R 5 -Ph; R 6 =Ph; Q-1 Q-2 Q-3 Q-4 973 A--CH 2
R
2
+R
3
=-(CH
2
R
4 =Ph; R 5 =Ph; R 6 =Ph; Q-1 Q-2 Q-3 Q-4 974 A--CH 2
R
2
+R
3
=-(CH
2
R
4 =Et; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 975 A=-CH 2
R
2
+R
3
=-(CH
2 3
R
4
CH
2 CH; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 976 A=CH 2
R
2
+R
3
=-(CH
2 3
R
4
CH
2
CHCH
2
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 977 A=-CH 2
R
2
.+R
3
=-(CH
2 3
R
4 =EtO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 WO095/21846 PCk, dS9S/01616 51 978 A--CH 2
R
2
+R
3
=-(CH
2 3
R
4 =i-PrO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 I 979 A=CH 2
R
2
+R
3
=-(CH
2 3
R
4 =EtO; R 5 =EtO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 980 A=CH 2
R
2
+R
3
=-CCH
2 3
R
4 =i-PrO; R 5 =i-pro; R 6 =Me; Q-1I Q-2 Q-3 Q-4 981 A-CH 2
R
2
+R
3
=-(CH
2 3
R
4 =EtQ;, R 5 =EtO; R 6 =EtO; Q-1I Q-2 Q-3 Q-4 982 A--CH 2
R
2
+R
3
=-(CH
2 3
R
4 =MeQ; R 5 =MeO; R 6 =MeO; Q-1 Q-2 Q-3 Q-4 983 A--CH 2
R
2
+R
3
=-(CH
2 3
R
4 =MeO; R 5 =MeQ; R 6 =Me; Q-1 Q 2 Q-3 Q-4 984 A--GH 2
R
2
+R
3
=-(CH
2 3
R
4 =MeO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 985 A=CH 2
R
2
+R
3
=-(CH
2 3
R
4
R
5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 986 A=CH 2
R
2
+R
3
=-(CH
2 3
R
4
R
5 -Et, R 6 -Et: Q-1 Q-2 Q-3 Q-4 987 A=CH 2
R
2
+R
3
=-(CH
2 3
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 988 A=(CH 2 3
R
2
+R
3
=-(CH
2 3
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 989 A--CH 2 CHCH R 2
+R
3
=-(CH
2 3
R
4 -Me; R 5 -Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 990 A=CH 2 CC; R 2
+R
3
=-(CH
2 3
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 991 A--CH 2
CH
2 CHCH; R 2
+R
3
=-(CH
2 3
R
4 =Me; R 5 =Me; Q-1 Q-2 Q-3 Q-4 Q-.i
R
6 =Me; 992 A--CH 2
CH
2 CC-, R 2
+R
3
=-(CH
2 3
R
4 =Me; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 993 A=o-Ph; R 2
+R
3
=-(CH
2 3
R
4 =Me; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 994 A=m-Ph; R 2
+R
3
=-(CH
2 3
R
4 =Me; R 5 =Me; RO--Me; Q-1 Q-2 Q-3 Q-4 995 A=p-Ph; R 2
+R,
3
=-(CH
2 3
R
4 =Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 9s A=(CH 2 3
R
2
+R
3
=-(CH
2 3
R
4 =Et; R 5 =Et; R 6 Et; Q-1 Q-2 Q-3 Q-4 9s A=(CH 2 3
R
2
+R
3 =-tCH 2 3
R
4 =iPr; R 5 =iPr; R 6 =iPr; Q-1 IQ-2 Q-3 Q-4 998 A=(CH 2 3
R
2
+R
3
=-(CH
2 3
R
4 =Ph; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 999 A=(CH2) 3
R
2
+R
3
=-(CH
2 3
R
4 =tBu; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 1000 A=(CH 2 3
R
2
+R
3
=-(CH
2 3
R
4 =EtQ; R 5 -EtO, R 6 =EtO; Q-1 Q-2 Q-3 Q-4 1001 A=(CH 2 3
R
2
+R
3
=-(CH
2 3
R
4 =MeO; R 5 =MeO; R 6 =MeO; Q-1 Q-2 Q-3 Q-4 1002 A=(CH 2 3
R
2
+R
3 =-(CH29 3
R
4 =Eto; R 5 =EtO; R 6 =Me; Q-1 Q-2 Q-.3 -Q-4 1003 A=(CH 2 3
R
2
+R
3
(CH
2 3
R
4 =EtO; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 1004 A=(CH 2 3
R
2
+R
3
=-(CH
2 3
R
4 =n-PrO;, R 5 =n-PrO; Q-1 Q-2 Q-3 i Q-4
R
6 =n-PrO; 1 1005 A=(CH 2 3
R
2
+R
3
=-(CH
2 3
R
4 =i-PrO; R 5 -i-PrO; Q-1 Q-2 Q-3 Q-4
R
6 =i-prO; 1006 A=(CH 2 4
R
2
+R
3
R
4 =Et; R 5 =Et; R 6 =Et; Q-1 Q-2 Q-3 Q-.4 1007 A=(CH 2 4
R
2
+R
3
R
4 =Eto; R 5 =EtO; R 6 =EtO; Q-1 Q-2 Q-3 Q-4 1008 A=(CH 2 4
R
2
+R
3
=-(CH
2 3
R
4 =MeO; R 5 =MeO; R 6 -MeO;, Q-1 Q-2 Q-3 Q-4 1009 A=(CH 2 4
R
2
+R
3
=-(CH
2 3
R
4 =EtO; R 5 =EtO; R 6 =Me; Q-1 Q-2 Q-3 Q-4 1010 A=(CH 2 3
R
2
R
3 =Me; R 4 =Et; R 5 =Et; R 6 =Et; Q-1 Q-2 Q-3 Q-4 1011 A=(CH 2 3
R
2 =Me; R 3 -Me; R 4 -Ph; R 5 =Me; R 6 =Mc; Q-1 Q-2 Q-3 Q-4 1012 A=(CH 2 3
R
2 =Me; R 3 =Me; R 4 =tBu; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 WO 95/21846 PCTIUS9S/01616 52 1013 A=(CH 2 3
R
2 =Me; R 3
R
4 =EtO; R 5 =EtQ; R 6 Q-1 Q-2 Q-3 Q-4 1014 A=(CH 2 3
R
2 =Me; R 3 =Me; R 4 =MeQ; R 5 =MeO; R 6 =MeO; Q-1 Q-2 Q-3 Q-4 1015 A=(CH 2 3
R
2 -Et; R 3 -Me; R 4 =Et; R 5 =Et, R 6 Q-1 Q-2 Q-3 Q-4 1016 A=(CH 2 3
R
2
R
3 =Me- R 4 -Ph; R 5
R
6 =Me; Q-1 Q-2 Q-3 Q-4 1017 A=(CH 2 3
R
2
R
3 -Me; R 4 =tBu; R 5 -Me; R 6 -Me; Q-1 Q-2 Q-3 Q-4 1018 A=(CH 2 3
R
2 =Et; R 3 =Me; R 4 =EtO; R 5 =EtO; R 6 =EtO; Q-1 Q-2 Q-3 Q-4 1019 A=(CH 2 3
R
2 =Et; R 3 =Me; R 4 MeO; R 5 =MeO; R 6 =-MeO; Q-1 Q-2 Q-3 Q-4 1020 A=(CH 2 4
R
2 Me; R 3
R
4 =Ph; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 1021 A=(CH 2 4
R
2 =Me; R 3 =Me; R 4 =tBu; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 1022 A-(CH 2 4
R
2 =Et; R 3 =Me; R 4 =Ph; R 5 =1Ae; R 6 =Me; Q-1 Q-2 Q-3 Q-4 1023 A=(CH 2 4
R
2 =Et; R 3 =Me; R 4 -tBu; R 5
R
6 -Me; Q-1 Q-2 Q-3 Q-4 1024 A=(CH 2 4
R
2
+R
3
=-CH
2
CH
2
R
4 =Me 3 Si:, R 5 =Me 3 Si; Q-1 Q-2 Q-3 Q-4
R
6 =-Me 3 Si; 1025 A=(CH 2 3
R
2
+R
3
CH
2
CH
2
R
4 -Me 3 Si; R 5 =Me 3 Si; Q-1 Q-2 Q-3 Q-4
R
6 =Me 3 Si; 1026 A-(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 =Me; R 5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =Me 3 SiCH 2 1027 A=(CH 2 3
R
2
+R
3
CH
2
CH
2
R
4 =Me; R 5 =Me; Q-1 Q-2 Q-3 Q-4
R
6 =Me 3 SiCH 2
Q;
1028 A=(CH 2 3
R
2
+R
3
-CH
2
CFI
2
R
4
R
5 Q-1 Q-2 Q-3 Q-4
R
6 =Me 3 SiCH 2
CH
2
O;
1029 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 -Me; R 5 =Me; Q-1I Q-2 Q-3 Q-4
R
6 =Me 3 SiCH 2
CH
2
S'
1030 A=(CH 2 3
R
2
+R
3
=-CH
2
CH
2
R
4 =Me 3 SiCH 2 O; Q-1 Q-2 Q-3 Q-4
R
5 =Me 3 SiCH 2 O; R 6 =-Me 3 SiCH 2
Q;
1031 A=(CH 2 3
R
2
+R
3
=CH
2
CH
2
R
4 =Me 3 Si(CH 2 2 0; Q-1 Q-2 Q-3 Q.-4
R
5 =Me 3 Si(CH 2 2 0- R6=-Me 3 Si(CH 2 2 0; 103? A=(CH 2 3
R
2
+R
3
-CH
2
CH
2
R
4 =MeS-, R 5 =MeS; R 6 =MeS; Q-1 Q-2 Q-3 Q-4 1033 A=(CH 2 3
R
2
+R
3
CH
2
CH
2
R
4
R
5 =Ph; R 6 =Me; Q-1 Q-2 Q-3 Q-4 1034 A=-(CH 2 3
R
2
+R
3
CH
2
CH
2
R
4 =nBu;, R 5 =nBu; R 6 =nBu;, Q-1 Q-2 Q-3 Q-4 1035 A--(CH 2 3
R
2
+R
3
-CH
2
CH
2
R
4 =Me; R 5 =Me 3 SiCH 2 Q-1 Q-2 Q-3 Q-4
R
6 =Me 3 SiCH 2 1036 A--CH 2 R7=H; R 3 =Me; R 4 =Me; R 5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 1037 A=-CH 2
R
2 =Me; R 3 =Me; R 4 -Me; R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 1038 A--CH 2
R
2 =Et; R 3
R
4 -Me* R 5 =Me; R 6 =Me; Q-1 Q-2 Q-3 Q-4 1039 A=-CH 2
R
2
+R
3
=-CH
2
CH
2
R
4 =Me; R 5 =Me, R 6 =Me, Q-1 Q-2 Q-3 Q-4 1040 A--CH 2
R
2
+R
3 =-CH(Me)CH 2
R
4
R
5 =Me; R 6 Q-1 Q-2 Q-3 Q-4 ii F;1 1 WO 95/21846 PCIT/US95/0116 53 Formulation/Utility Compounds of this invention will generally be used in formulation with an agriculturally suitable carrier comprising a liquid or solid diluent. Useful formulations include dusts, granules, baits, pellets, solutions, suspensions, emulsions, wettable powders, emulsifiable concentrates, dry flowables and the like, consistent with the physical properties of the active ingredient, mode of application and environmental factors such as soil type, moisture and temperature. Sprayable formulations can be extended in suitable media and used at spray volumes from about one to several hundred liters per hectare. High strength compositions are primarily used as intermediates for further formulation. The formulations will typically contain effective amounts of active ingredient, diluent and surfactant within the following approximate ranges which add up 100 weight percent.
Weight Percent Ingrdiient Diluent Surfactant Wettable Powders 5-90 0-74 1-10 Oil Suspensions, Emulsions, 5-50 40-95 0-15 Solutions, (including Emulsifiable Concentrates) Dusts 1-25 70-99 Granules, Baits and Pellets 0.01-99 5-99,99 0-15 High Strength Compositions 90-99 0-10 0-2 Typical solid diluents are described in Watkins, et al., Handbook of Insecticide Dust Diluents and Carriers, 2nd Ed., Dorland Books, Caldwell, New Jersey. Typical liquid diluents and solvents are described in Marsden, Solvents Guide, 2nd Ed., Interscience, New York, 1950. McCutcheon's Detergents and Emulsifiers Annual, Allured Publ. Corp., Ridgewood, New Jersey, as well as Sisely and Wood, Encyclopedia of Surface Active Agents, Chemical Publ. Co., Inc., New York, 1964, list surfactants and recommended uses. All formulations can contain minor amounts of additives to reduce foam, caking, corrosion, microbiological growth, and the like.
Solutions are prepared by simply mixing the ingredients. Fine solid compositions are made by blending and, usually, grinding as in a hammer mill or fluid energy mill.
Water-dispersible granules can be produced by agglomerating a fine powder composition; see for example, Cross et al., Pesticide Formulations, Washington, D.C., 1988, pp 251-259. Suspensions are prepared by wet-milling; see, for example, U.S. 3,060,084. Granules and pellets can be made by spraying the active material upon preformed granular carriers or by agglomeration techniques. See Browning, I IC -Is WO 95/21846 PCT/US95/01616 54 "Agglomeration", Chemical Engineering, December 4, 1967, pp 147-148, Perry's Chemical Engineer's Handbook, 4th Ed., McGraw-Hill, New York, 1963, pages 8-57 and following, and WO 91/13546.
For further information regarding the art of formulation, see U.S. 3,235,361, Col. 6, line 16 through Col. 7, line 19 and Examples 10-41; U.S. 3,309,192, Col. ine 43 through Col. 7, line 62 and Examples 8, 12, 15, 39, 41, 52, 53, 58, 132, 138 -140, 162-164, 166, 167 and 169-182; U.S. 2,891,855, Col. 3, line 66 through Col. 5, line 17 and Examples 1-4; Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, pp 81-96; and Hance et al., Weed Control Handbook, 8th Ed., Blackwell Scientific Publications, Oxford, 1989.
In the following Examples, all percentages are by weight and all formulations are prepared in conventional ways. Compound numbers refer to compounds in Index Table A.
Example A Wettable Powder Compound 1 65.0% dodecylphenol polyethylene glycol ether sodium ligninsulfonate sodium silicoaluminate montmorillonite (calcined) 23.0%.
Example B Granule Compound 1 10.0% attapulgite granules (low volatile matter, 0.71/0.30 mm; U.S.S. No.
25-50 sieves) 90.0%.
Example C Extruded Pellet Compound 1 25.0% anhydrous sodium sulfate 10.0% crude calcium ligninsulfonate sodium alkylnaphthalenesulfonate calcium/magnesium bentonite 59.0%.
Example D Emulsifiable Concentrate Compound 1 20.0% blend of oil soluble sulfonates and polyoxyethylene ethers 10.0% isophorone 70.0%.
I ii Il P- WO 95/21846 PCTUS95/01616 The compounds of this invention exhibit activity against a wide spectrum of foliar-feeding, fruit-feeding, stem or root feeding, seed-feeding, aquatic and soil-inhabiting arthropods (term "arthropods" includes insects, mites and nematodes) which are pests of growing and stored agronomic crops, forestry, greenhouse crops, ornamentals, nursery crops, stored food and fiber products, livestock, household, and public and animal health. Those skilled in the art will appreciate that not all compounds are equally effective against all growth stages of all pests. Nevertheless, all of the compounds of this invention display activity against pests that include: eggs, larvae and adults of the Order Lepidoptera; eggs, foliar-feeding, fruit-feeding, root-feeding, seed-feeding larvae and adults of the Order Coleoptera; eggs, immatures and adults of the Orders Hemiptera and Homoptera; eggs, larvae, nymphs and adults of the Order Acari; eggs, immatures and adults of the Orders Thysanoptera, Orthoptera and Dermaptera; eggs, immatures and adults of the Order Diptera; and eggs, junveniles and adults of the Phylum Nematoda. The compounds of this invention are also active against pests of the Orders Hymenoptera, Isoptera, Siphonaptera, Blattaria, Thysanura and Psocoptera; pests belonging to the Class Arachnida and Phylum Platyhelminthes..
Specifically, the compounds are active against southern corn rootworm (Diabrotica undecimpunctata howardi), aster leafhopper (Mascrostelesfascifrons), boll weevil (Anthonomus grandis), two-spotted spider mite (Tetranychus urticae), fall armyworm (Spodopterafrugiperda), black bean aphid (Aphisfabae), green peach aphid (Myzus persica), cotton aphid (Aphis gossypii), Russian wheat aphid (Diuraphis noxia), English grain aphid (Sitobion avenae), tobacco budworm (Heliothis virescens), rice water weevil (Lissorhoptrus oryzophilus), rice leaf beetle (Oulema oryzae), whitebacked planthopper (Sogatellafurcifera), green leafhopper (Nephotettix cincticeps), brown planthopper (Nilaparvata lugens), small brown planthopper (Laodelphax striatellus), rice stem borer (Chilo suppressalis), rice leafroller (Cnaphalocrocis medinalis), black rice stink bug (Scotinophara lurida), rice stink bug (Oebalus pugnax), rice bug (Leptocorisa chinensis), slender rice bug (Cletus puntiger), and southern green stink bug (Nezara viridula). The compounds are active on mites, demonstrating ovicidal, larvicidal and chemosterilant activity against such families as Tetranychidae including Tetranychus urticae, Tetranychus cinnabarinus, Tetranychus mcdanieli, Tetranychus pacificus, Tetranychus turkestani, Byrobia rubrioculus, Panonychus ulmi, Panonychus citri, Eotetranychus carpini borealis, Eotetranychus, hicoriae, Eotetranychus sexmaculatus, Eotetranychus yumensis, Eotetranychus banksi and Oligonychus pratensis; Tenuipalpidae including Brevipalpus lewisi, Brevipalpus phoenicis, Brevipalpus californicus and Brevipalpus obovatus; Eriophyidae including Phyllocoptruta oleivora, Eriophyes sheldoni, Aculus cornutus, Epitrimerus pyri and Eriophyes mangiferae. See WO 90/10623 and WO 92/00673 for more detailed pest descriptions.
II
WO 95/21846 PCTIUS95/01616 56 Compounds of this invention can also be mixed with one or more other insecticides, fungicides, nematocides, bactericides, acaricides, growth regulators, chemosterilants, semiochemicals, repellants, attractants, pheromones, feeding stimulants or other biologically active compounds to form a multi-component pesticide giving an even broader spectrum of agricultural protection. Examples of other agricultural protectants with which compounds of this invention can be formulated are: insecticides such as avermectin B, monocrotophos, carbofuran, tetrachlorvinphos, malathion, parathion-methyl, methomyl, chlordimeform, diazinon, deltamethrin, oxamyl, fenvalerate, esfenvalerate, permethrin, profenofos, sulprofos, triflumuron, diflubenzuron, methoprene, buprofezin, thiodicarb, acephate, azinphosmethyl, chlorpyrifos, dimethoate, fipronil, flufenprox, fonophos, isofenphos, methidathion, minetha-midophos, phosmet, phosphamidon, phosalone, pirimicarb, phorate, terbufos, trichlorfon, methoxychlor, bifenthrin, biphenate, cyfluthrin, tefluthrin, fenpropathrin, fluvalinate, flucythrinate, tralomethrin, imidacloprid, metaldehyde and rotenone; fungicides such as carbendazim, thiuram, dodine, maneb, chloroneb, benomyl, cymoxanil, fenpropidine, fenpropimorph, triadimefon, captan, thiophanate-methyl, thiabendazole, phosethyl-Al, chlorothalonil, dichloran, metalaxyl, captafol, iprodione, oxadixyl, vinclozolin, kasugamycin, myclobutanil, tebuconazole, difenoconazole, diniconazole, fluquinconazole, ipconazole, metconazole, penconazole, propiconazole, uniconzole, flutriafol, prochloraz, pyrifenox, fenarimol, triadimenol, diclobutrazol, copper oxychloride, furalaxyl, folpet, flusilazol, blasticidin S, diclomezine, edifenphos, isoprothiolane, iprobenfos, mepronil, neo-asozin, pencycuron, probenazole, pyroquilon, tricyclazole, validamycin, and flutolanil; nematocides such as aldoxycarb, fenamiphos and fosthietan; bactericides such as oxytetracyline, streptomycin and tribasic copper sulfate; acaricides such as binapacryl, oxythioquinox, chlorobenzilate, dicofol, dienochlor, cyhexatin, hexythiazox, amitraz, propargite, tebufenpyrad and fenbutatin oxide; and biological agents such as entomopathogenic bacteria, virus and fungi.
In certain instances, combinations with other arthropodicides having a similiar spectrum of control but a different mode of action will be particularly advantageous for resistance management.
Arthropod pests are controlled and protection of agronomic, horticultural and specialty crops, animal and human health is achieved by applying one or more of the compounds of this invention, in an effective amount, to the environment of the pests including the agronomic and/or nonagronomic locus of infestation, to the area to be protected, or directly on the pests to be controlled. Thus, the present invention further comprises a method for the control of foliar and soil inhabiting arthropods and nematode pests and protection of agronomic and/or nonagronomic crops, comprising applying one or more of the compounds of Formula I, or compositions containing at least one such compound, in an effective amount, to the environment of the pests IL ll I I WO 95/21846 PCTIUS95101616 57 including the agronomic and/or nonagronomic locus of infestation, to the area to be protected, or directly on the pests to be controlled. A preferred method of application is by spraying. Alternatively, granular formulations of these compounds can be applied to the plant foliage or the soil. Other methods of application include direct and residual sprays, aerial sprays, seed coats, microencapsulations, systemic uptake, baits, eartags, boluses, foggers, fumigants, aerosols, dusts and many others. The compounds can be incorporated into baits that are consumed by the arthropods or in devices such as traps and the like.
The compounds of this invention can be applied in their pure state, but most often application will be of a formulation comprising one or more compounds with suitable carriers, diluents, and surfactants and possibly in combination with a food depending on the contemplated end use. A preferred method of application involves spraying a water dispersion or refined oil solution of the compounds. Combinations with spray oils, spray oil concentrations, spreader stickers, adjuvants, and synergists and other solvents such as piperonyl butoxide often enhance compound efficacy.
The rate of application required for effective control will depend on such factors as the species of arthropod to be controlled, the pest's life cycle, life stage, its size, location, time of year, host crop or animal, feeding behavior, mating behavior, ambient moisture, temperature, and the like. Under normal circumstances, application rates of about 0.01 to 2 kg of active ingredient per hectare are sufficient to control pests in agronomic ecosystems, but as little as 0.001 kg/hectare may be sufficient or as much as 8 kg hectare may be required. For nonagronomic applications, effective use rates will range from about 1.0 to 50 mg/square meter but as little as 0.1 mg/square meter may be sufficient or as much as 150 mg/square meter may be required.
The following TESTS demonstrate the control efficacy of compounds of this invention on specific pests. "Control efficacy" represents inhibition of arthropod development (including mortality) that causes significantly reduced feeding. The pest control protection afforded by the compounds is not limited, however, to these species, See Index Tables A-E for compound descriptions.
Index Table A R0 2 N SiMe 3 I I
R
2
R
3 ~CT~e -PPT sr~l WO 95121846 WO 9521846PCTIUS95101616 Cmpd R__ 3-CH 2 -6-CI-pyr 3-CH 2 -6-Cl-pyr 3-CH 2 -6-CI-pyr 2 -2-CI-thiazolyl 2 -2-CI-thiazolyl MeSCH 2
CH
2 MeSCHICH 2 3-CH 2 -pyr 3-CH 2 -pyr 3-CH 2 -5,6-iC-pyr 3-CH 2 -6-Cl-pyr 2 -3-Me-isoxazolyl R2+ R 3
-CH(CH
3
)CH
2 (b)
-CH(CH
3
)CH
2 (b)
-CH
2
CH-
2
-CH
2
CH
2
-CH(CH
3
)CH
2
-CH
2
CH
2
CH(CH
3
)CH
2 (b)
-CH
2
CH
2
-CH(CH
3
)CH
2
-CH
2
CH
2
-CH
2
CH
2 M.P. (TC) 112-115 145- 147 145.5-147.0 148-151 133-137 105-107 oil 158.5-160.0 155.0-156.5 162.5-164.0 89-93 116-118 config (a) racemic
R
achiral achiral racemic achiral racemic achiral racemic achiral achiral achiral Cnipd 13 3-CH 2 -6-CI-pyr
M.P.(OC
oil config (a) achiral Configuration refers to the configuration at the chiral carbon. The "R" designation is defined according to the Cahn, Ingold and Prelog procedure.
"Racemic" is defined as a substantially equal mixture of both R and S enantiomers.
"Achiral" denotes compounds which do not contain a chiral center.
CH carbon atom is attached to the nitrogen atom which contains R 1 Index Table B cmad 14 16 17 18 19
A
(CH
2 3
(CH
2 3
(CH
2 3
(CH
2 4
(CH
2 3
BR
4 EtO MeO EtO EtO EtO Ph EtO MeO EtO Eta EtO me DtO MeO Me Me EtO Me 140-142 87-90 112-114 97-98 138-140 147-149 config (a) achiral achiral achiral achiral ra~eniC achiral WO 95/21846 WO 9521846PCTIUS95IOI616
CH
2
CH
2
(CH
2 3
(CH
2 3
(CH
2 3
(CH
2 3
(CH
2 3 oil oil 81-85 133-136 152-153 148-150 144-149 racemidc
R
racemic achiral achiral achiral achiral Configuration refers to the configuration at the chiral carbon. The tIR" designation is defined according to the Cahm, Ingold and Prelog procedure. "Raceic" is defined as a substantially equal mixture of both R and S enantiomers. Achiral denotes compounds which do not contain a chiral center.
The following additional notations have been used to represent various embodiments of Q in Table C: Q-1 6-CI-3-pyridyl, Q-2 5,6-dichloro-3-pyridyl, Q-3 2-chloro-5-tii:azolyl and Q-5 CH 3
SCH
2 Index Table C 27 28 29 31 32 33 (a) (b) -Q R Q-3 H Q-1 H Q-5 Me(a) Q-1 H Q-1 Me(b) Q-2 H Q-2 H Racemric R-enantiomer
A
CH
2
(CH
2 3
CH
2
CH
2
CH
2 oil 104-106 oil 152.5-154.0 108-1 134-141 98-104 WO 95/21846 PCT/US95/01616 Index Tabk D 02N R4 Cmpdl- R6A 34 3-CH 2 -6-CI-pyr- CH 2 Si Et Me Me 115-117 3-CH 2 -6-CI-pyr CH 2 Si Ph Me Me oil Index Table E IH NMR (CDCII) DATA (a) Crnpd. No.
7 4.47-4.36 4.02 3.90-3,73 (ni,4H), 3.49 (dt, 1H), 3.22 (dd,1H), 2.82-2.68 2.12 2.08 (ABq,2H), 1.39 0. 10 (OH).
13 8.30 7.69 (dd,1H), 7.32 4.50 4.18 (d,1H), 3.60-3.40 3.32-3.21 2.99 1.97 (s,211), 1.19 t,3H), 0. 10 (s,9H).
(300 MHz) 8.31 7.78 (dd,1H), 7.50 (dd,2H), 7.40-7.32 (m,3H), 7.30 5.08 4.65 3.9-3.65 3.18 (t,1H), 2.83 (dd,1H), 2.19 (ABq,2H), 1.19 0.39 0.35 (s,3H).
21 (300 MHz) 8.32 (d,1IH), 7.79 (dd, 1H), 7.52 (dd,2H), 7.42-7.35 (m,3H), 7.30 5.07 4.66 3.9-3.65 3.17 (t,1H), 2.83 (dd,1H), 2.19 (ABq,2H), 1.19 0.39 0.35 (s,3H).
22 (300 MHz) 8.30 7.80 7.50-7.40 7.40-7.30 7.30 5.00 4.75 3.90-3.65 (m,6H), 3.20-3. 10 (m,1IH), 2.40-2.30 1.60-1.45 1.24 (d,3H), 0.80-0.70 0.28 (s,6H).
26 8.35 7.85 7.60 7.55-7.50 7.43-7.35 4.79 3.84 3.78 3.51 2.5 (t,2H), 1.80-1.65 1.45-1.35 (m,2H).
27 (300 MHz) 7.52 (dd,2H), 7.45 7.42-7.35 4.93 (s,2H), 3.81 3.78 3.54 (distorted t,2H), 3.14 (distorted t,2H), 2.28 0.38 (s,6H).
I
WO 95/21846 PCT/US95/01616 61 29 (300 MHz) 7.57 (dd,2H), 7.39 4.40 3.93-3.82 (m,4H) 3.72 3.45 3.34 2.85 .8-2.6 (m,2H), 2.35 (ABq,2H), 2.10 1.31 0.40 0.36 (s,3H).
32 (300 MHz) 8.26 8.07 4.85 3.91 3.78 3.63 2.07 0.96 0.58 0.09 (s,6H).
33 (300 MHz) 8.27 8.05 7.55 7.40 4.82 3.82 3.79 3.46 3.15 (distorted t,2H), 2.31 0.40 (s,6H).
8.30 7.64 (apparent d,lH), 7.54 7.38 7.31 4.59 (br s,2H), 3.72 3.27 3.11 2.17 1.97 0.39 (s,6H).
Unless indicated otherwise, spectra were obtained in CDC13 at 400MHz.
Chemical shift values are relative to Me 4 Si 0.O0ppm. s singlet, d doublet, t triplet, q quartet, m multiplet.
TEST A Fall Armyworm Test units, each consisting of a H.I.S. (high impact styrene) tray with 16 cells were prepared. Wet filter paper and approximately 8 cm 2 of lima bean leaf was placed into twelve of the cells. A 0.5 cm layer of whett germ diet was placed into the four remaining cells. Fifteen to twenty third-instar larvae of fall armyworm (Spodoptera frugiperda) were placed into a 230 mL (8 ounce) plastic cup. Solutions of each of the test compounds in 75/25 acetone/distilled water solvent were sprayed into the tray and cup. Spraying was accomplished by passing the tray and cup on a conveyer belt directly beneath a flat fan hydraulic nozzle which discharged the spray at a rate of 0.55 kg of active ingredient per hectare (about 0.5 pounds per acre) at 207 kPa (30 The insects were transferred from the 230 mL cup to the H.I.S. tray (one insect per cell).
The trays were covered and held at 27 0 C and 50% relative humidity for 48 h, after which time readings were taken on the twelve cells with lima bean leaves. Of the compounds tested, the following gave control efficacy levels of 80% or greater: 1, 2, 3, 6, 14*, 19*, 27*, 28*, 29*, 30*, 31* and 27*.
tested at 0.14 kg/ha.
TEST B Southern Corn Rootworm Test units, each consisting of a 230 mL (8 ounce) plastic cup containing a 2.54 cm 2 plug (1 square inch) of a wheatgerm diet, were prepared. The test units were sprayed as described in TEST A with individual solutions of the test compounds. After the spray on the cups had dried, five second-instar larvae of the southern corn L -II I ~Jr __1 WO 95/21846 PCT/US95/01616 62 rootworm (Diabrotica undecimpunctata howardi) were placed into each cup. The cups were held at 27 0 C and 50% relative humidity for 48 h, after which time mortality readings were taken. Of the compounds tested, the following gave control efficacy levels of 80% or greater: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 13, 14*, 15*, 16*, 20*, 21*, 22*, 24*, 26*, 27*, 28*, 30*, 32* and 34*.
tested at 0.14 kg/ha.
TEST C Aster Leafhopper Test units were prepared from a series of 350 mL (12 ounce) cups, each containing oat (Avena sativa) seedlings in a 2.54 cm (1 inch) layer of sterilized soil. The test units were sprayed as described in TEST A with individual solutions of the test compounds.
After the oats had dried from the spraying, 10 to 15 adult aster leafhoppers (Mascrostelesfascifrons) were aspirated into each of the cups. The cups were covered with vented lids and held at 27 0 C and 50% relative humidity for 48 h, after which time mortality readings were taken. Of the compounds tested, the following gave mortality levels of 80% or higher: 1, 2, 3, 4, 5, 6, 7, 10, 11, 13, 14* and 16*, 19*, 20*, 21*, 23*, 24*, 25*, 26*, 27*, 28*, 29*, 30*, 31*, 32* and 34*.
tested at 0.14 kg/ha.
TEST D Boll Weevil Test units consisting of 260 mL (9 ounce) cups containing five adult boll weevils (Anthonomus grandis grandis) were prepared. The test units were sprayed as described in TEST A with individual solutions of the test compounds. Each cup was covered with a vented lid and held at 27 0 C and 50% relative humidity for 48 h, after which time mortality readings were taken. Of the compounds tested, the following gave mortality levels of 80% or higher: 2, 3, 4, 5, 6, 7, 10 and 16*.
tested at 0.14 kg/ha.
TEST E Black Bean Aphid Individual nasturtium leaves were infested with 10 to 15 aphids (all morphs and growth stages of Aphisfabae) and sprayed with their undersides facing up as described in TEST A. The leaves were then set in 0.94 cm (3/8 inch) diameter vials containing 4 mL of sugar solution (approximately 1.4 g per liter) and covered with a clear plastic 29 mL (1 ounce) cup to prevent escape of the aphids that drop from the leaves. The test units were held at 27 0 C and 50% relative humidity for 48 hours, after which time mortality readings were taken. Of the compounds tested, the following gave mortality levels of 80% or higher: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 13, 14*, 15* and 16*, 19*, 21*, 22*, 23*, 24*, 25*, 26*, 28*, 29*, 30*, 31*, 32* and 34*.
tested at 0.14 kg/ha.
L ~L -LI ~plp~W WO 95/21846 PCT/US95/01616 63 TEST F Contact Activity Against Green Leafhopper Nymphs Three rice (Oryza sativa) seedlings, 1.5 leaf stage and about 10 cm tall were transplanted into a 14 mL (1/2 ounce) plastic cup containing Kumiai Brown artificial soil. Seven milliliters of distilled water were then added to the cup. The test chemical was prepared by first dissolving the chemical in acetone and then adding water to produce a final test concentration of 75:25 (acetone:water). Four plastic cups, each cup serving as a replicate, were then placed on a spray chamber turntable. The cups were sprayed for 45 seconds with 50 mL of the chemical solution at a pressure of 2.0 kg/cm 2 with air atomizing spray nozzles. The turntable completes 7.5 rotations during the second spray interval. After chemical application, the treated cups were held in a vented enclosure to dry for about 2 h. After drying, the cups were placed into conical shaped test units and the surface of the soil covered with 2 to 3 mm of quartz sand.
Eight to ten 3rd-instar nymphs of the green leafhopper (Nephotettix cincticeps) were transferred into the test units using an aspirator. The test units were held at 27°C and relative humidity. Counts of the number of live and dead nymphs were taken at 24 and 48 h post-infestation. Insects which cannot walk are classified as dead. Of the compounds tested, the following gave mortality levels of 80% or higher at 48 h at an application rate equivalent to 0.05 kilograms per hectare: 1, 2, 3 4, 5, 6, 7 and 8.
TEST G Contact Activity Against Brown Planthopper Nymphs Three rice (Oryza sativa) seedlings, 1.5 leaf stage and about 10 cm tall were transplanted into a 14 mL (1/2 ounce) plastic cup containing Kumiai Brown artificial soil. Seven milliliters of distilled water was then added to the cup. The test chemical was prepared by first dissolving the chemical in acetone and then adding water to produce a final test concentration of 75:25 (acetone:water). Four plastic cups, each cup serving as a replicate, were then placed on a spray chamber turntable. The cups were sprayed for 45 seconds with 50 mL of the chemical solution at a pressure of 2.0 kg/cm 2 with air atomizing spray nozzles. The turntable completes 7.5 rotations during the 45 second spray interval. After chemical application, treated cups were held in a vented enclosure to dry for about 2 h. After drying, the cups were placed into conical shaped test units and the surface of the soil covered with 2 to 3 mm of quartz sand. Eight to ten 3rd-instar nymphs of the brown planthopper (Nilaparvata lugens) were then transferred into the test units using an aspirator. The test units were held at 27 0 C and 65% relative humidity. Counts of the number of live and dead nymphs are taken at 24 and 48 h post-infestation. Insects which cannot walk are classified as dead. Of the compounds tested, the following gave mortality levels of 80% or higher at 48 h at an application rate equivalent to 0.05 kilograms per hectare: 1, 2, 3, 4, 5, 6, 7, 8 and 9.
I 1 1
Claims (8)
1. A compound of the formula 16 R R RL__GjN/A R2 R 3 I wherein X is selected from the group Si and Ge; A is selected from the group C I -C 20 alkylene, C 2 -C 20 alkenylene, C 2 -C 20 alkynylene, C 3 -C 8 cycloalkylene, C 7 -C 10 aralkylene and phenylene, each group optionally substituted with 1-3 substituents independently selected from W; or A is a direct bond; R 1 and R 3 are independently selected from the group H, C I -C 10 alkyl, C 2 -C 10 alkenyl or C 2 -C 1 0 alkynyl, each group optionally substituted with 1-2 substituents independently selected from the group halogen, CN, C(O)R 7 C(S)R 7 NO 2 OH, SC(O)R 7 SC(S)R 7 OC(O)R 7 OC(S)R 7 NR 8 C(O)R 7 NR 8 C(S)R 7 SH, Si(R 8 C 1 -C 4 alkoxy, CI-C 4 haloalkoxy, C 1 -C 4 alkylthio, C 1 -C 4 alkylamino, C 2 -C 8 dialkylamino, C 3 -C 8 cycloalkyl and phenyl optionally substituted with 1-3 substituents independently selected from W 1 C 3 -C 8 cycloalkyl optionally substituted with 1-3 substituents independently selected from the group halogen, CI-C 2 alkyl and C 1 -C 2 haloalkyl; C(O)R 1 1; C(S)R 1 1; phenyl optionally substituted with 1-3 substituents independently selected from W 1 C 1 -C 3 alkyl substituted with a or 6-membered aromatic ring, attached through carbon or nitrogen, containing 1 to 4 heteroatoms independently selected from the group 0-4 nitrogen, 0-1 oxygen, and 0-1 sulfur, the ring optionally substituted with 1-3 substituents independently selected from W 1 and a 5- or 6-membered aromatic ring, attached through carbon or nitrogen, containing 1 to 4 heteroatoms independently selected from the group 0-4 nitrogen, 0-1 oxygen, and 0-1 sulfur, the ring optionally substituted with 1-3 substituents independently selected from W 1 R 2 is selected from the group H, CI-C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 6 alkenyl, C 2 -C 6 haloalkenyl, C 2 -C 6 alkynyl, C 2 -C 6 haloalkynyl, C 3 -C 7 cycloalkyl, C 3 -C 7 halocycloalkyl and C4-C 7 cycloalkylalkyl, each group optionally substituted with 1-3 substituents independently selected from W; or II -LIB WO 95/21846 PCT/US95/01616 R 2 and R 3 can be taken together as CH 2 CH 2 and CH 2 CH 2 CH 2 each group optionally substituted with 1-2 CH 3 R 4 is selected from the group H and C 3 -C 6 trialkylsilyl; or R 4 is selected from the group C 1 -CIO alkyl, C 2 -C 10 alkenyl, C 2 -Co 10 alkynyl, C 1 -CO 10 alkoxy, CI-CIO alkylthio, phenyl, phenoxy, phenylthio and naphihyl, each group optionally substituted with 1-3 substituents independently selected from WI; R 5 and R 6 are independently selected from the group CI-C 10 alkyl, C 2 -C 10 alkenyl, C 2 -CIO alkyny, C 1 -CO 10 alkoxy, C 1 -Cl 0 alkylthio, phenyl, phenoxy, phenylthio and naphthyl, each group optionally substituted with 1-3 substituents independently selected from W 1 OH; and C 3 -C 6 trialkylsilyl; R 7 is selected from the group H, NH 2 OH, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 1 -C 6 alkylthio, Cl-C 4 alkylamino, C 2 -C 8 dialkylamino and phenyl optionally substituted with 1-3 substituents independently selected from W 1 R 8 is H; or R 8 is selected from the group C 1 -CIO alkyl, C 2 -CO 10 alkenyl, C 2 -C 1 0 alkynyl, Cl-CO 10 alkoxy, phenoxy, phenyl and naphthyl, each group optionally substituted with 1-3 substituents independently selected from W 1 R 9 and R 10 are independently selected from the group C 1 -CO 10 alkyl, C 2 -C 1 0 alkenyl, C 2 -C 10 alkynyl, C 1 -C 10 alkoxy, phenoxy, phenyl and naphthyl, each group optionally substituted with 1-3 substituents independently selected from W 1 and OH; R 1 is selected from the group H, NH 1 OH, CI-C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, CI-C 2 alkylthio, CI-C 4 alkylamnino, C 2 -C 8 dialkylamino and phenyl optionally substituted with 1-3 substituents independently selected from W 1 W is selected from the group halogen, CN, NO 2 OH, C 1 -C 6 aikyl, C 1 -C 6 haloalkyl, C 1 -C 6 alkoxy and CI-C 6 haloalkoxy; and W 1 is selected from the group halogen, CN, NOZ 2 C-C 2 alkyl, CI-C 2 haloalkyl, CI-C 2 alkoxy, C 1 -C 2 haloalkoxy, C 1 -C 2 alkylthio, C 1 -C 2 haloalkylthio, C 1 -C alkylsulfonyl, C -C 2 haloalkylsulfonyl, C 1 -C 4 alkylamino, C2-C 8 dialkylamino and C 3 -C 6 trialkylsilyl.
2. A compound according to Claim 1 wherein: A is C 1 -C 6 alkylene; R 1 is C 1 -C 3 alkyl substituted with a 5- or 6-membered aromatic ring, attached through carbon or nitrogen, containing 1 to 4 heteroatoms independently selected from the group 0-4 nitrogen, 0-1 oxygen, and 0-1 sulfur, the ring optionally substituted with 1-3 substituents independently selected from W 1 r~l~l _qC 7i- WO 95/21846 PCT/US95/0 i 616 66 R 4 is selected from the group C 1 -C 1 o alkyl and phenyl, each group optionally substituted with 1-3 substituents independently selected from W 1 R 5 and R 6 are independently selected from the group CI-C 10 alkyl and phenyl, each group optionally substituted with 1-3 substituents independently selected from W 1 and W 1 is selected from the group halogen and C 1 -C 2 haloalkyl.
3. A compound according to Claim 2 wherein: X is Si; R 1 is CH 2 substituted with pyridyl, thiazole or isoxazole, the ring optionally substituted with 1-2 halogen or 1-2 methyl; R 2 and R 3 are taken together as CH 2 CH 2 or CH 2 CH 2 CH 2 each group optionally substituted with 1-2 CH 3 and R 4 R 5 and R 6 are C 1 -C 3 alkyl, CI-C 3 alkoxy and phenyl.
4. A compound according to Claim 2 wherein: X is Si; R 1 is CH 2 substituted with pyridyl, thiazole or isoxazole, the ring optionally substituted with 1-2 halogen; R 2 is selected from the group H and CI-C 3 alkyl; and R 4 R 5 and R 6 are C 1 -C 3 alkyl, CI-C 3 alkoxy and phenyl. A compound according to Claim 3 which is: 1-[(6-chloro-3-pyridinyl)methyl]- 1,2,3,5,6,7-hexahydro-2-methyl-8- nitro-6-[(trimethylsilyl)methyl]imidazo[ 1,2-c]pyrimidine.
6. A compound according to Claim 3 which is: 1-[(6-chloro-3-pyridinyl)methyl]- 1,2,3,5,6,7-hexahydro-8-nitro- 6-[(trimethylsilyl)methyl]imidazo[1,2-c]pyrimidine.
7. An arthropodicidal composition comprising an arthropodicidally effective amount of a compound according to Claim 1 and a carrier therefor.
8. A method for controlling arthropods comprising contacting the arthropods or their environment with an arthropodicidally effective amount of a compound according to Claim 1. i -'IF i INTERNATIONAL SEARCH REPORT I Application No Inton nal Application No PCT/US 95/01616 A. CLASSIFICATION OF SUBJECT MATTER IPC 6 C07F7/08 C07F7/30 A01N55/00 According to International Patent Classification (IPC) or to both natonal classification and IPC B. FIELDS SEARCHED Minimum documentation searched (classification system followed by classification symbols) IPC 6 C07F A01N Documentation searched other than minimum documentation to the extent that such documents are included in the fields searched Electronic data base consulted during the international search (name of data base and, where practical, search terms used) C. DOCUMENTS CONSIDERED TO BE RELEVANT Category Citaton of document, with indication, where appropriate, of the relevant passages Relevant to claim No. A EP,A,O 247 477 (BAYER AG) 2 December 1987 1 see the whole document US,A,4 831 036 (WOLF, H. ET AL.) 16 May 1989 cited in the application O Further documents are listed in the continuation of box C. j Patent family members are listed in annex. Special categories of cited documents: T' later document published alter the mtemational filing date Sdocument dein the eral state of the art whch ior priority date and not in conflict with the aplication but A n document defining the general stat e of th art which s notted to understand the principle or theory underlying the considered to be of particular relevance invention earlier document but published on or after the international X document or particular relevance; the claimed invention filing date cannot be considered novel or cannot be considered to document which may throw doubts on pnonty claim(s) or involve an inventive step when the document is taken alone which is ated to establish the publication date of another document of particular relevance; the claimed invention citation or other special reason (as specified) cannot be considered to involve an inventive step when the O0' document referring to an oral disclosure, use, exhibition or document is combined with one or more other such docu- other means ments, such combination being obvious to a person sdlled document published pnor to the international filing date but in the art. later than the pnority date claimed document member of the same patent family Date of the actual completion of the international search Date of mailing of the international search report 18 April 1995
24. 05.95 Name and mailing address of the ISA Authorzed officer European Patent Office, P.B. 5818 Patentlaan 2 NL 2280 HV Rijswilk Tel (+31-70) 340-2040, Tx. 31 651 ponl, Rinkel Fax 3170) 340-3016 ne, L Form PCT/ISAS/2I (secend shoet (July IY)] ~c I INTERNATIONAL SEARCH REPORT' Fn ul Application No IPCT/US 95/01616 Patent document I Publication IPatent family Publication cited in search report date member(s) f dame EP-A-0247477 02-12-87 DE-A- 3638121 03-12-87 AU-B- 597375 3 1-05-90 AU-A- 7368187 10-12-87 JP-A- 62292765 19-12-87 US-A- 4831036 16-05-89 US-A-4831036 16-05-89 DE-A- 3638121 03-12-87 AU-B- 597375 31-05-90 AU-A- 7368187 10-12-87 EP-A,B 0247477 02-12-87 JP-A- 62292765 19-12-87 IL Form PCr/ISA/21 0 (psCOL family annax) (July 1992)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19421494A | 1994-02-09 | 1994-02-09 | |
US194214 | 1994-02-09 | ||
US27859794A | 1994-07-21 | 1994-07-21 | |
US278597 | 1994-07-21 | ||
PCT/US1995/001616 WO1995021846A1 (en) | 1994-02-09 | 1995-02-09 | Arthropodicidal tetrahydropyrimidines |
Publications (2)
Publication Number | Publication Date |
---|---|
AU1913495A AU1913495A (en) | 1995-08-29 |
AU679350B2 true AU679350B2 (en) | 1997-06-26 |
Family
ID=26889795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU19134/95A Ceased AU679350B2 (en) | 1994-02-09 | 1995-02-09 | Arthropodicidal tetrahydropyrimidines |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0743947A1 (en) |
JP (1) | JPH09507676A (en) |
CN (1) | CN1140452A (en) |
AU (1) | AU679350B2 (en) |
BR (1) | BR9506960A (en) |
HU (1) | HUT76814A (en) |
IL (1) | IL112577A0 (en) |
MX (1) | MX9603273A (en) |
PL (1) | PL315813A1 (en) |
WO (1) | WO1995021846A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6828275B2 (en) | 1998-06-23 | 2004-12-07 | Bayer Aktiengesellschaft | Synergistic insecticide mixtures |
JP2012102088A (en) * | 2010-10-14 | 2012-05-31 | Sumitomo Chemical Co Ltd | Heteroaromatic ring compound and use thereof for pest control |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4831036A (en) * | 1986-05-30 | 1989-05-16 | Bayer Aktiengesellschaft | 1,2,3,6-tetrahydro-5-nitro-pyrimidine derivatives |
-
1995
- 1995-02-08 IL IL11257795A patent/IL112577A0/en unknown
- 1995-02-09 MX MX9603273A patent/MX9603273A/en unknown
- 1995-02-09 JP JP7521314A patent/JPH09507676A/en active Pending
- 1995-02-09 HU HU9602186A patent/HUT76814A/en unknown
- 1995-02-09 BR BR9506960A patent/BR9506960A/en not_active Application Discontinuation
- 1995-02-09 WO PCT/US1995/001616 patent/WO1995021846A1/en not_active Application Discontinuation
- 1995-02-09 CN CN95191561.4A patent/CN1140452A/en active Pending
- 1995-02-09 PL PL95315813A patent/PL315813A1/en unknown
- 1995-02-09 EP EP95911641A patent/EP0743947A1/en not_active Withdrawn
- 1995-02-09 AU AU19134/95A patent/AU679350B2/en not_active Ceased
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4831036A (en) * | 1986-05-30 | 1989-05-16 | Bayer Aktiengesellschaft | 1,2,3,6-tetrahydro-5-nitro-pyrimidine derivatives |
Also Published As
Publication number | Publication date |
---|---|
HU9602186D0 (en) | 1996-10-28 |
MX9603273A (en) | 1997-03-29 |
CN1140452A (en) | 1997-01-15 |
EP0743947A1 (en) | 1996-11-27 |
WO1995021846A1 (en) | 1995-08-17 |
PL315813A1 (en) | 1996-12-09 |
IL112577A0 (en) | 1995-05-26 |
AU1913495A (en) | 1995-08-29 |
HUT76814A (en) | 1997-11-28 |
JPH09507676A (en) | 1997-08-05 |
BR9506960A (en) | 1997-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1995003306A1 (en) | Arthropodicidal azacyclic heterocycles | |
WO1995007278A1 (en) | Fungicidal, miticidal and arthropodicidal aminopyrimidines | |
EP0712394B1 (en) | Arthropodicidal oxazolines and thiazolines | |
EP0944314A1 (en) | Methyl substituted fungicides and arthropodicides | |
WO1999031072A1 (en) | Cyclohexylamine arthropodicides and fungicides | |
EP0737188B1 (en) | Arthropodicidal oxadiazine carboxanilides | |
WO1993022291A1 (en) | Arthropodicidal and fungicidal aminopyrimidines | |
EP0646111B1 (en) | Arthropodicidal oxazolines and thiazolines | |
WO1997011057A1 (en) | Arthropodicidal 1,4-dihydropyridines and 1,4-dihydropyrimidines | |
EP0869963A1 (en) | Arthropodicidal and fungicidal organosilanes and organogermanes | |
AU679350B2 (en) | Arthropodicidal tetrahydropyrimidines | |
WO1995019972A1 (en) | Arthropodicidal 2-oxa and thia-zolines | |
WO1993021160A1 (en) | Arthropodicidal pyrazole sulfonates | |
WO1997005145A1 (en) | Arthropodicidal tetrahydropyrimidines | |
WO1997013773A1 (en) | Arthropodicidal oxazolines and thiazolines | |
WO1994008954A1 (en) | Arthropodicidal semicarbazones | |
WO1996033180A1 (en) | Oxazoline and thiazoline arthropodicides | |
US5767281A (en) | Arthropodicidal oxazolines and thiazolines | |
WO1995016676A1 (en) | Arthropodicidal pentafluorothio substituted anilides | |
WO1994008976A1 (en) | Fungicidal and miticidal aminopyrimidines | |
WO1997005146A1 (en) | Arthropodicidal nitromethylenes | |
WO1995000491A1 (en) | Arthropodicidal sulfonates | |
CA2143625A1 (en) | Arthropodicidal tetrahydropyrimidines | |
WO1994012491A1 (en) | Arthropodicidal nitroethylene diamines | |
EP0637302A1 (en) | Arthropodicidal oxa- and thia-zolines |